Document:

Exhibit

Exhibit 10.1

AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN 
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

Private & Confidential (Addressee Only)

{EMPNAME}
 
{EMPNUM}

We are pleased to advise you (the “Participant”) that Analog Devices, Inc., a Massachusetts corporation (the “Company”), has granted to the Participant that number of Performance Restricted Stock Units (“Performance RSUs”) set forth below, subject to the terms and conditions of the Analog Devices, Inc. Amended and Restated 2006 Stock Incentive Plan (the “Plan”) and this Performance Restricted Stock Unit Agreement, including Appendix A, which includes additional performance-based vesting conditions, and Appendix B, which includes any applicable country-specific provisions.  This Performance Restricted Stock Unit Agreement, together with Appendix A and Appendix B, is referred to as the “Agreement.”  The grant of Performance RSUs reflects the Company’s confidence in the Participant’s commitment and contributions to the success and continued growth of the Company.  All terms not defined in this Agreement shall have the meaning set forth in the Plan. 
		
	1.
	Performance Restricted Stock Unit.

Subject to the terms and conditions of the Plan and this Agreement, the Company has granted to the Participant that number of Performance RSUs (the “Award”) effective on the Date of Grant set forth below:
Date of Grant:      {GRANTDATE}
Number of Performance RSUs (“Initial Grant Number”):    {PERFSHARESGRANTED}
Vesting Date:      {PERFVESTDATE}
Each one (1) Performance RSU shall, if and when it vests in accordance with this Agreement, automatically convert into one (1) share of common stock, US$0.16 2/3 par value, of the Company (“Common Stock”) issuable as provided below.  The Performance RSUs are subject to the vesting provisions set forth in Section 2 (including any performance-based vesting conditions set forth in Appendix A), the restrictions on transfer set forth in Section 3, and the right of the Company to retain Shares (as defined below) pursuant to Section 7.  If this Award is granted to a Covered Employee, the Award is intended to constitute “qualified performance-based compensation” within the meaning of Section 162(m) of the Code and the Treasury Regulations thereunder, and to the extent applicable, shall be construed accordingly.
		
	2.
	Vesting and Conversion.

		
	(a)
	Subject to the terms of the Plan and this Agreement, the Performance RSUs shall vest in accordance with the vesting conditions set forth in Section 1 and the performance-based vesting conditions set forth in Appendix A.  For purposes of this Agreement, Performance RSUs that have not vested as of the Vesting Date in accordance with this Section 2(a) and Appendix A are referred to as “Unvested Performance RSUs.”  The shares of Common Stock that are issuable upon the vesting and conversion of the Performance RSUs are referred to in this Agreement as “Shares.”  As soon as administratively practicable after the issuance of any Shares upon the vesting and conversion of Performance RSUs, and subject to the terms and conditions set forth in the Agreement, the Company shall deliver or cause to be delivered evidence (which may include a book entry by the Company’s transfer agent) of the Shares so issued in the name of the Participant to the brokerage firm designated by the Company to maintain the brokerage account established for the Participant or the Participant’s heirs, in the case of Section 2(c).Notwithstanding the foregoing, the Company shall not be obligated to issue Shares to or in the name of the Participant upon the vesting and conversion of any Performance RSUs unless the issuance of such Shares shall comply with all relevant provisions of law and other legal requirements including, without limitation, any applicable securities laws and the requirements of any stock exchange upon which shares of Common Stock may then be listed.

		
	(b)
	In the event the Participant’s employment with the Company or the Employer (as defined in Section 2(e)) is terminated either by the Participant, the Company, or the Employer for any reason or no reason (other than due to death or the Participant becoming Disabled, as defined in Section 2(d)), then in each such case, all of the Unvested Performance RSUs as of the date of termination shall terminate and be canceled immediately and automatically and the Participant shall have no further rights with respect to such Unvested Performance RSUs.

		
	(c)
	In the event of the Participant’s death prior to the end of the Performance Period, the Unvested Performance RSUs shall vest immediately upon death with respect to the Initial Grant Number of Shares underlying the Performance RSUs, notwithstanding that the Participant was not employed as of the Vesting Date.  In the event of the Participant’s death after the end of the Performance Period, the Unvested Performance RSUs shall vest with respect to the number of Shares underlying the Performance RSUs that would have vested in accordance with Appendix A had the Participant continued employment through the Vesting Date had he or she not died. 

1

		
	(d)
	In the event the Participant becomes Disabled prior to the end of the Performance Period, the Unvested Performance RSUs shall vest immediately as of the date the Participant is determined to be Disabled with respect to the Initial Grant Number of Shares underlying the Performance RSUs, regardless of whether the Participant terminates employment prior to the Vesting Date.  In the event the Participant becomes Disabled after the end of the Performance Period, the Unvested Performance RSUs shall vest with respect to the number of Shares underlying the Performance RSUs that would have vested in accordance with Appendix regardless of whether the Participant continues employment through the Vesting Date.  “Disabled” with respect to the Participant means, when and if, as a result of disease, injury or mental disorder, the Participant is incapable of engaging in regular service or occupation with the Company or the Employer (as defined in Section 2(e)) which has lasted or can be expected to last for a continuous period of not less than 12 months, as determined by the Company.

		
	(e)
	For purposes of this Agreement, employment shall include being an employee with the Company.  Employment shall also include being an employee with any direct or indirect parent or subsidiary of the Company, or any successor to the Company or any such parent or subsidiary of the Company (the “Employer”).  Should a Participant transfer employment to become a director, consultant or advisor to the Company or the Employer following the Date of Grant, he or she will still be considered employed for vesting purposes until he or she ceases to provide services to the Company or any direct or indirect parent or subsidiary of the Company, or any successor to the Company or any such parent or subsidiary of the Company.

		
	3.
	Restrictions on Transfer.

		
	(a)
	The Participant shall not sell, assign, transfer, pledge or otherwise encumber any Performance RSUs, either voluntarily or by operation of law.

		
	(b)
	The Company shall not be required (i) to transfer on its books any of the Performance RSUs which have been transferred in violation of any of the provisions set forth herein or (ii) to treat as the owner of such Performance RSUs any transferee to whom such Performance RSUs have been transferred in violation of any of the provisions contained herein.

		
	4.
	Not a Shareholder.  The Performance RSUs represent an unfunded, unsecured promise by the Company to deliver Shares upon vesting and conversion of the Performance RSUs, and until vesting of the Performance RSUs and issuance of the Shares, the Participant shall not have any of the rights of a shareholder with respect to the Shares underlying the Performance RSUs.  For the avoidance of doubt, the Participant shall have no right to receive any dividends and shall have no voting rights with respect to the Shares underlying the Performance RSUs for which the record date is on or before the date on which the Shares underlying the Performance RSUs are issued to the Participant.

		
	5.
	Provisions of the Plan.  The Performance RSUs and Shares, including the grant and issuance thereof, are subject to the provisions of the Plan.  A copy of the Plan prospectus is available on the Company’s Intranet at https://thecircuit.web.analog.com/Pages/CircuitHome.aspx.  (From Circuit home page, click Knowledge Centers, HR, Employee Stock Programs.  The related documents can be found in the right-hand column.)  If the Participant is unable to access this information via the Intranet, the Company’s or the Participant’s regional stock plan administrator can provide the Participant with copies. 

		
	6.
	Withholding Taxes.

		
	(a)
	Regardless of any action the Company and/or the Employer, if different, takes with respect to any or all income tax (including U.S. federal, state and local taxes and/or non-U.S. taxes), social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related withholding (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax-Related Items legally applicable to the Participant is and remains the Participant’s responsibility and may exceed the amount actually withheld by the Company or the Employer.  The Participant further acknowledges that the Company and the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Performance RSUs, including the grant of the Performance RSUs, the vesting of the Performance RSUs, the subsequent sale of any Shares acquired pursuant to the Performance RSUs and the receipt of any dividends; and (ii) do not commit to structure the terms of the grant or any aspect of the Performance RSUs to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular tax result.  Further, if the Participant becomes subject to Tax-Related Items in more than one jurisdiction between the Date of Grant and the date of any relevant taxable or tax withholding event, as applicable, the Participant acknowledges that the Company and/or the Employer may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

		
	(b)
	Prior to any relevant taxable or tax withholding event, as applicable, the Participant will pay or make adequate arrangements satisfactory to the Company to satisfy all Tax-Related Items.  In this regard, the Participant authorizes the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the methods set forth below:

		
	(i)
	the Company may withhold a sufficient number of whole Shares otherwise issuable upon the vesting of the Performance RSUs that have an aggregate Fair Market Value sufficient to pay the minimum Tax-Related Items required to be withheld with respect 

2

to the Shares.  The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items (determined by reference to the closing price of the Common Stock on the NASDAQ Global Select Market on the applicable vesting date); or
		
	(ii)
	the Company may, in its discretion, withhold any amount necessary to pay the Tax-Related Items from the Participant’s salary or other amounts payable to the Participant; or

		
	(iii)
	the Company may withhold from proceeds of the sale of Shares either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant’s behalf pursuant to this authorization);

provided, however, that if the Participant is a Section 16 officer of the Company under the Exchange Act, then the Company will withhold a sufficient number of whole Shares otherwise issuable upon the vesting of the Performance RSUs pursuant to (i) above, unless the use of such withholding method is problematic under applicable tax or securities law or has materially adverse accounting consequences, in which case, the obligation for Tax-Related Items will be satisfied pursuant to (iii).
The Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case the Participant may receive a refund of any over-withheld amount in cash and will not be entitled to the equivalent amount in Shares.  If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, the Participant is deemed to have been issued the full number of Shares subject to the vested Performance RSU, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.
In the event the withholding requirements are not satisfied through the withholding of Shares or through the Participant’s salary or other amounts payable to the Participant, no Shares will be issued upon vesting of the Performance RSUs unless and until satisfactory arrangements (as determined by the Compensation Committee of the Board)  have been made by the Participant with respect to the payment of any Tax-Related Items which the Company and/or the Employer determine, in each of its sole discretion, must be withheld or collected with respect to such Performance RSUs.  No fractional Shares will be withheld or issued pursuant to the grant of the Performance RSUs and the issuance of Shares hereunder.  By accepting this grant of Performance RSUs, the Participant expressly consents to the withholding of Shares and/or cash as provided for hereunder.  All other Tax-Related Items related to the Performance RSUs and any Shares delivered in payment thereof are the Participant’s sole responsibility.
		
	7.
	Option of Company to Deliver Cash.  Notwithstanding any of the other provisions of this Agreement, and except as set forth in Appendix B, where share settlement is otherwise prohibited under local law or may present adverse tax consequences to the Participant, at the time the Performance RSUs vest, the Company may elect, in the sole discretion of the Compensation Committee of the Board, to deliver by wire transfer to the Participant in lieu of Shares an equivalent amount of cash (determined by reference to the closing price of the Common Stock on the NASDAQ Global Select Market on the applicable vesting date).  If the Company elects to deliver cash to the Participant, the Company is authorized to retain such amount as is sufficient in the opinion of the Company to satisfy the Tax-Related Items withholding obligations of the Company pursuant to Section 6 herein. 

		
	8.
	Data Privacy.  The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of personal data set forth in this Agreement and any other RSU grant materials by and among, as applicable, the Employer, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan.

The Participant understands that the Company and the Employer may hold certain personal information about him/her, including, without limitation, the Participant’s name, home address, email address and telephone number, date of birth, social insurance number, passport or other identification number, salary, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan. 
The Participant understands that Data will be transferred to Fidelity (or one of its subsidiaries) or such other stock plan service provider as may be selected by the Committee in the future (any such entity, “Broker”), which is assisting the Company with the implementation, administration and management of the Plan.  Participant understands that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country.  The Participant understands that, if he or she resides outside the United States, he or she may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local human resources representative.  The Participant authorizes the Company, the Broker and any other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the participation of Participant and other participants in the Plan.  The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the 

3

Participant’s participation in the Plan.  The Participant understands that he or she may, at any time, view Data, request information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local human resources representative.  Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, his or her employment status or service with the Employer will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant the RSUs or other equity awards to the Participant or administer or maintain such awards.  Therefore, Participant understands that refusing or withdrawing the Participant’s consent will not affect the Participant’s employment status or service with the Employer; the only consequence of refusing or withdrawing consent is it affects the Participant’s ability to participate in the Plan.  For more information on the consequences of a refusal to consent or withdrawal of consent, the Participant may contact his or her local human resources representative.
		
	9.
	Repatriation and Other Legal Requirements.  The Participant agrees as a condition of the grant of the Performance RSUs, as applicable, to repatriate all payments attributable to the Shares and/or cash acquired under the Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Shares acquired pursuant to the Performance RSUs) in accordance with all foreign exchange rules and regulations applicable to the Participant.  In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with all laws, rules and regulations applicable to the Participant.  Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under all laws, rules and regulations applicable to the Participant.

		
	10.
	Miscellaneous.

		
	(a)
	No Rights to Employment.  The grant of the Performance RSUs shall not confer upon the Participant any right to continue in the employ of the Company or the Employer, nor limit in any way the right of the Company or the Employer to terminate the Participant’s employment at any time.  Except in the event the Participant becomes Disabled or termination of employment due to death, the vesting of the Performance RSUs pursuant to Section 2 and Appendix A, is earned only by satisfaction of the performance-based vesting conditions and continuing service as an employee at the will of the Company or the Employer through the Vesting Date (not through the act of being hired or engaged or being granted the Performance RSUs hereunder). 

		
	(b)
	Discretionary Nature.  The Participant acknowledges and agrees that the Plan is discretionary in nature and may be amended, canceled, or terminated by the Company at any time, to the extent permitted under the Plan.  The Participant’s participation in the Plan is voluntary.  The grant of the Performance RSUs under the Plan is a one-time benefit and does not create any contractual or other right to receive a grant of Performance RSUs or any other award under the Plan or other benefits in lieu thereof in the future.  Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions.  Any amendment, modification or termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Participant’s employment with the Company or the Employer.  The Performance RSUs and income from such Performance RSUs shall not be included in any calculation of severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.  The Performance RSUs should in no event be considered as compensation for, or relating in any way to, past services for the Company or the Employer.

		
	(c)
	Exclusion from Termination Indemnities and Other Benefits.  This Section 10(c) applies if the Participant resides outside the U.S.:  The value of the Performance RSUs and any other awards granted under the Plan is an extraordinary item of compensation outside the scope of the Participant’s employment with the Company or the Employer (and the Participant’s employment contract, if any).  Any grant under the Plan, including the grant of the Performance RSUs and the income and value of same, is not part of normal or expected compensation or salary.  Further, the Performance RSUs and the Shares, and the income and value of same, are not intended to replace any pension rights or compensation.

		
	(d)
	No Entitlement.  This Section 10(d) applies if the Participant resides outside the U.S. and/or the Company is not the Participant's employer:  In consideration of the grant of Performance RSUs, no claim or entitlement to compensation or damages shall arise from forfeiture of the Performance RSUs resulting from termination of the Participant’s employment with the Company or the Employer (regardless of the reason for such termination and whether or not later to be found invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment contract, if any) and the Participant irrevocably releases the Company from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, the Participant shall be deemed irrevocably to have waived the Participant’s entitlement to pursue such claim.

		
	(e)
	Exchange Rates.  This Section 10(e) applies if the Participant resides outside the U.S.:  The Participant acknowledges and agrees that neither the Company nor the Employer shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United States Dollar that may affect the value of the Performance RSUs or of any amounts due to the Participant pursuant to the vesting and settlement of the Performance RSUs or the subsequent sale of any Shares.

4

		
	(f)
	Future Value of Shares.  The future value of the underlying Shares is unknown, indeterminable, and cannot be predicted with certainty.

		
	(g)
	Severability.  The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.

		
	(h)
	Binding Effect.  This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and his or her respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 3 of this Agreement.

		
	(i)
	Notice.  Each notice relating to this Award shall be in writing (which shall include electronic form) and delivered in person, electronically or by first class mail, postage prepaid, to the address as hereinafter provided.  Each notice shall be deemed to have been given on the date it is received.  Each notice to the Company shall be addressed to it at its offices at Analog Devices, Inc., One Technology Way, Norwood, Massachusetts, 02062, Attention:  Chief Financial Officer.  Each notice to the Participant shall be addressed to the Participant at the Participant’s last known mailing or email address, as applicable, on the records of the Company.

		
	(j)
	Pronouns.  Whenever the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns and pronouns shall include the plural, and vice versa.

		
	(k)
	Entire Agreement.  This Agreement and the Plan constitute the entire understanding between the parties, and supersede all prior agreements and understandings, relating to the subject matter of these documents.

		
	(l)
	Governing Law.  This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the Commonwealth of Massachusetts without regard to any applicable conflicts of laws. 

		
	(m)
	Compliance with Laws.  Notwithstanding any other provision of the Plan or this Agreement, unless there is an available exemption from any registration, qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares prior to the completion of any registration or qualification of the Shares under any local, state, federal or foreign securities or exchange control law or under rulings or regulations of the U.S. Securities and Exchange Commission (“SEC”) or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any local, state, federal or foreign governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable.  The Participant understands that the Company is under no obligation to register or qualify the Shares with the SEC or any state or foreign securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Shares.  The Participant also understands and agrees that the Awards granted under the Plan, including the Performance RSUs and the underlying Shares, are subject to the listing standards of any national securities exchange or association on which the Company's securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act, and any SEC regulations, as now or hereafter in effect. Further, the Participant agrees that the Company shall have unilateral authority to amend the Plan and the Agreement without the Participant’s consent to the extent necessary to comply with securities or other laws applicable to issuance of Shares. 

		
	(n)
	Interpretation.  The interpretation and construction of any terms or conditions of this Agreement or the Plan, or other matters related to the Plan, by the Compensation Committee of the Board shall be final and conclusive.

		
	(o)
	Participant’s Acceptance.  The Participant is urged to read this Agreement carefully and to consult with his or her own legal counsel regarding the terms and consequences of this Agreement and the legal and binding effect of this Agreement.  By virtue of his or her acceptance of this Award, the Participant is deemed to have accepted and agreed to all of the terms and conditions of this Agreement and the provisions of the Plan.

		
	(p)
	Electronic Delivery.  The Company may, in its sole discretion, decide to deliver any documents related to the Performance RSUs or other awards granted to the Participant under the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

		
	(q)
	English Language.  The Participant acknowledges and agrees that it is the Participant’s express intent that this Agreement, the Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Performance RSUs, be drawn up in English.  If the Participant has received this Agreement, the Plan or any other documents related to the Performance RSUs translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version shall control.

5

		
	(r)
	Appendix B.  Notwithstanding any provisions herein to the contrary, if the Participant transfers the Participant’s residence and/or employment to a country other than the United States, the Performance RSUs shall be subject to any special terms and conditions for such country as may be set forth in Appendix B to this Agreement.  Moreover, if the Participant relocates to one of the countries included in Appendix B, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.  Appendix B constitutes part of this Agreement.

		
	(s)
	Additional Requirements.  The Company reserves the right to impose other requirements on the Performance RSUs, any Shares acquired pursuant to the Performance RSUs, and the Participant’s participation in the Plan, to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable for legal or administrative reasons.  Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

		
	(t)
	Private Placement.  The Company has submitted filings in the United States in connection with the stock incentive plan under which this Award was made.  The Company has not submitted any registration statement, prospectus or other filings with other local securities authorities (unless otherwise required under such local law), and the grant of the Award is not intended to be a public offering of securities in any other jurisdiction or subject to the supervision of other local securities authorities.

		
	(u)
	Changes in Capitalization.  In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any non-cash distribution to holders of Common Stock, the number of Performance RSUs, and Shares issuable upon vesting and conversion thereof, shall be appropriately adjusted in such manner as shall be determined by the Compensation Committee of the Board.

		
	(v)
	No Advice Regarding Grant.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of Shares.  The Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

		
	(w)
	Insider Trading Restrictions/Market Abuse Laws.  The Participant acknowledges that, depending on his or her country of residence, the Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect Participant’s ability to, directly or indirectly, acquire, sell, or attempt to sell Shares or rights to Shares under the Plan during such times as Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions or the Participant’s country).  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  The Participant acknowledges that it is his or her responsibility to comply with any applicable restrictions, and the Participant is advised to speak to his or her personal advisor on this matter.

		
	(x)
	Foreign Asset/Account, Exchange Control, and Tax Reporting.  Depending on the Participant’s country, the Participant may be subject to foreign asset/account, exchange control and/or tax reporting requirements as a result of the vesting of the Performance RSUs, the acquisition, holding, and/or transfer of Shares or cash resulting from participation in the Plan and/or the opening and maintenance of a brokerage or bank account in connection with the Plan.  The Participant may be required to report such assets, accounts, account balances and values and/or related transactions to the applicable authorities in his or her country.  The Participant acknowledges that he or she is responsible for ensuring compliance with any applicable foreign asset/account, exchange control and tax reporting requirements.  The Participant further understands that he or she should consult the Participant’s personal legal advisor on these matters.

		
	(y)
	Waiver.  The Participant acknowledges that a waiver by the Company or breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant or any other participant.

	
		
	s
	V

        Ray Stata    Vincent Roche
        Chairman of the Board    President & Chief Executive Officer

6

APPENDIX A TO
AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN 
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

		
	1.
	Performance Period.  The twelve-month period beginning on the first day of the third quarter of the Company’s fiscal year 2019 and ending on the last day of the second quarter of the Company’s fiscal year 2020 (the “Performance Period”).    

		
	2.
	Vesting Date. {PERFVESTDATE}.

		
	3.
	Certification Date:  The date the Compensation Committee of the Board certifies in writing, in accordance with the requirements of Section 162(m) of the Code, the level of attainment of the Operating Profit Goal (as defined below).  The Certification Date shall be a date as soon as possible following the end of the Performance Period but prior to the Vesting Date.

		
	4.
	Performance-Based Vesting Terms.  

		
	(a)
	Except as otherwise provided in Sections 2(c) and 2(d) of the Agreement, if, and only if, the attainment of the Operating Profit Goal is certified by the Compensation Committee of the Board, a number of Performance RSUs subject to the Award equal to 120% of the Initial Grant Number shall vest, subject to (i) the Participant’s continued employment through the Vesting Date and (ii) any reduction to the number of Performance RSUs subject to the Award that would otherwise be eligible to vest if the Operating Profit Goal has been certified to be attained, as determined in the sole discretion of the Compensation Committee of the Board pursuant to Section 4(b) of this Appendix A.  If the Compensation Committee of the Board, on or before the Vesting Date, fails to certify whether the Operating Profit Goal was attained or determines that the Operating Profit Goal was not attained, the Award shall be forfeited in its entirety, and there will be no settlement of Shares related to such Award, without regard to whether the Net Synergy Performance Goal or LTC Cumulative Revenue Performance Goal (each, as defined below) may be considered to be attained. 

		
	(b)
	The Compensation Committee of the Board may, in its sole discretion, reduce (but not increase) the number of Performance RSUs subject to the Award (that would otherwise vest if the Operating Profit Goal were certified to be attained) based on the achievement of the Net Synergy Performance Goal and the LTC Cumulative Revenue Goal.  A number of Performance RSUs equal to 50% of the Performance RSUs that vest based on the attainment of the Operating Profit Goal may be reduced based on the attainment level of the Net Synergy Performance Goal (the “Synergy Goal-Related RSUs”).  A number of Performance RSUs equal to 50% of the Performance RSUs that vest based on the attainment of the Operating Profit Goal may be reduced based on the attainment level of the LTC Cumulative Revenue Performance Goal (the “LTC Revenue Goal-Related RSUs”).

		
	(c)
	The “Net Synergy Performance Goal” shall mean the amount of synergies achieved with respect to the combined cost of goods sold (“COGS”) and operating expenses, calculated on a net basis, resulting from the Company’s acquisition of Linear Technology Corporation (“LTC”), as measured by subtracting the difference between (i) the sum of (A) COGS and operating expenses of the Company for the fourth quarter of the Company’s fiscal year 2016 (determined on an annualized basis), plus (B) COGS and operating expenses of LTC for the second quarter of LTC’s fiscal year 2017 (determined on an annualized basis), minus (ii) COGS and operating expenses of the Company for the first quarter of the Company’s fiscal year 2019 (determined on an annualized basis), the attainment of which shall be calculated by the Company and approved by the Compensation Committee of the Board with such adjustments as may be determined in the sole discretion of the Compensation Committee of the Board.  The table below, which sets forth the number of Performance RSUs that may be determined to be eligible to vest based on the attainment level of the Net Synergy Performance Goal (equal to the product of the number of Synergy Goal-Related RSUs, multiplied by the Attainment Percentage set forth on the left column of the below table), shall serve as a guideline for the Compensation Committee of the Board with respect to its exercise of negative discretion in determining the actual number of Performance RSUs that shall actually vest:

	
		
	Attainment Percentage of  
Synergy Goal-Related RSUs
	Net Synergy Performance Goal Achieved
(amounts in millions)

	0%
	Less than $120M

	80%
	$120M

	100%
	$150M

	120%
	Equal to or Greater than $180M

The Attainment Percentage set forth on the left column of the above table shall be calculated based on linear interpolation among the attainment levels set forth in the table and will be rounded to the nearest whole percentage point.  

APPENDIX A - 1
VERSION 5/17

		
	(d)
	The “LTC Cumulative Revenue Goal” shall mean the range of goals approved by the Compensation Committee of the Board in connection with the granting of the Award relating to the cumulative revenue generated by LTC, on a stand-alone basis during the period commencing on the first day of the third quarter of the Company’s fiscal year 2017 and ending on the last day of the second quarter of the Company’s fiscal year 2020, the attainment of which shall be calculated by the Company and approved by the Compensation Committee of the Board with such adjustments as may be determined in the sole discretion of the Compensation Committee of the Board. The number of Performance RSUs that may be determined to be eligible to vest based on the attainment level of the LTC Cumulative Revenue Performance Goal shall be equal to the product of the number of LTC Revenue Goal-Related RSUs, multiplied by the attainment percentage of the LTC Cumulative Revenue Performance Goal, which shall serve as a guideline for the Compensation Committee of the Board with respect to its exercise of negative discretion in determining the actual number of Performance RSUs that shall actually vest.

		
	(e)
	Notwithstanding anything to the contrary herein, the Compensation Committee of the Board may exercise its negative discretion to adjust the performance goals herein in a manner that would result in a decrease to the number of the Performance RSUs that would otherwise vest based on the attainment of the Net Synergy Performance Goal or Operating Profit Goal.   

		
	(f)
	“Operating Profit Goal” shall mean Non-GAAP Operating Profit Before Taxes for the Performance Period as a percentage of Revenue equal to or exceeding a percentage approved by the Compensation Committee of the Board in connection with the granting of the Award.

		
	(g)
	“Revenue” shall mean “Revenue,” as reported by the Company in its earnings press release furnished to the Securities and Exchange Commission (“SEC”), which shall be determined in accordance with GAAP, as adjusted to exclude the revenue generated from one-time licensing and the financial accounting impact of acquisition-related adjustments, including conforming the acquired entity’s revenue policies to Company revenue policies.

		
	(h)
	“Non-GAAP Operating Profit Before Taxes” means Operating Profit Before Taxes, as reported by the Company in its earnings press release furnished to the SEC, which shall be  determined in accordance with GAAP, as adjusted to exclude the financial accounting impact of the following items: (1) revenue generated from one-time licensing, (2) stock-based compensation expense, (3) gains arising from litigation (including, without limitation, gains arising from any settlements), (4) impairments resulting from investments, (5) impairments resulting from goodwill and intangible assets, (6) gains or losses from sales of investments, (7) gains or losses from sale of product lines or businesses, (8) impairments resulting from fixed assets, (9) transaction costs resulting from acquisitions, (10) adjustments to Revenue resulting from acquisitions, and (11) the following expenses related to acquisitions: fair value adjustments to inventory, property, plant and equipment; amortization of acquisition-related intangibles; the fair value adjustment associated with the replacement of share-based awards, as adjusted pursuant to Section 4(f) of Appendix A.

		
	(i)
	Non-GAAP Operating Profit Before Taxes shall be adjusted (without duplicating exclusions that were applied in determining Non-GAAP Operating Profit Before Taxes before the following adjustments) to exclude the financial accounting impact of (i)  unusual, nonrecurring or infrequent occurring events, (ii) gains or losses resulting from the dispositions of discontinued operations; (iii) the cumulative effects of changes in accounting principles; (iv) the write-down of assets; (v) stock-based compensation expense; and (vi) charges for restructuring and rationalization programs.

  

2

APPENDIX B TO
AMENDED AND RESTATED 2006 STOCK INCENTIVE PLAN 
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT

This Appendix B includes additional terms and conditions that govern the Performance RSUs granted to the Participant if the Participant resides in one of the countries listed herein.  These terms and conditions are in addition to, or, if so indicated, in place of, the terms and conditions set forth in the Agreement.  Capitalized terms used but not defined in this Appendix B shall have the meanings set forth in the Plan and/or the Agreement.

This Appendix B also includes certain issues of which the Participant should be aware with respect to his or her participation in the Plan.  The information is based on the securities, exchange control, income tax and other laws in effect in the respective countries as of May 2017.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that the Participant not rely on the information noted herein as the only source of information relating to the consequences of participation in the Plan because the information may be out of date when the Performance RSUs vest or Shares acquired under the Plan subsequently are sold.

In addition, the information is general in nature and may not apply to the Participant’s particular situation, and the Company is not in a position to assure the Participant of any particular result.  Therefore, the Participant is advised to seek appropriate professional advice as to how the relevant laws in the Participant’s country may apply to his or her situation.

Finally, the Participant understands that if he or she is a citizen or resident of a country other than the one in which the Participant is currently working, transfers employment after the Date of Grant, or is considered a resident of another country for local law purposes, the information contained herein may not apply to the Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.

IRELAND

Exclusion from Termination Indemnities and Other Benefits.  This provision supplements Section 10(b) of the Agreement: 
By accepting the Performance RSUs, the Participant acknowledges, understands, and agrees that the benefits received under the Plan will not be taken into account for any redundancy or unfair dismissal claim.

APPENDIX B - 1
VERSION 5/17EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
  

 
  

AGREEMENT AND PLAN OF MERGER 
 by
and among 
 ULTRA ELECTRONICS HOLDINGS PLC, 

ULTRA ELECTRONICS ANEIRA INC. 

and 
 SPARTON CORPORATION 

Dated as of July 7, 2017 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	  	Page	 
	 ARTICLE I THE MERGER
	  	 	2	 
			
	 Section 1.01.
	 	 The Merger
	  	 	2	 
	 Section 1.02.
	 	 Closing
	  	 	2	 
	 Section 1.03.
	 	 Effective Time
	  	 	2	 
	 Section 1.04.
	 	 Articles of Incorporation; Code of Regulations
	  	 	3	 
	 Section 1.05.
	 	 Directors and Officers
	  	 	3	 
		
	 ARTICLE II EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE CONSTITUENT
CORPORATIONS
	  	 	3	 
			
	 Section 2.01.
	 	 Effect on Capital Stock
	  	 	3	 
	 Section 2.02.
	 	 Treatment of Company Equity Awards
	  	 	4	 
	 Section 2.03.
	 	 Surrender of Shares
	  	 	5	 
	 Section 2.04.
	 	 Withholding Rights
	  	 	8	 
	 Section 2.05.
	 	 Dissenters’ Rights
	  	 	8	 
	 Section 2.06.
	 	 Adjustments to Prevent Dilution
	  	 	9	 
		
	 ARTICLE III REPRESENTATIONS AND WARRANTIES
	  	 	9	 
			
	 Section 3.01.
	 	 Representations and Warranties of the Company
	  	 	9	 
	 Section 3.02.
	 	 Representations and Warranties of Parent and Merger Sub
	  	 	39	 
		
	 ARTICLE IV COVENANTS RELATING TO CONDUCT OF BUSINESS
	  	 	46	 
			
	 Section 4.01.
	 	 Conduct of Business Pending the Merger
	  	 	46	 
	 Section 4.02.
	 	 Acquisition Proposals
	  	 	50	 
		
	 ARTICLE V ADDITIONAL AGREEMENTS
	  	 	54	 
			
	 Section 5.01.
	 	 Proxy Statement; Company Shareholders Meeting
	  	 	54	 
	 Section 5.02.
	 	 Parent Shareholders Meeting; Parent Shareholder Circular; Parent Adverse Recommendation
Change
	  	 	55	 
	 Section 5.03.
	 	 Filings; Other Actions; Notification
	  	 	58	 
	 Section 5.04.
	 	 Access and Reports; Confidentiality
	  	 	62	 
	 Section 5.05.
	 	 Stock Exchange Delisting
	  	 	63	 
	 Section 5.06.
	 	 Publicity
	  	 	63	 
	 Section 5.07.
	 	 Employee Matters
	  	 	63	 
	 Section 5.08.
	 	 Expenses
	  	 	65	 
	 Section 5.09.
	 	 Indemnification; Directors’ and Officers’ Insurance
	  	 	65	 
	 Section 5.10.
	 	 Rule 16b-3
	  	 	67	 
	 Section 5.11.
	 	 Written Consents, Resolutions and Other Materials
	  	 	67	 
	 Section 5.12.
	 	 Merger Sub and Surviving Corporation Compliance
	  	 	67	 
	 Section 5.13.
	 	 Takeover Statutes
	  	 	68	 
	 Section 5.14.
	 	 Control of Operations
	  	 	68	 
	 Section 5.15.
	 	 Resignation of Directors and Officers
	  	 	68	 
	 Section 5.16.
	 	 Transaction Litigation
	  	 	68	 
	 Section 5.17.
	 	 Government Contracts
	  	 	68	 

  
 i 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	Page	 
	 Section 5.18.
	 	 Notification of Certain Matters
	  	 	69	 
	 Section 5.19.
	 	 Sale of MDS
	  	 	69	 
	 Section 5.20.
	 	 Equity Financing
	  	 	71	 
	 Section 5.21.
	 	 Letters of Credit; Company Credit Facilities
	  	 	71	 
		
	 ARTICLE VI CONDITIONS
	  	 	71	 
			
	 Section 6.01.
	 	 Conditions to Each Party’s Obligation to Effect the Merger
	  	 	71	 
	 Section 6.02.
	 	 Additional Conditions to Obligations of Parent and Merger Sub
	  	 	72	 
	 Section 6.03.
	 	 Additional Conditions to Obligation of the Company
	  	 	73	 
		
	 ARTICLE VII TERMINATION
	  	 	74	 
			
	 Section 7.01.
	 	 Termination
	  	 	74	 
	 Section 7.02.
	 	 Effect of Termination and Abandonment
	  	 	76	 
	 Section 7.03.
	 	 Termination Fee
	  	 	77	 
	 Section 7.04.
	 	 Parent Termination Fee
	  	 	78	 
	 Section 7.05.
	 	 VAT
	  	 	78	 
	 Section 7.06.
	 	 Costs and Expenses
	  	 	78	 
	 Section 7.07.
	 	 Limitation
	  	 	79	 
		
	 ARTICLE VIII MISCELLANEOUS
	  	 	79	 
			
	 Section 8.01.
	 	 Non-Survival
	  	 	79	 
	 Section 8.02.
	 	 Modification or Amendment
	  	 	79	 
	 Section 8.03.
	 	 Waiver
	  	 	80	 
	 Section 8.04.
	 	 Notices
	  	 	80	 
	 Section 8.05.
	 	 Definitions
	  	 	82	 
	 Section 8.06.
	 	 Interpretation
	  	 	82	 
	 Section 8.07.
	 	 Counterparts
	  	 	83	 
	 Section 8.08.
	 	 Parties in Interest
	  	 	83	 
	 Section 8.09.
	 	 Governing Law
	  	 	83	 
	 Section 8.10.
	 	 Entire Agreement; Assignment
	  	 	84	 
	 Section 8.11.
	 	 Specific Enforcement; Consent to Jurisdiction
	  	 	84	 
	 Section 8.12.
	 	 WAIVER OF JURY TRIAL
	  	 	85	 
	 Section 8.13.
	 	 Severability
	  	 	86	 
	 Section 8.14.
	 	 Transfer Taxes
	  	 	86	 
	 Section 8.15.
	 	 Disclosure Letters
	  	 	86	 
	 Section 8.16.
	 	 Further Assurances
	  	 	86	 
		
	 Annex I
         Definitions
	  			
		
	 Exhibit A       Articles of Incorporation of the
Surviving Corporation
	  			
		
	 Exhibit B       Code of Regulations of the Surviving
Corporation
	  			

  
 ii 

 AGREEMENT AND PLAN OF MERGER 

This AGREEMENT AND PLAN OF MERGER, dated as of July 7, 2017 (this “Agreement”), is entered into by and among Ultra
Electronics Holdings plc, a company organized under the Laws of England and Wales (“Parent”), Ultra Electronics Aneira Inc., an Ohio corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”) and
Sparton Corporation, an Ohio corporation (the “Company”). 
 RECITALS 

WHEREAS, the board of directors of Parent (the “Parent Board”) has (a) determined that it is in the best interests of
Parent and the shareholders of Parent (the “Parent Shareholders”) that Parent enter into this Agreement and consummate the Merger and the other transactions contemplated by this Agreement on the terms and subject to the conditions
set forth in this Agreement, (b) approved this Agreement and the transactions contemplated by this Agreement, including the Merger, and (c) resolved, subject to the terms and conditions of this Agreement, to recommend that the Parent
Shareholders pass the Parent Shareholder Resolution to approve the transactions contemplated by this Agreement, as required by Chapter 10 of the Listing Rules; 

WHEREAS, the board of directors of the Company (the “Company Board”) has (a) determined that it is in the best
interests of the Company and the shareholders of the Company (the “Company Shareholders”) that the Company enter into this Agreement and consummate the Merger and the other transactions contemplated by this Agreement on the terms
and subject to the conditions set forth in this Agreement, (b) approved this Agreement and the transactions contemplated by this Agreement, including the Merger and (c) resolved, subject to the terms and conditions of this Agreement, to
recommend that the Company Shareholders adopt this Agreement; 
 WHEREAS, the board of directors of Merger Sub has (a) determined that
it is in the best interests of Merger Sub and the sole shareholder of Merger Sub that Merger Sub enter into this Agreement and consummate the Merger and the other transactions contemplated by this Agreement on the terms and subject to the conditions
set forth in this Agreement, (b) approved this Agreement and the transactions contemplated by this Agreement, including the Merger and (c) resolved to recommend that the sole shareholder of Merger Sub adopt this Agreement; 

WHEREAS, simultaneously with the execution and delivery of this Agreement, Parent is entering into the Placing Agreement, the net proceeds of
which are expected to be used to pay the aggregate Per Share Merger Consideration, to consummate the Merger and to pay the fees and expenses of, and any other amounts payable by, Parent, Merger Sub and the Surviving Corporation in connection with
the Equity Financing, the Merger and the other transactions contemplated by this Agreement; and 
 WHEREAS, the Company, Parent and Merger
Sub desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also to prescribe various conditions to the Merger. 

  
 1 

 NOW, THEREFORE, in consideration of the premises, and of the representations, warranties,
covenants and agreements contained in this Agreement, and intending to be legally bound hereby, the Company, Parent and Merger Sub hereby agree as follows: 

ARTICLE I 
 THE MERGER

 Section 1.01. The Merger. Upon the terms and subject to the conditions set forth in this Agreement and in accordance
with the Ohio General Corporation Law (the “OGCL”), at the Effective Time, Merger Sub shall be merged with and into the Company and the separate corporate existence of Merger Sub shall thereupon cease and the Company shall continue
as the surviving corporation (sometimes hereinafter referred to as the “Surviving Corporation”) and an indirect wholly owned Subsidiary of Parent (the “Merger”). The Merger shall have the effects set forth in this
Agreement and in the applicable provisions of the OGCL. Without limiting the generality of the foregoing and subject thereto, at the Effective Time, all of the assets, property, rights, privileges, immunities, powers, franchises and authority of the
Company and Merger Sub shall vest in the Surviving Corporation and the Surviving Corporation shall be liable for all of the obligations of the Company and Merger Sub. If, at any time after the Effective Time, the Surviving Corporation considers or
is advised that any deeds, bills of sale, assignments, assurances or any other actions or things are necessary or desirable to vest, perfect or confirm of record or otherwise in the Surviving Corporation, its full right, title, possession or
interest in, to or under any of the rights, properties, assets, privileges, powers or franchises of either of the Company or Merger Sub vested in or to be vested in the Surviving Corporation as a result of, or in connection with, the Merger or
otherwise to carry out this Agreement, the officers and directors of the Surviving Corporation will execute and deliver, in the name and on behalf of the Company, Merger Sub or the Surviving Corporation, all such deeds, bills of sale, assignments
and assurances and will take and do, in the name and on behalf of each of such corporations or otherwise, all such other actions and things as may be necessary or desirable to vest, perfect or confirm any and all right, title, possession and
interest in, to and under such rights, properties, assets, privileges, powers or franchises in the Surviving Corporation or otherwise to carry out this Agreement. 

Section 1.02. Closing. The closing for the Merger (the “Closing”) shall take place at the offices of Mayer Brown
LLP, 71 South Wacker Drive, Chicago, Illinois 60606, at 9:00 a.m., local time, on the third (3rd) Business Day following the first (1st)
day on which all of the conditions set forth in ARTICLE VI (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing) have been satisfied
or waived in accordance with this Agreement, or at such other time and place as the Company and Parent may agree in writing. The date on which the Closing occurs is referred to in this Agreement as the “Closing Date”. 

Section 1.03. Effective Time. As soon as practicable on the Closing Date, the Company and Parent will cause the Merger to become
effective by filing with the Secretary of State of the State of Ohio a certificate of merger (the “Certificate of Merger”), in such form as required by, and to be executed and filed in accordance with, the applicable provisions of
the OGCL. The Merger shall become effective at the time when the Certificate of Merger has been duly filed with the Secretary of State of the State of Ohio or at such later time as may be agreed by Parent and the Company in writing and specified in
the Certificate of Merger (the “Effective Time”). 

  
 2 

 Section 1.04. Articles of Incorporation; Code of Regulations. 

(a)    At the Effective Time, the articles of incorporation of the Surviving Corporation shall be amended
in its entirety to read as set forth on Exhibit A, and, as so amended, shall be the articles of incorporation of the Surviving Corporation until thereafter amended in accordance with the provisions thereof and applicable Law. 

(b)    At the Effective Time, the code of regulations of the Surviving Corporation shall be amended in its
entirety to read as set forth on Exhibit B and, as so amended, shall be the code of regulations of the Surviving Corporation until thereafter amended in accordance with the provisions thereof and applicable Law. 

Section 1.05. Directors and Officers. 

(a)    The Company and the Surviving Corporation shall take all necessary action (including procuring the
resignations of members of the Company Board in accordance with Section 5.15) such that, at the Effective Time, the directors of Merger Sub as of immediately prior to the Effective Time shall, from and after the Effective
Time, be the directors of the Surviving Corporation until their respective successors have been duly elected or appointed and qualified or until their earlier death, resignation or removal in accordance with the articles of incorporation and the
code of regulations of the Surviving Corporation. 
 (b)    The officers of Merger Sub as of immediately
prior to the Effective Time shall, from and after the Effective Time, be the officers of the Surviving Corporation until their respective successors have been duly elected or appointed and qualified or until their earlier death, resignation or
removal in accordance with the articles of incorporation and the code of regulations of the Surviving Corporation. 
 ARTICLE II 

EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE 

CONSTITUENT CORPORATIONS 

Section 2.01. Effect on Capital Stock. At the Effective Time, by virtue of the Merger and without any action on the part of the
Company, Parent, Merger Sub or the holders of any shares of capital stock of the Company, Parent or Merger Sub: 

(a)    Merger Consideration. Each share of common stock, par value $1.25 per share, of the Company
(including any Restricted Shares that fully vest pursuant to Section 2.02(a)) (each, a “Share”) issued and outstanding immediately prior to the Effective Time, other than (i) the Cancelled Shares,
which shall be treated in accordance with Section 2.01(b), and (ii) the Dissenting Shares, which shall be treated in accordance with Section 2.05, shall be converted into the right to receive

  
 3 

 
$23.50 per Share in cash, without interest thereon (the “Per Share Merger Consideration”). At the Effective Time, all such Shares shall cease to be outstanding, shall be
cancelled and shall cease to exist, and each such Share, whether represented by a certificate (“Certificate”) or in non-certificated form and represented by book-entry (“Book-Entry
Shares”), shall thereafter represent only the right to receive the Per Share Merger Consideration in accordance with this ARTICLE II. 

(b)    Cancellation of Cancelled Shares. Each Share that immediately prior to the Effective Time is
owned by Parent, Merger Sub or any other wholly owned Subsidiary of Parent and each Share that immediately prior to the Effective Time is owned by the Company or any wholly owned Subsidiary of the Company (including as treasury stock) (collectively,
the “Cancelled Shares”) shall at such time automatically cease to be outstanding, be cancelled without payment of any consideration therefor and cease to exist. 

(c)    Capital Stock of Merger Sub. Each common share, no par value, of Merger Sub issued and
outstanding immediately prior to the Effective Time shall be converted into and become one (1) validly issued, fully paid and nonassessable common share, no par value, of the Surviving Corporation, and all such shares when so converted shall
constitute the only outstanding shares of capital stock of the Surviving Corporation. 
 Section 2.02. Treatment of Company Equity
Awards. 
 (a)    Treatment of Restricted Stock. With respect to each Share that is subject to
any vesting, forfeiture, repurchase or other lapse restriction under any Company Equity Award Plan (each, a “Restricted Share”) and outstanding as of immediately prior to the Effective Time, such vesting, forfeiture, repurchase or
other lapse restriction shall lapse as of the Effective Time and such Restricted Share shall be fully vested and shall be converted into the right to receive the Per Share Merger Consideration as provided in
Section 2.01(a). 
 (b)    Treatment of Restricted Stock Units. At the
Effective Time, each restricted stock unit award in respect of Shares granted under a Company Equity Award Plan that is outstanding immediately prior to the Effective Time (a “Company RSU”) shall fully vest and shall be cancelled
and converted automatically into the right to receive, as soon as reasonably practicable (but no later than five (5) Business Days) after the Effective Time, from or on behalf of the Surviving Corporation, an amount in cash, without interest,
equal to the Per Share Merger Consideration in respect of each Share underlying such Company RSU. 

(c)    Treatment of Company Options. At the Effective Time, each option award in respect of Shares
granted under a Company Equity Award Plan that is outstanding immediately prior to the Effective Time (a “Company Option”), whether vested or unvested, and has an exercise price per Share that is less than the Per Share Merger
Consideration shall fully vest and shall be cancelled and converted automatically into the right to receive, as soon as reasonably practicable (but no later 

  
 4 

 
than five (5) Business Days) after the Effective Time, from or on behalf of the Surviving Corporation, an amount in cash, without interest, equal to the product of (i) the amount by
which the Per Share Merger Consideration exceeds the exercise price per Share of such Company Option and (ii) the total number of Shares subject to such Company Option. At the Effective Time, each Company Option that has an exercise price per
Share that is greater than or equal to the Per Share Merger Consideration shall cease to be outstanding, be cancelled and cease to exist and the holder of any such Company Option shall not be entitled to payment of any consideration therefor;
provided, that the Company Board has adopted resolutions whereby the Company Board has authorized such cancellation. From and after the Effective Time, there shall be no outstanding Company Options. 

(d)    Corporate Actions. Prior to the Effective Time, the Company, the Company Board and the
compensation committee of the Company Board, as applicable, shall adopt any resolutions and take any actions that are necessary to effectuate the provisions of Sections 2.02(a) through 2.02(c). Prior to the Closing, the Company shall
take all actions necessary to ensure that, from and after the Effective Time, neither Parent nor the Surviving Corporation will be required to deliver Shares or other capital stock of the Company to any Person pursuant to or in settlement of
Restricted Shares, Company RSUs, Company Options or any other awards under any Company Equity Award Plan. 

(e)    Funding. As promptly as practicable after the Effective Time, Parent shall make a cash
contribution to the Surviving Corporation in immediately available funds to permit the Surviving Corporation to make or cause to be made the payments required under Sections 2.02(b) and 2.02(c) to the extent, if any, the Surviving
Corporation does not otherwise have sufficient funds to make such payments. 
 Section 2.03. Surrender of Shares. 

(a)    Paying Agent. Prior to the Effective Time, Parent shall select a paying agent (the
“Paying Agent”) that is reasonably acceptable to the Company and enter into an agreement with such Paying Agent (the “Paying Agent Agreement”) in form and substance reasonably acceptable to the Company wherein the
Paying Agent will act as agent for the Company Shareholders in connection with the Merger and receive payment of the aggregate Per Share Merger Consideration to which the Company Shareholders shall become entitled pursuant to
Section 2.01(a). At or prior to the Effective Time, Parent shall deposit or cause to be deposited with the Paying Agent, in trust for the benefit of the holders of Shares, a cash amount in immediately available funds
sufficient in the aggregate to provide all funds necessary for the Paying Agent to make payments required pursuant to Section 2.01(a) upon due surrender of Certificates (or affidavits of loss in lieu thereof) or Book-Entry
Shares in accordance with Section 2.03(b) (such cash amount being hereinafter referred to as the “Exchange Fund”). The Paying Agent shall invest the Exchange Fund as directed by Parent; provided,
however, that such investments shall be in obligations of or guaranteed by the United States of America, in commercial paper obligations rated A-1 

  
 5 

 
or P-1 or better by Moody’s Investors Service, Inc. or Standard & Poor’s Corporation, respectively, in certificates of deposit, bank
repurchase agreements or banker’s acceptances of commercial banks with capital exceeding $1 billion, or in money market funds having a rating in the highest investment category granted by a recognized credit rating agency at the time of
acquisition or a combination of the foregoing and, in any such case, no such instrument shall have a maturity exceeding three (3) months. Subject to Section 2.03(c), to the extent that there are losses with respect to
such investments, or the Exchange Fund diminishes for other reasons below the level required to make prompt cash payment of the aggregate Per Share Merger Consideration as contemplated by Section 2.01(a), Parent shall
promptly replace or restore the cash in the Exchange Fund lost through such investments or other events so as to ensure that the Exchange Fund is at all applicable times maintained at a level sufficient to make such payments. Any interest and other
income resulting from such investment shall become a part of the Exchange Fund, and any amounts in excess of the amounts payable under Section 2.01(a) shall be promptly returned to Parent or the Surviving Corporation, as
requested by Parent. The funds deposited with the Paying Agent pursuant to this Section 2.03(a) shall not be used for any purpose other than as contemplated by this Section 2.03(a). 

(b)    Exchange Procedures. 

(i)    Transmittal Materials. Promptly after the Effective Time (and, in any event, within four
(4) Business Days thereafter), Parent shall cause the Paying Agent to mail or otherwise provide to each Person who was, as of immediately prior to the Effective Time, a holder of record of Shares (other than holders of Cancelled Shares and
Dissenting Shares) (A) transmittal materials, including a letter of transmittal, specifying that delivery of Shares shall be effected, and risk of loss and title with respect to Shares shall pass, only upon proper delivery of Certificates (or
affidavits of loss in lieu thereof) or Book-Entry Shares to the Paying Agent, such transmittal materials to be in such form and have such other provisions as Parent and the Company may reasonably agree, and (B) instructions for use in effecting
the surrender of the Certificates (or affidavits of loss in lieu thereof) or Book-Entry Shares to the Paying Agent. 

(ii)    Payment of Per Share Merger Consideration. Upon surrender of Certificates (or affidavits of
loss in lieu thereof) or Book-Entry Shares to the Paying Agent together with the transmittal materials, duly completed and validly executed in accordance with the instructions thereto, and such other documents as may reasonably be required pursuant
to such instructions or by the Paying Agent, the holder of such Certificates (or affidavits of loss in lieu thereof) or Book-Entry Shares shall be entitled to receive, and Parent shall cause the Paying Agent to pay and deliver promptly after the
Effective Time, a cash amount in immediately available funds equal to the product of (A) the number of Shares represented by such holder’s properly surrendered Certificates (or affidavits of loss in lieu thereof) and Book-Entry Shares and
(B) the Per Share Merger Consideration, without any interest thereon, and any Certificates so surrendered shall forthwith be cancelled. No interest shall be paid or accrued on any amount payable upon due surrender of Certificates (or affidavits
of loss in lieu thereof) or Book-Entry Shares. 

  
 6 

 (iii)    Unrecorded Transfers; Other Payments. In the
event of a transfer of ownership of Shares that is not registered in the transfer records of the Company or if payment of the Per Share Merger Consideration is to be made to a Person other than the Person in whose name the surrendered Certificate is
registered, a check or wire transfer for any cash to be exchanged upon due surrender of the Certificate may, in the reasonable discretion of the Paying Agent, be issued to such transferee or other Person if the Certificate formerly representing such
Shares is presented to the Paying Agent accompanied by all documents required to evidence and effect such transfer and to evidence that any applicable transfer or other similar Taxes have been paid or, to the reasonable satisfaction of Parent, are
not applicable. For the avoidance of doubt, payment of the Per Share Merger Consideration with respect to Book-Entry Shares shall only be made to the Person in whose name such Book-Entry Shares are registered. 

(iv)    Rights of Holders of Shares; Expenses. Until surrendered as contemplated by this
Section 2.03(b), each Share shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender (together with the transmittal materials, duly completed and validly executed in
accordance with the instructions thereto, and such other documents as may reasonably be required pursuant to such instructions or by the Paying Agent) the Per Share Merger Consideration as contemplated by Section 2.01(a),
except for (A) Dissenting Shares, which shall be deemed to represent the right to receive the consideration due with respect to such Dissenting Shares in accordance with Section 2.05 and to the extent provided by
Section 1701.85 of the OGCL and (B) Cancelled Shares. Parent shall pay or cause to be paid all charges and expenses of the Paying Agent set forth in the Paying Agent Agreement. 

(c)    Termination of the Exchange Fund. Any portion of the Exchange Fund (including the proceeds of
any investment thereof) that remains undistributed one (1) year after the Effective Time shall be delivered to Parent or the Surviving Corporation, upon demand by Parent. Any holders of Shares (other than Cancelled Shares or Dissenting Shares)
who have not theretofore complied with this ARTICLE II shall thereafter be entitled to look only to Parent and the Surviving Corporation for payment of the Per Share Merger Consideration upon surrender of their Certificates (or affidavits of
loss in lieu thereof) or Book-Entry Shares in accordance with the provisions set forth in Section 2.03(b), and Parent and the Surviving Corporation shall remain liable for (subject to applicable abandoned property, escheat
or other similar Law) payment of their claims for the Per Share Merger Consideration payable upon due surrender of their Certificates (or affidavits of loss in lieu thereof) or Book-Entry Shares. Notwithstanding the foregoing, none of the Surviving
Corporation, Parent, the Company, the Paying Agent or any other Person shall be liable to any Person for any amount properly delivered to a public official pursuant to applicable abandoned property, escheat or other similar Law. If any Certificate
or Book-Entry Share shall not have been surrendered prior to the date on which the related Per Share Merger 

  
 7 

 
Consideration would escheat to or become the property of any Governmental Entity, any such Per Share Merger Consideration shall, to the extent permitted by applicable Law, immediately prior to
such time become the property of Parent, free and clear of all claims or interest of any Person previously entitled thereto. 

(d)    Transfers. From and after the Effective Time, the stock transfer books of the Company shall
be closed and there shall be no transfers on the stock transfer books of the Company of the Shares that were outstanding immediately prior to the Effective Time. If, after the Effective Time, acceptable evidence of a Certificate (or affidavit of
loss in lieu thereof) or Book-Entry Share (other than a Certificate (or affidavit of loss in lieu thereof) or Book-Entry Share in respect of Dissenting Shares) is presented to the Surviving Corporation, Parent or the Paying Agent for transfer, the
holder of such Shares shall be given a copy of the transmittal materials referred to in Section 2.03(b)(i) and instructed to comply with the instructions thereto in order to receive the cash amount to which such holder is
entitled pursuant to Section 2.01(a). 
 (e)    Lost Certificates. In
the case of any Certificate that has been lost, stolen or destroyed, upon (i) the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Paying Agent, Surviving
Corporation or Parent, the posting by such Person of a bond in a reasonable amount as the Paying Agent, Surviving Corporation or Parent may direct as indemnity against any claim that may be made against it with respect to such Certificate and
(ii) delivery of the other materials provided for in Section 2.03(b)(ii), the Paying Agent shall pay and deliver promptly after the Effective Time in exchange for such Certificate a cash amount in immediately available
funds equal to the product of (A) the number of Shares represented by such lost, stolen or destroyed Certificate and (B) the Per Share Merger Consideration, without any interest thereon. 

Section 2.04. Withholding Rights. Notwithstanding anything in this Agreement to the contrary, each of the Paying Agent, Parent
and the Surviving Corporation shall be entitled to deduct and withhold, or cause to be deducted or withheld, from the consideration otherwise payable pursuant to this Agreement to any holder of Shares, Restricted Shares, Company RSUs or Company
Options such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any other applicable state, local or foreign Tax Law, taking into account any applicable exemption under such Law. To the
extent that amounts are so withheld by the Paying Agent, Surviving Corporation or Parent, as the case may be, such withheld amounts (a) shall be promptly remitted by the Paying Agent, Parent or the Surviving Corporation, as applicable, to the
applicable Governmental Entity and (b) shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding were made by the Paying Agent, Surviving Corporation or Parent, as
the case may be. 
 Section 2.05. Dissenters’ Rights. Notwithstanding anything in this Agreement to the
contrary, Shares that are held by any record holder who is entitled to demand and properly demands payment of the fair cash value of such Shares as a dissenting shareholder pursuant to, and who complies in all respects with, the provisions of
Section 1701.85 of the OGCL (the 

  
 8 

 
“Dissenting Shares”) shall not be converted into the right to receive the Per Share Merger Consideration payable pursuant to Section 2.01(a), but
instead at the Effective Time shall become entitled to receive the fair cash value of such Dissenting Shares in accordance with the provisions of Section 1701.85 of the OGCL and, at the Effective Time, all such Dissenting Shares shall cease to
be outstanding and shall automatically be canceled and cease to exist, and the holder of such Dissenting Shares shall cease to have any rights with respect thereto, except as set forth in this Section 2.05 and the OGCL.
Notwithstanding the immediately preceding sentence, if any such holder fails to perfect or otherwise waives, withdraws or loses the right to proceed under Section 1701.85 of the OGCL or a court of competent jurisdiction determines that such
holder is not entitled to the relief provided by Section 1701.85 of the OGCL, then the right of such holder to be paid the fair cash value of such holder’s Dissenting Shares under Section 1701.85 of the OGCL shall be forfeited and
cease, and each of such holder’s Dissenting Shares shall be deemed to have been converted at the Effective Time into, and shall have become, the right to receive the Per Share Merger Consideration. The Company shall deliver prompt notice to
Parent of any demands for the fair cash value of any Shares, attempted withdrawals of such demands and any other instruments delivered to the Company pursuant to the OGCL with respect to a demand for the fair cash value of the Shares, and shall
provide Parent with the opportunity to participate in all negotiations and Proceedings with respect to any demands under Section 1701.85 of the OGCL. Prior to the Effective Time, the Company shall not, without the prior written consent of
Parent, make any payment with respect to, or settle or offer to settle, any such demands, or agree to take any such action. 

Section 2.06. Adjustments to Prevent Dilution. In the event that the number of Shares or securities convertible or exchangeable
into or exercisable for Shares issued and outstanding after the date hereof and prior to the Effective Time shall have been changed into a different number of Shares or securities or a different class as a result of a reclassification, stock split
(including a reverse stock split), stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer, or other similar transaction, the Per Share Merger Consideration shall be equitably adjusted, without duplication, to
provide the holders thereof the same economic effect contemplated by this Agreement prior to such change; provided, however, that nothing in this Section 2.06 shall be construed to permit the Company, any
Subsidiary of the Company or any other Person to take any action that is otherwise prohibited by the terms of this Agreement. 
 ARTICLE
III 
 REPRESENTATIONS AND WARRANTIES 

Section 3.01. Representations and Warranties of the Company. Except (x) as disclosed in the SEC Reports filed with the SEC
since June 30, 2014 and publicly available at least two (2) Business Days prior to the date of this Agreement (and only as and to the extent disclosed therein), other than any disclosures in any such SEC Reports contained under the
captions “Risk Factors”, “Quantitative and Qualitative Disclosures About Market Risk” and “Forward-Looking Statements” sections thereof or other similarly cautionary, forward-looking or predictive statements in such SEC
Reports but it being understood that this clause (x) shall not be applicable to Sections 3.01(b) (Subsidiaries), 3.01(c) (Capital Structure), 3.01(d)(i) (Authority), 3.01(s) (Voting
Requirements), 3.01(t) (Brokers and Other Advisors) and 3.01(u) (Opinions of  

  
 9 

 
Financial Advisors) of this Agreement, or (y) as set forth in the Company Disclosure Letter (it being agreed that disclosure of any item in any section or subsection of the Company
Disclosure Letter shall also be deemed disclosure with respect to any other section or subsection of this Agreement to the extent that it is reasonably apparent on its face that such information is relevant to such other sections or subsections),
the Company represents and warrants to Parent and Merger Sub as follows: 
 (a)    Organization,
Standing and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of Ohio and has all requisite corporate power and authority to carry on its business as presently conducted. The
Company is duly qualified or licensed to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction where the nature of its business or the ownership, leasing or operation of its properties makes
such qualification or licensing necessary, other than where the failure to be so qualified, licensed or in good standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect . Each of
the Company’s Subsidiaries is a legal entity duly organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Law of its respective jurisdiction of organization and has all requisite
corporate or similar power and authority to carry on its business as presently conducted and each of the Company’s Subsidiaries is duly qualified or licensed to do business and is in good standing (where such concept is recognized under
applicable Law) in each jurisdiction where the nature of its business or the ownership, leasing or operation of its properties makes such qualification or licensing necessary, other than where the failure to be so qualified, licensed or in good
standing has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The Company has made available to Parent prior to the date of this Agreement a true and complete copy of the Second
Amended Articles of Incorporation of the Company (the “Company Articles of Incorporation”) and the Amended and Restated Code of Regulations of the Company (the “Company Code of Regulations”), as amended to date, and
each as so made available is in full force and effect. The Company is not in material violation of any of the provisions of the Company Articles of Incorporation or the Company Code of Regulations. 

(b)    Subsidiaries. Section 3.01(b) of the Company Disclosure Letter sets forth a complete and
correct list of each Subsidiary of the Company and the jurisdiction of organization of each such Subsidiary. All of the outstanding shares of capital stock of, or other equity interests in, each Subsidiary of the Company have, in all cases, been
duly authorized and validly issued and are fully paid and nonassessable, and are wholly owned, directly or indirectly, by the Company, free and clear of all preemptive rights, rights of first refusal, option or similar rights, pledges, liens,
charges, mortgages, encumbrances, adverse claims and interests, or security interests of any kind or nature whatsoever (including any restriction on the right to vote or transfer the same, except for such transfer restrictions of general
applicability as may be provided under the Securities Act, the “blue sky” Laws of the various states of the United States or similar Law of other applicable jurisdictions) (collectively, “Liens”), other than Permitted
Liens. Except for its interests in its 

  
 10 

 
Subsidiaries, the Company does not own, directly or indirectly, any capital stock of, or other equity or voting interests in, any Person. The Company has made available to Parent prior to the
date of this Agreement true and complete copies of the organizational documents of each of its Subsidiaries, each as amended to date, and each as made available are in full force and effect. None of the Subsidiaries of the Company is in material
violation of its respective organizational documents. 
 (c)    Capital Structure. 

(i)    The authorized capital stock of the Company consists of 15,000,000 Shares and
200,000 shares of serial preferred stock, without par value (such preferred stock, the “Company Preferred Stock”). At the close of business on July 5, 2017 (the “Cutoff Date”), there were (A)(1) 9,860,635
Shares issued and outstanding (which number includes 25,912 Restricted Shares) and (2) no Shares held by the Company in its treasury, (B) 128,134 Shares underlying the outstanding Company RSUs, (C) 100,022 Shares reserved for issuance
pursuant to outstanding Company Options, and (D) no shares of Company Preferred Stock issued or outstanding. Except as set forth in the immediately preceding sentence, at the close of business on the Cutoff Date, no shares of capital stock or
other voting securities of the Company were issued or outstanding or subject to issuance in connection with an outstanding Company RSU, Company Option or other security, obligation or arrangement of the Company giving any Person a right to subscribe
for or acquire shares of capital stock or other voting securities of the Company. Since the Cutoff Date to the date of this Agreement, (x) there have been no issuances by the Company of shares of capital stock or other voting securities of the
Company other than pursuant to the exercise of Company Options or the vesting of Company RSUs, in each case, outstanding as of the Cutoff Date and (y) there have been no issuances by the Company of options, restricted stock units, warrants,
other rights to subscribe for or acquire shares of capital stock of the Company or other rights that give the holder thereof any economic interest of a nature accruing to the holders of Shares. All outstanding Shares are, and all such shares that
may be issued prior to the Effective Time, including all Shares reserved for issuance pursuant to outstanding Company Options as noted in clause (C) of the second sentence of this Section 3.01(c), will be, when issued,
duly authorized, validly issued, fully paid and nonassessable and not subject to preemptive rights. 

(ii)    Section 3.01(c)(ii) of the Company Disclosure Letter sets forth the aggregate amount of
Company Options, Restricted Shares and Company RSUs outstanding as of the Cutoff Date, including with respect to each such award, as applicable, the holder, type of award, date of grant, exercise price, vesting schedule, expiration date, total
initial number of Shares underlying such award and total outstanding number of Shares underlying such award. 

(iii)    No Subsidiary of the Company owns any shares of capital stock of the Company. There are no bonds,
debentures, notes, obligations or other Indebtedness or obligations of the Company or any of its Subsidiaries that give 

  
 11 

 
the holders thereof the right to vote (or that are convertible into, or exchangeable for, securities having the right to vote) on any matters on which holders of Shares or the securityholders of
the Company’s Subsidiaries may vote (“Voting Company Debt”). Except for any obligations pursuant to this Agreement or as otherwise set forth above, as of the date hereof, there are no subscriptions, options, warrants, calls,
rights (including preemptive, conversion, stock appreciation, redemption or repurchase rights), convertible or exchangeable securities, profits interests, stock-based performance units or other similar rights, Contracts or undertakings of any kind
to which the Company or any of its Subsidiaries is a party or by which any of them is bound (A) obligating the Company or any of its Subsidiaries to issue, transfer, deliver or sell, or cause to be issued, transferred, delivered or sold, shares
of capital stock or other securities of, or equity or voting interests in, or any security convertible or exchangeable for any capital stock or other security of, or equity or voting interest in, the Company or any of its Subsidiaries or any Voting
Company Debt, (B) obligating the Company or any of its Subsidiaries to issue, grant, extend or enter into any such subscription, option, warrant, call, right, security, unit, profits interest or other similar right, Contract or undertaking or
(C) that give any Person the right to subscribe for or acquire any securities of the Company or any of its Subsidiaries, or to receive any economic interest of a nature accruing to the holders of Shares or otherwise based on the performance or
value of shares of capital stock of the Company or any of its Subsidiaries. As of the date of this Agreement, there are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any shares of
capital stock or other equity or voting interests of the Company or any Subsidiary of the Company, other than (pursuant to the Company Equity Award Plans. There are no stockholder agreements, registration right agreements, voting trusts, voting
agreements or proxies (other than customary revocable proxies solicited by the Company for any meeting of the holders of Shares) to which the Company or any of its Subsidiaries is a party with respect to equity interests of the Company. 

(d)    Authority; Noncontravention. 

(i)    The Company has all requisite corporate power and authority to execute and deliver, and perform its
obligations under, this Agreement and to consummate the transactions contemplated by this Agreement, subject, in the case of the Merger only, to receipt of the Company Requisite Vote. The execution, delivery and performance of this Agreement by the
Company and the consummation by the Company of the transactions contemplated by this Agreement have been duly and validly authorized by all necessary corporate action on the part of the Company, subject, in the case of the Merger only, to receipt of
the Company Requisite Vote. This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by each of the other parties hereto, constitutes a legal, valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency and other Laws of general applicability relating to or affecting creditors’ rights and to general equity principles.

  
 12 

 (ii)    The Company Board duly and validly adopted
resolutions (A) determining that the Merger is in the best interests of the Company Shareholders, (B) authorizing, approving and declaring advisable the execution, delivery and performance of this Agreement and the transactions
contemplated by this Agreement, including the Merger, (C) directing that the adoption of this Agreement be submitted to a vote at a meeting of the Company Shareholders (the “Company Shareholders Meeting”) and
(D) recommending that the Company Shareholders adopt this Agreement (the “Company Board Recommendation”), which resolutions, as of the date of this Agreement, have not been rescinded, modified or withdrawn in any way. 

(iii)    The execution, delivery and performance by the Company of this Agreement do not, and the
consummation of the Merger and the other transactions contemplated by this Agreement and compliance with the provisions of this Agreement will not, conflict with, or result in any breach or violation of, or default, with or without notice, lapse of
time or both, under, or give rise to any right or obligation (including a right of termination, modification, cancellation or acceleration of any right or obligation or any right of first refusal, participation or similar right) under, or cause the
loss of any benefit under, or require consent under, or result in the creation of any Lien (other than Permitted Liens and Liens created solely as a result of any action taken by Parent or Merger Sub or any of their respective Affiliates) upon any
of the properties or assets of the Company or any of its Subsidiaries under, any provision of (A) the Company Articles of Incorporation, the Company Code of Regulations or the comparable organizational or governing documents of any of the
Company’s Subsidiaries or (B) subject to the filings and other matters referred to in the immediately following sentence, (1) any Permit or Contract to which the Company or any of its Subsidiaries is a party or by which any of their
respective properties or assets are bound, or (2) any Law, in each case applicable to the Company or any of its Subsidiaries or any of their respective properties or assets, other than, in the case of the foregoing clause (B), any such
conflicts, violations, defaults, rights, losses or Liens that have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the
Company’s ability to perform any of its obligations under this Agreement. No consent, approval, order, waiver or permit of, action by, authorization of, or registration, declaration or filing with, or notice to, any Governmental Entity is
required to be obtained or made, or in the case of the CFIUS Approval, advisable to be obtained, by or with respect to the Company, any of its Subsidiaries or any of the material assets or businesses of the Company or any of its Subsidiaries in
connection with the execution, delivery and performance of this Agreement by the Company or the consummation by the Company of the transactions contemplated by this Agreement, except for (I) the filing of a premerger notification and report
form by the Company under the HSR Act, and any other filings required or advisable under any applicable non-United 

  
 13 

 
States antitrust or competition Law listed on Section 3.01(d)(ii) of the Company Disclosure Letter, (II) joint notification to, and submission of any supplementary information and any
mitigation agreement requested by, CFIUS in order to obtain the CFIUS Approval, (III) filings with, and submissions as may be advisable to, the DSS or other agency of the U.S. government in accordance with the NISPOM, (IV) notification to,
and submission of any supplementary information and any agreement requested by, DDTC pursuant to Section 122.4(b) and other provisions of ITAR, (V) the filing with the SEC of such reports and other documents under the Exchange Act and the
rules and regulations promulgated thereunder as may be required in connection with this Agreement and the transactions contemplated by this Agreement (including the filing of the Proxy Statement), and state securities, takeover and “blue
sky” Laws, (VI) the filing of the Certificate of Merger with the Secretary of State of the State of Ohio, (VIII) any filings required under the rules and regulations of the NYSE, (IX) any consents, approvals, orders, waivers,
permits, actions, authorizations, registrations, declarations, filings and notices required to be made or obtained by Parent or any of its Affiliates or as a result of the identity of Parent or any of its Affiliates and (X) such other consents,
approvals, orders, waivers, permits, actions, authorizations, registrations, declarations, filings and notices, the failure of which to be obtained or made has not had and would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. 

(e)    Applicable SEC Reports; Financial Statements; Undisclosed Liabilities. 

(i)    The Company has timely filed or furnished, as applicable, all SEC Reports, including all schedules,
forms, statements and other documents, required to be filed or furnished by it with the SEC since June 30, 2014 (such SEC Reports, the “Applicable SEC Reports”). As of their respective effective dates (in the case of Applicable
SEC Reports that are registration statements filed pursuant to the requirements of the Securities Act) and as of their respective dates of filing (in the case of all other Applicable SEC Reports) or, if amended or superseded by a subsequent filing
made prior to the date of this Agreement, as of the date of the last such amendment or superseding filing prior to the date of this Agreement, the Applicable SEC Reports complied in all material respects with the applicable requirements of the
Securities Act, the Exchange Act and the Sarbanes Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), as the case may be, and the applicable rules and regulations promulgated thereunder, each as in effect on the date of any
such effectiveness or filing. As of the time of effectiveness, filing with, or furnishing to, the SEC, none of the Applicable SEC Reports (or, if amended or superseded prior to the date of this Agreement, as of the date of such amendment or
superseding filing) contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances in which they were made, not
misleading, except to the extent that any such information in such 

  
 14 

 
Applicable SEC Reports has been amended or superseded by a later Applicable SEC Report that was effective, filed or furnished with the SEC prior to the date of this Agreement. The Company has
made available to Parent true and complete copies of all material correspondence between the SEC, on one hand, and the Company and any of its Subsidiaries, on the other hand, occurring since June 30, 2014, and prior to the date hereof. As of
the date hereof, there are no material outstanding or unresolved comments received from the SEC with respect to any of the Applicable SEC Reports, and to the Knowledge of the Company, none of the Applicable SEC Reports is the subject of ongoing SEC
review. As of the date hereof, none of the Company’s Subsidiaries is subject to the reporting requirements of Section 13(a) or Section 15(d) under the Exchange Act. 

(ii)    As of their respective dates, the audited and unaudited consolidated financial statements of the
Company (including any related notes thereto) included or incorporated by reference in the Applicable SEC Reports (A) have been prepared (except, as applicable, as permitted by Form 10-Q of the SEC or
other applicable rules and regulations of the SEC) in accordance with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved (except as may be indicated in the notes
thereto) and fairly present, in all material respects, the consolidated financial position of the Company and its Subsidiaries as of the respective dates thereof (taking into account the notes thereto) and the consolidated results of their
operations and cash flows for the periods indicated (taking into account the notes thereto) and subject, in the case of unaudited financial statements, to normal year-end adjustments and (B) have been
prepared from, and in accordance with, the books and records of the Company and its Subsidiaries, in all material respects. Since June 30, 2014, the Company has not received any written advice or written notification from its independent
certified public accountants that it has used any improper accounting practice that would have the effect of not reflecting or incorrectly reflecting in the financial statements or in the books and records of the Company and its Subsidiaries, any
properties, assets, liabilities, revenues or expenses in any material respect, or that have identified any “significant deficiencies” or “material weaknesses” (as defined by the Public Company Accounting Oversight Board) in the
design or operation of internal controls over financial reporting that are reasonably likely to adversely affect in any material respect the Company’s ability to record, process, summarize and report financial information. 

(iii)    The Company maintains disclosure controls and procedures required by Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act. The Company has established and maintains a system of internal controls over financial reporting required by Rule
13a-15(f) or Rule 15d-15(f) under the Exchange Act. Since June 30, 2014, the Company’s principal executive officer and its principal financial officer have
disclosed to the Company’s auditors and the audit committee of the Company Board (A) any known significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange 

  
 15 

 
Act) and (B) any known fraud or allegation of fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls
over financial reporting. The Company has made available to Parent a summary of all such disclosures made by management to the Company’s auditors and the audit committee of the Company Board since June 30, 2014. 

(iv)    Each of the principal executive officer and the principal financial officer of the Company (or
each former principal executive officer and each former principal financial officer of the Company, as applicable) has made all certifications required by Rule 13a-14 or
15d-14 under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act with respect to the Applicable SEC Reports, and the statements contained in such certifications are true and accurate in
all material respects. For purposes of this Agreement, “principal executive officer” and “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley Act. Neither the Company nor any of its
Subsidiaries has outstanding (nor has arranged or modified since the enactment of the Sarbanes-Oxley Act) any “extensions of credit” (within the meaning of Section 402 of the Sarbanes-Oxley Act) to directors or executive officers (as
defined in Rule 3b-7 under the Exchange Act) of the Company or any of its Subsidiaries. The Company is otherwise in compliance with all applicable provisions of the Sarbanes-Oxley Act and the applicable
listing and corporate governance rules of the NYSE, except for any non-compliance that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely
affect the Company’s ability to perform any of its obligations under this Agreement. 

(v)    There are no liabilities or obligations, whether accrued or unaccrued, known or unknown, or matured
or unmatured, of the Company or any of its Subsidiaries of a nature that would be required under GAAP to be reflected on a consolidated balance sheet of the Company and its Subsidiaries, other than (A) liabilities or obligations reflected or
reserved against in the Company’s unaudited consolidated balance sheet (or the notes thereto) (the “Balance Sheet”) as of April 2, 2017 (the “Balance Sheet Date”) included in the Company’s Quarterly
Report on Form 10-Q filed with the SEC on May 9, 2017, (B) liabilities or obligations incurred in the ordinary course of business consistent with past practice since the Balance Sheet Date,
(C) liabilities or obligations incurred under or in accordance with this Agreement or in connection with the transactions contemplated by this Agreement and (D) liabilities or obligations that have not had and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect. 
 (vi)    Except as
described in the Applicable SEC Reports filed prior to the date of this Agreement, neither the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to (A) any joint venture,
off-balance sheet partnership, or any similar Contract or arrangement (including any Contract or arrangement relating to any transaction or 

  
 16 

 
relationship between or among the Company or any of its Subsidiaries, on the one hand, and any other Person, including any structured finance, special purpose, or limited purpose Person, on the
other hand); or (B) any “off balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K under the Exchange Act). 

(f)    Disclosure Documents. 

(i)    The Proxy Statement and any amendment or supplement thereto, when filed, will comply as to form in
all material respects with the applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder. At the time the Proxy Statement and any amendments or supplements thereto are first mailed to the Company Shareholders
and at the time the Company Shareholders vote on the adoption of this Agreement, the Proxy Statement, as supplemented or amended, if applicable, will not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to
statements made or incorporated by reference in the Proxy Statement based on information supplied by or on behalf of Parent or Merger Sub or any Affiliates thereof expressly for inclusion or incorporation by reference therein. 

(ii)    All of the information supplied in writing by, or on behalf of, the Company, its Subsidiaries or
its Affiliates to Parent expressly for inclusion, or expressly to support statements made, (A) in the announcement of the Merger and Share Issuance to be released immediately following execution of this Agreement in compliance with the Listing
Rules (the “Merger Announcement”), (B) in the Parent Shareholder Circular, or any amendment or supplement thereto, or (C) in any announcement issued or released by Parent via any regulatory information service in connection
with transactions contemplated by this Agreement, and in any other related documents required to be filed by Parent with the UKLA or published by Parent pursuant to the Listing Rules in connection with the transactions contemplated by this
Agreement, will, at the time the relevant document or announcement in its final form is published, issued or released (i) be in accordance with the facts, and (ii) not contain any omission likely to affect the import of such information.

 (g)    Absence of Certain Changes or Events. Since April 2, 2017, (i) there have not
been any changes, effects, events, occurrences, state of circumstances, or developments (changes, effects, events, occurrences, state of circumstances, and developments being collectively referred to as “Changes”) that have had or
would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or would otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement,
(ii) except as contemplated or required by this Agreement, the Company and its Subsidiaries have conducted their respective businesses in all material respects in the ordinary 

  
 17 

 
course of business consistent with past practice, and (iii) neither the Company nor any of its Subsidiaries has taken, or agreed or committed to take, any actions that would constitute a
breach or violation of Sections 4.01(a)(v), (ix), (xi), (xii) or (xv) if such covenants had been in effect as of April 2, 2017. 

(h)    Litigation. (i) There is no, and since June 30, 2014 there has not been any suit,
action, arbitration, litigation, mediation or legal, arbitral, administrative or other proceeding (each, a “Proceeding”) pending or, to the Knowledge of the Company, threatened against, the Company or any of its Subsidiaries or any
of their respective properties or assets, at law or in equity, (ii) there is no pending or, to the Knowledge of the Company, threatened material governmental or regulatory audit, review, inspection, survey or investigation of, the Company or
any of its Subsidiaries or any of their respective properties or assets, at law or in equity, and (iii) there is no injunction, order, judgment, ruling, decree or writ of any Governmental Entity outstanding against the Company or any of its
Subsidiaries or any of their respective directors or officers in their capacities as such or any of their respective properties or assets, at law or in equity, except, in each case, as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. 

(i)    Contracts. Section 3.01(i) of the Company Disclosure Letter sets forth a correct and
complete list of the following Contracts (excluding in each case any Company Benefit Plan) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is otherwise bound, in each case, as of the date
of this Agreement: 
 (i)    any Contract that would be required to be filed by the Company as a
“material contract” pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act; 

(ii)    any Contract creating or evidencing any Indebtedness of the Company or any of its Subsidiaries, in
each case having an outstanding amount in excess of $1,000,000, other than any Contract between or among the Company and its Subsidiaries; 

(iii)    any Contract constituting a guaranty by the Company or any of its Subsidiaries of Indebtedness of
any third party; 
 (iv)    any Contract that restricts the ability of the Company or any of its
Subsidiaries to (A) engage in any line of business in any geographic area, solicit customers or compete with any other Person or (B) acquire or dispose of the securities of another Person; 

(v)    any Contract that contains a requirement for the Company or any of its Subsidiaries to conduct its
business on an exclusive or preferential basis or any “most favored nation” or any other provisions for the benefit of a third party that restricts the type of business activity of the Company or any of its Subsidiaries in a material
manner; 

  
 18 

 (vi)    any Contract that is related to the creation,
governance or operation of any joint venture, partnership, limited liability company, strategic alliance or other similar arrangement, other than any such Contract solely between or among the Company and its Subsidiaries; 

(vii)    any Contract that by its terms calls for aggregate payments, commitments or expenditures by the
Company or any of its Subsidiaries of more than $2,000,000 in any fiscal year period or $3,000,000 in the aggregate over the term of such Contract, except for any such Contract that may be cancelled by the Company, without any material penalty or
other liability to the Company or any of its Subsidiaries, upon notice of ninety (90) days or less; 

(viii)    any Contract that involves, or is reasonably expected in the future to involve, annual revenues
of $2,000,000 or more; 
 (ix)    any Contract for an acquisition, disposition, merger or similar
transaction by the Company or any of its Subsidiaries of properties or assets, including securities, (A) in each case, for aggregate consideration of more than $5,000,000 or (B) that contains material continuing obligations of the Company
or any of its Subsidiaries following the date of this Agreement; 
 (x)    any Government Contract that
contains a legal obligation of the Company or any of its Subsidiaries to provide goods or services that resulted in revenues in an aggregate amount that exceeded $2,500,000; 

(xi)    any Contract of employment, consulting, management, separation, or other similar agreement (in
each case with respect to which the Company or any of its Subsidiaries has continuing obligations on or after the date hereof) with any current or former employee, any consultant or any individual who is an independent contractor providing for total
annual compensation from the Company or any of its Subsidiaries in excess of $300,000; 
 (xii)    any
Contract of employment, consulting, management, separation, severance, indemnification or similar agreement with any member of the Company Board, any executive officer of the Company or any Person holding more than five percent (5%) of the
outstanding shares of common stock of the Company as of July 3, 2016; 
 (xiii)    any Contract
that contains any standstill or similar agreement pursuant to which the Company or any of its Subsidiaries has agreed not to acquire any of the assets or securities of any Person; 

(xiv)    any Contract constituting an Affiliate Transaction; 

  
 19 

 (xv)    any employee collective bargaining agreement or
other Contract with any labor union or association representing employees of the Company or any of its Subsidiaries; 

(xvi)    any Contract that grants any right of first refusal, right of first negotiation, right of first
offer, or similar right to any Person with respect to the sale, transfer, or other disposition of any business or line of business or any material assets, rights or properties of the Company or any of its Subsidiaries; 

(xvii)    any Contract between the Company and its Subsidiaries, on the one hand, and a Company
Shareholder beneficially owning five percent (5%) or more of the outstanding shares of common stock of the Company or such shareholder’s Affiliate, on the other hand, other than Contracts entered into in the ordinary course of business of the
Company or any of its Subsidiaries; 
 (xviii)    any IP Contract that is material to the business of
the Company or any of its Subsidiaries; 
 (xix)    any lease or sublease of personal property providing
for annual payments of $5,000,000 or more; and 
 (xx)    any Contract relating to any swap, forward,
futures, warrant, option or other derivative transactions; 
 (xxi)    any Contract with a Major
Supplier or Major Customer; and 
 (xxii)    each amendment, modification or supplement in respect of
any of the foregoing. 
 Each such Contract described in the foregoing clauses (i) through (xxii) is referred to herein as a “Material
Contract”. Except as, individually or in the aggregate, has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (A) each of the Material Contracts is valid and binding on
the Company or the Subsidiary of the Company party thereto and, to the Knowledge of the Company, as of the date hereof, the other party or parties thereto, and is in full force and effect and is enforceable against the Company or its Subsidiaries
parties thereto and, to the Knowledge of the Company, each other party thereto, in accordance with its terms, (B) the Company and each of its Subsidiaries and, to the Knowledge of the Company, each other party thereto, has substantially
performed all obligations required to be performed by it to date under each Material Contract and is not in breach of or default under such Material Contract, (C) since June 30, 2014, neither the Company nor any of its Subsidiaries has
received written notice of breach or default under any Material Contract or the existence of any event or condition which constitutes or, after notice or lapse of time or both, will constitute, a default or breach on the part of the Company or any
of its Subsidiaries under any such Material Contract, and, to the Knowledge of the Company, no such condition exists, and (D) neither the Company nor any of its Subsidiaries has received written notice from any other party to a Material
Contract with respect to the termination of any Material Contract that has not been cured or withdrawn. 

  
 20 

 (j)    Compliance with Law; Permits. 

(i)    The Company and each of its Subsidiaries are, and since June 30, 2014, have at all times been,
in compliance with, and are not in default under or in violation of, any applicable Law, except where such non-compliance, default or violation has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. Since June 30, 2014, neither the
Company nor any of its Subsidiaries has (A) received any written notice from any Governmental Entity regarding any violation of, or failure to comply with, any Law, or (B) provided any written notice to any Governmental Entity regarding
any violation of the Company or any of its Subsidiaries of any Law, except, in each case, where such non-compliance or violation has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. 

(ii)     The Company and its Subsidiaries are in possession of all franchises, grants, authorizations,
licenses, permits, easements, variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and orders of all Governmental Entities and have filed all tariffs, reports, notices, and other
documents with all Governmental Entities necessary for the Company and its Subsidiaries to own, lease and operate their properties and assets and to carry on their businesses as presently conducted (collectively, “Permits”), except
where the failure to have any of such Permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s
ability to perform any of its obligations under this Agreement. All Permits are valid and in full force and effect and are not subject to any administrative or judicial Proceeding or investigation that would reasonably be expected to result in
modification, termination or revocation thereof, except where the failure to be in full force and effect or any modification, termination or revocation thereof has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. The Company is, and each of its Subsidiaries is, in compliance with
the terms and requirements of such Permits, except where non-compliance has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or would not
otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. Since June 30, 2014, neither the Company nor any of its Subsidiaries has received notice that any Permit will be
terminated, revoked or modified, is threatened with suspension or cannot be renewed in the ordinary course of business consistent with past practice, and the Company has no Knowledge of any reasonable basis for any such termination, revocation,
modification, suspension or non-renewal, except, in each case, where such 

  
 21 

 
termination, revocation, modification, suspension or non-renewal has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect or would not otherwise prevent or materially adversely affect the Company’s ability to perform any of its obligations under this Agreement. 

(k)    Labor and Employment Matters. 

(i)    Neither the Company nor any of its Subsidiaries is a party to, bound by, or subject to, or is
currently negotiating in connection with entering into, any collective bargaining agreement or understanding with a labor union or similar organization. As of the date hereof, (A) to the Knowledge of the Company, there are no union or other
labor organizing activities occurring concerning any employees of the Company or any of its Subsidiaries and (B) there are no labor strikes, slowdowns, work stoppages or lockouts pending or, the Knowledge of the Company, threatened against the
Company or any of its Subsidiaries. There are no material legal actions, labor grievances or investigations by any Governmental Entity pending or, to the Knowledge of the Company, threatened relating to any employment-related matter involving any
Company Employee or applicant, including claims of unlawful discrimination, harassment or retaliation, failure to provide reasonable accommodation, denial of a leave of absence, failure to provide compensation or benefits, employee classification,
unfair labor practices, or other alleged violations of employment-related Law. 
 (ii)    The Company
and its Subsidiaries are, and have been since June 30, 2014, in compliance in all material respects with all applicable Laws respecting labor, employment, discrimination in employment, terms and conditions of employment, payroll, worker
classification, wages, mandatory social security schemes, hours and occupational safety and health and employment practices. 

(iii)    Since June 30, 2014, (A) neither the Company nor any of its Subsidiaries has effectuated a
“plant closing” (as defined in the Worker Adjustment Retraining and Notification Act of 1988, as amended (the “WARN Act”)) affecting any site of employment or one or more facilities or operating units within any site of
employment or facility, (B) there has not occurred a “mass layoff” (as defined in the WARN Act) by the Company or any of its Subsidiaries affecting any site of employment or one or more facilities or operating units within any site of
employment or facility, and (C) neither the Company nor any of its Subsidiaries has engaged in any transaction or engaged in layoffs or employment terminations sufficient in number to trigger application to the Company or any of its
Subsidiaries of any similar Law. During the three (3) years prior to the date of this Agreement, each Person employed by the Company or any of its Subsidiaries was or is properly classified as exempt or
non-exempt in accordance with applicable overtime laws, and no Person treated as an independent contractor or consultant by the Company or any of its Subsidiaries should have been properly classified as an
employee under applicable Laws. 

  
 22 

 (l)    Employee Benefit Matters. 

(i)    Section 3.01(l)(i) of the Company Disclosure Letter sets forth a complete and accurate list of
each Company Benefit Plan in effect as of the date of this Agreement. True and complete copies (or summaries for any Company Benefit Plan for which a separate document does not exist) of all Company Benefit Plans listed on Section 3.01(l)(i) of
the Company Disclosure Letter have been made available to Parent, and the Company has made available to Parent where applicable (i) the most recently prepared actuarial report or financial statement, (ii) the most recent summary plan
description, and all material modifications thereto, (iii) the most recent annual report (Form 5500 Series) and accompanying schedule, (iv) the most recent determination letter or opinion letter, (v) copies of any material written
correspondence with a Governmental Entity relating to a Company Benefit Plan since June 30, 2014, and (vi) any related funding arrangements. Except as specifically provided in the foregoing documents delivered or made available to
Parent, there are no amendments to any Company Benefit Plan that have been adopted or approved nor have the Company or any of its Subsidiaries undertaken to make any such amendments or to adopt or approve any new Company Benefit Plan. 

(ii)     (A) Each Company Benefit Plan (and any related trust or other funding vehicle) has been in
all material respects established, operated and administered in accordance with its terms and is in compliance with ERISA, the Code and all other applicable Law, (B) all material contributions or other amounts payable by the Company or any of
its Subsidiaries with respect to each Company Benefit Plan in respect of current or prior plan years have been paid or accrued in accordance with GAAP, the Code, the terms of such plans and other applicable Laws, (C) each of the Company and its
Subsidiaries is in compliance in all material respects with ERISA, the Code and all other Laws, in each case, applicable to Company Benefit Plans and (D) each Company Benefit Plan (and any related trust) that is intended to be qualified under
Section 401(a) of the Code has received a favorable determination or opinion letter, or has pending or has time remaining in which to file an application for such determination or opinion from the IRS. 

(iii)    As of the date hereof, (A) no Proceedings (other than routine claims for benefits in the
ordinary course of business) are pending or, to the Knowledge of the Company, threatened relating to or otherwise in connection with any Company Benefit Plan or the assets thereof and (B) there are no pending or, to the Knowledge of the
Company, threatened material administrative investigations, audits or other administrative Proceedings by the Department of Labor, the Pension Benefit Guaranty Corporation, the IRS or other Governmental Entity relating to any Company Benefit Plan.

  
 23 

 (iv)    None of the Company, any of its Subsidiaries or any
Commonly Controlled Entity of the Company has, within the past six (6) years, sponsored, maintained, contributed to or been required to maintain or contribute to, or has any liability under, any employee benefit plan (within the meaning of
Section 3(3) of ERISA) that is (and no Company Benefit Plan is) subject to Section 302 or Title IV of ERISA or Sections 412 or 4971 of the Code, or is otherwise a defined benefit plan (as defined in Section 4001 of ERISA).
The fair market value of assets available for benefits under each Company Benefit Plan which is subject to Title IV of ERISA exceeds the present value of accumulated benefit obligations under such Company Benefit Plan, and also, on a plan
termination basis, exceeds the value of “benefit liabilities” under such Company Benefit Plan within the meaning of Section 4001(a)(16) of ERISA, and the actuarial valuation of each such Company Benefit Plan for the most recent plan
year accurately reflects its actuarial condition as of the first day of such plan year, and there has been no material change in such actuarial condition since such date. 

(v)    Neither the Company nor any of its Subsidiaries nor any Commonly Controlled Entity of the Company
has any liability for providing health, medical or life insurance or other welfare benefits after retirement or other termination of employment (other than for continuation coverage required under Section 4980(B)(f) of the Code or other similar
applicable Law). 
 (vi)    None of the execution and delivery of this Agreement, the obtaining of the
Company Requisite Vote or the consummation of the Merger (alone or in conjunction with any other event, including any termination of employment on or following the Effective Time) would reasonably be expected to (A) entitle any current or
former director, officer, employee or independent contractor of the Company or any of its Subsidiaries to any compensation or material benefit, (B) accelerate the time of payment or vesting, or trigger any payment or funding, of any
compensation or material benefits or trigger any other material obligation under any Company Benefit Plan, (C) result in any material breach or violation of, or material default under, or limit the Company’s right to amend, modify,
terminate or transfer the assets of, any Company Benefit Plan or (D) directly or indirectly cause the Company to transfer or set aside any assets to fund any benefits, or otherwise give rise to any material liability, under any Company Benefit
Plan. 
 (vii)    No amount paid or which could become payable (whether in cash or property or the
vesting of property) by the Company or any of its Subsidiaries as a result of the execution and delivery of this Agreement, the obtaining of the Company Requisite Vote or the consummation of the Merger (in each case, alone, or in combination with
any other event, whether or not such other event could reasonably be expected to occur) to any of their respective employees, officers, directors or independent contractors, or otherwise, could not be deductible by reason of Section 280G of the
Code or may be subject to an excise tax under Section 4999 of the Code. There is no agreement, plan or other arrangement to which the Company or any of its Subsidiaries is a party or by which any of them is otherwise bound to compensate any
Person in respect of Taxes imposed pursuant to Section 4999 of the Code. 

  
 24 

 (viii)    Each Company Benefit Plan that constitutes in any
part a nonqualified deferred compensation plan within the meaning of Section 409A of the Code is in all material respects in operational and documentary compliance with Section 409A of the Code and all IRS guidance promulgated thereunder,
to the extent such section and such guidance are applicable to such Company Benefit Plan. To the Knowledge of the Company, all prior instances of material operational and/or documentary non-compliance with
respect to Section 409A of the Code have been corrected under applicable IRS guidance. There is no agreement, plan or other arrangement to which the Company or any of its Subsidiaries is a party or by which any of them is otherwise bound to
compensate any Person in respect of Taxes imposed pursuant to Section 409A of the Code. 
 (ix)    
Neither the Company nor any of its Subsidiaries nor, to the Knowledge of the Company, any other Person has engaged in a transaction in connection with which the Company or any of its Subsidiaries would reasonably be expected to be subject to either
a material civil penalty assessed pursuant to Section 409 or 502(i) of ERISA or a material Tax imposed pursuant to Section 4975 or 4976 of the Code. 

(x)    As of the date hereof (A) each Company Benefit Plan which is for the benefit of any employee
or former employee, officer, director or independent contractor of the Company or any of its Subsidiaries who is located outside or whose principal place of work is outside the United States but excluding any employee benefit plan that is
statutorily required, government sponsored or not otherwise sponsored, maintained or controlled by the Company or any of its Subsidiaries (each an “International Plan”) that under applicable Laws requires registration has been duly
registered with the necessary Governmental Entity and no event has occurred which is reasonably likely to cause the loss of such registered status, (B) the Company and each Subsidiary has complied with and performed all material obligations
under and in respect of the International Plans under the terms thereof, any funding agreements and all applicable Law (including any fiduciary, funding, investment and administration obligations), (C) there are no taxes, penalties or interest owing
in respect of any International Plan and (D) the solvency liabilities of each International Plan (using actuarial methods and assumptions which are consistent with the valuations last filed with the applicable Governmental Entities and which
are consistent with generally accepted actuarial principles) do not exceed the market value of the assets held in connection with such plan in any material respect. 

(m)    Taxes. 

(i)    (A) All material Tax Returns required to be filed by or with respect to the Company or any of its
Subsidiaries have been timely filed (taking into account any valid extension of time within which to file) and all such Tax 

  
 25 

 
Returns are correct and complete in all material respects, (B) all Taxes of the Company and its Subsidiaries (whether or not shown on any Tax Return) that are required to be paid or
discharged have been timely paid and discharged other than Taxes being contested in good faith by appropriate Proceedings and for which adequate reserves have been established and maintained on the financial statements of the Company and its
Subsidiaries in accordance with GAAP, (C) there are no Tax Liens, other than for Taxes not yet due and payable, on any asset of the Company or any of its Subsidiaries that exist in connection with any failure (or alleged failure) to pay any Tax
and (D) neither the Company nor any of its Subsidiaries has executed any waiver of any statute of limitations for the assessment or collection of any Tax, which waiver is currently in effect. 

(ii)    Any unpaid Taxes of the Company and each of its Subsidiaries (A) did not, as of the Balance
Sheet Date, exceed the reserve for Tax liability (rather than any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the Balance Sheet and (B) do not exceed that reserve as adjusted
for the passage of time in accordance with the past custom and practice of the Company and its Subsidiaries in filing their Tax Returns. 

(iii)    All assessments for Taxes due with respect to completed and settled audits or examinations have
been fully paid. No federal, state, local or non-U.S. audits, examinations, investigations or Proceedings are being conducted, have been threatened in writing against the Company or any of its Subsidiaries or,
to the Knowledge of the Company, are pending in respect of any Taxes, which audits, examinations, investigations or Proceedings have not been resolved. 

(iv)    The Company and each of its Subsidiaries has withheld and paid or remitted Taxes required by Law
to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, stockholder, non-resident or other Person. 

(v)    Neither the Company nor any of its Subsidiaries (A) is a party to, is bound to, or has any
obligation under any Tax allocation or sharing agreement or any Tax indemnity agreement (other than any commercial Contracts entered in the ordinary course of business that do not relate primarily to Taxes such as a lease or a loan or to which the
only parties are the Company or any of its Subsidiaries), (B) has been a “controlled corporation” or a “distributing corporation” in any distribution occurring during the five (5)-year period ending on the date hereof that was
purported or intended to be governed by Section 355 or Section 361 of the Code (or any analogous provision of state, local or non-U.S. Law), (C) is a party to any Contract, arrangement or plan that
has resulted or could reasonably be expected to result, individually or in the aggregate, in the payment of any amount that will not be fully deductible as a result of Section 162(m) of the Code (or any analogous provision of state, local or non-U.S. law), (D) is or has been a member of an affiliated group (other than a group the common parent of which is or was the Company) filing an affiliated, 

  
 26 

 
consolidated, combined or unitary Tax return, (E) has any liability for the Taxes of any other Person (other than the Company and its Subsidiaries) arising from the application of Treasury
Regulation §1.1502-6 (or any analogous provision of state, local or non-U.S. Law), as a transferee or successor or by Contract (other than customary Tax
indemnifications contained in commercial agreements the primary purpose of which does not relate to Taxes such as a lease or a loan), (F) has engaged in any “reportable transaction” described in Treasury Regulation §1.6011-4(b) or (G) has received a written inquiry from a Governmental Entity in a jurisdiction where the Company or any of its Subsidiaries does not file Tax Returns claiming that the Company or any such
Subsidiary is or may be subject to taxation by that jurisdiction. 
 (vi)    In the past three
(3) taxable years, none of the Company or any of its Subsidiaries has ever had to include material amounts in income under Section 951(a) of the Code. 

(vii)    If the Company or any of its Subsidiaries is required to be registered for value added tax or any
similar tax on consumption (“VAT”) in any jurisdiction, it (A) is so registered in each such applicable jurisdiction, (B) has complied in all material respects with all applicable Law in respect of such VAT,
(C) maintains full and accurate records with respect to VAT to the extent required by applicable Law and (D) has not in the six (6) year period ending with the Closing Date been subject to any material interest, forfeiture, surcharge
or penalty in respect of VAT. None of the Company or its Subsidiaries is or has been in the six (6) year period ending with the Closing Date a member of a group or consolidation with any company other than the Company or any of its Subsidiaries
for purposes of VAT. 
 (viii)    Neither the Company nor any of its Subsidiaries has agreed, or is
required, to make any material adjustments after the Closing Date pursuant to Section 481(a) of the Code or any similar Law by reason of a change in accounting method initiated by it or any other relevant party prior to the Closing Date, and,
as of the date hereof, the IRS has not proposed any such adjustment or change in accounting method in writing nor does the Company or any of its Subsidiaries have any application pending with any Governmental Entity requesting permission for any
changes in accounting methods that relate to the business or assets of the Company or any of its Subsidiaries. 

(ix)    Neither the Company nor any of its Subsidiaries will be required to include any material item of
income in, or exclude any material item of deduction from, taxable income for any taxable period ending after the Closing Date as a result of any: (A) installment sale or other open transaction disposition; (B) closing agreement described
in Section 7121 of the Code or any similar provision of Applicable Law; (C) required change in accounting method; (D) prepaid amount received prior to the Closing Date; (E) intercompany transaction or excess loss account
described in Treasury Regulations Section 1.1502 or any similar provision of Applicable Law, in each case occurring, entered into, made or in existence prior to the Effective Time; or (F) any election under Section 108(i) of the Code.

  
 27 

 (x)    Neither the Company nor any of its Subsidiaries is a
party to any Contract, arrangement or plan that has resulted or would result, individually or in the aggregate, in the payment of any “excess parachute payment” within the meaning of Section 280G of the Code (or any corresponding
provision of any other Tax Laws) arising out of the transactions contemplated by this Agreement. 

(n)    Environmental Matters. Except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, (i) each of the Company and its Subsidiaries is, and since June 30, 2014 has been, in compliance with all applicable Environmental Laws and, since June 30, 2014, neither the
Company nor any of its Subsidiaries has received any written notice from any Governmental Entity that has not been fully resolved alleging that the Company or any of its Subsidiaries is in violation of, or has any liability under, any Environmental
Law, including a request for information pursuant to Section 104(e) of the Comprehensive Environmental Response, Compensation and Liability Act, (ii) each of the Company and its Subsidiaries possesses and is in compliance with all Permits
required under applicable Environmental Laws to conduct its business as presently conducted, and all such Permits are valid and in good standing, (iii) since June 30, 2014, there have been no Proceedings or investigations pursuant to
any Environmental Law pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries, or any real property currently or, to the Knowledge of the Company, formerly owned, leased or operated by the Company or
any of its Subsidiaries, (iv) there have been no releases or threatened releases of Hazardous Materials at, on or from any property currently or, to the Knowledge of the Company, formerly owned, leased or operated by the Company or any of its
Subsidiaries, in each case, in a manner that would reasonably be expected to result in any obligation to conduct any investigation, remediation or other corrective or response action by the Company or any of its Subsidiaries, and (v) neither
the Company nor any of its Subsidiaries is subject to any consent decrees, orders, settlements or compliance agreements, nor has any of them entered into by Contract or, to the Knowledge of the Company, by operation of Law any other commitments that
impose any current or future obligations under Environmental Law. The Company has made available to Parent copies of all environmental assessments and investigative or remedial action reports for any property currently or formerly owned, leased or
operated by the Company or any of its Subsidiaries, and all material documents and reports regarding liabilities or obligations of the Company or any of its Subsidiaries under Environmental Laws, in each case, to the extent such assessments, reports
and documents are within the custody or control of the Company or any Subsidiary. 

(o)    Insurance. The Company has delivered or otherwise made available to Parent copies of all
material insurance policies and all material self-insurance programs and arrangements relating to the business, assets and operations 

  
 28 

 
of the Company and its Subsidiaries in effect as of the date hereof (collectively, the “Insurance Policies”). The Insurance Policies provide coverage in such amounts and against
such risks as the Company has reasonably determined to be prudent, taking into account the industries in which the Company and its Subsidiaries operate, and as is sufficient to comply with applicable Laws. Except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect: (i) all Insurance Policies are in full force and effect and all premiums thereon have been timely paid, or if not yet due, accrued; (ii) there has
not been any default by the insured under any Insurance Policy or any event which, with the giving of notice or lapse of time or both, would constitute a default by the insured and preclude coverage thereunder; (iii) no notice of cancellation
has been given to the Company or any of its Subsidiaries with respect to any Insurance Policy; (iv) the Company and its Subsidiaries are in compliance with the terms of each Insurance Policy; (v) as of the date of this Agreement, there is
no claim pending under any Insurance Policy as to which coverage has been questioned, denied or disputed in writing by the underwriters of such policies; and (vi) as of the date of this Agreement, the Company has no Knowledge of any threatened
termination of, or material premium increase with respect to, any Insurance Policy. 

(p)    Property. 

(i)    Section 3.01(p)(i) of the Company Disclosure Letter contains a correct and complete list of
all Contracts (each, a “Company Real Property Lease”) under which the Company or any Subsidiary thereof is the tenant, subtenant or occupant with respect to material real property leased, subleased, licensed or otherwise occupied
(whether as tenant, subtenant or pursuant to other occupancy arrangements) by the Company or any of its Subsidiaries (collectively, including the improvements thereon, the “Company Leased Real Property”). The Company has made
available to Parent a true and complete copy of each Company Real Property Lease (including all exhibits, schedules, amendments and extensions thereto). Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, (A) each Company Real Property Lease is valid, binding and enforceable against the Company or the Subsidiary of the Company party thereto, and, to the Knowledge of the Company, each other party thereto,
(B) there is no uncured default of any provision of any Company Real Property Lease by the Company or any of its Subsidiaries or, to the Knowledge of the Company, by any other party thereto, and no event has occurred that with the lapse of time
or the giving of notice or both would reasonably be expected to constitute a default thereunder by the Company or any of its Subsidiaries or, to the Knowledge of the Company, by any other party thereto and (C) the Company’s or its
Subsidiary’s possession and quiet enjoyment of the Company Leased Real Property has not been disturbed, and, to the Knowledge of the Company, there are no disputes with respect to the corresponding Company Real Property Lease. Neither the
Company nor any of its Subsidiaries has assigned, pledged, mortgaged, hypothecated, or otherwise transferred any Company Real Property Lease or any material interest therein nor has the Company or any of its Subsidiaries subleased, licensed or

  
 29 

 
otherwise granted any Person (other than another Subsidiary of the Company) a material right to use or occupy any Company Leased Real Property or any material portion thereof. 

(ii)    The Company or one of its Subsidiaries has good and valid fee simple title to all material real
property currently owned by the Company or any of its Subsidiaries (collectively, the “Company Owned Real Property” and, with the Company Leased Real Property, collectively the “Company Real Property”). The fee
simple or leasehold (as applicable) title held by the Company or its Subsidiaries to the Company Real Property is free and clear of all Liens (other than Permitted Liens), except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. Section 3.01(p)(ii) of the Company Disclosure Letter contains a true and complete list by address and legal description of the Company Owned Real Property. Except as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (A) the buildings, structures, fixtures and improvements located on the Company Owned Real Property, taken as a whole, are adequately
maintained and are in good operating condition and repair for the requirements of the business of the Company and its Subsidiaries as currently conducted, ordinary wear and tear and deferred maintenance excepted, (B) to the Knowledge of the
Company, there are no pending or threatened condemnation Proceedings against the Company Real Property, (C) to the Knowledge of the Company, there are no material latent defects or material adverse physical conditions affecting the Company Real
Property or any of the facilities, buildings, component parts or other constructions, structures, erections, improvements, fixtures and fixed assets of a permanent nature annexed, affixed or attached to, or located on the Company Real Property. The
Company has provided to Parent true and correct copies of all title reports and title policies (including all exception documents referenced therein), zoning reports, appraisals, surveys and engineering reports in the possession or control of the
Company or any of its Subsidiaries regarding the Company Owned Real Property. There are no outstanding options, rights of first offer, rights of refusal or similar preemptive rights granted to third parties to purchase or lease any of the Company
Owned Real Property, or any portion thereof or interest therein. 
 (iii)    Except as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (A) each of the Company and its Subsidiaries has title to, or a valid leasehold interest in, as applicable, all personal property used in
their respective businesses free and clear of any Liens, except for Permitted Liens and (B) such personal property is, to the Knowledge of the Company, in good operating condition and repair, ordinary wear and tear and deferred maintenance
excepted. 
 (q)    Intellectual Property. 

(i)    Registered IP. Section 3.01(q)(i) of the Company Disclosure Letter sets forth a true
and complete list of all Registered Intellectual 

  
 30 

 
Property (including pending applications therefor) owned by the Company or any of its Subsidiaries and material to the business of the Company and its Subsidiaries, taken as a whole, as currently
conducted, whether considered individually or in the aggregate, that has not otherwise been abandoned or expired in the ordinary course of business consistent with past practice, indicating for each item the registration or application number and
the applicable filing jurisdiction (the “Company Registered Intellectual Property”). 

(ii)    Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, (A) the Company or a Subsidiary of the Company (1) is the sole and exclusive legal and beneficial, and with respect to the Company Registered Intellectual Property, record, owner of all right, title
and interest in and to the Company Intellectual Property, (2) has the valid and enforceable right to use, sell, convey, transfer, license and otherwise exploit the Company Intellectual Property, (3) has the valid and enforceable right to
use the Licensed Intellectual Property which is currently used or held for use in or necessary for the conduct of the businesses of the Company and its Subsidiaries as currently conducted, in each case, free and clear of all Liens other than
Permitted Liens, and (4) since June 30, 2014, has not received a written notice of breach of any agreement that licenses or grants to Company any Licensed Intellectual Property, and to the Knowledge of the Company, is not in breach of any
agreement that licenses or grants to Company any Licensed Intellectual Property, and (B) the consummation of the transactions contemplated hereunder will not result in the loss or impairment of or payment of any additional amounts with respect
to, nor require consent of any other Person in respect of, the Company’s or any of its Subsidiaries’ rights with respect to Company Intellectual Property or material Licensed Intellectual Property currently used in or necessary for the
conduct of the business of the Company or its Subsidiaries as currently conducted. 
 (iii)    Except as
has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (A) to the Knowledge of the Company, neither the Company nor any of its Subsidiaries has since June 30, 2014 infringed,
misappropriated, diluted or otherwise violated the Intellectual Property Rights of any Person and (B) as of the date of this Agreement, there are no investigations or Proceedings (including any oppositions, interferences or re-examinations) pending or, to the Knowledge of the Company, since June 30, 2014, threatened in writing against the Company or any of its Subsidiaries (1) alleging that the operation or conduct of the
Company’s or any of its Subsidiaries’ business infringes, misappropriates, dilutes or otherwise violates the Intellectual Property Rights of any Person or (2) challenging the validity, enforceability, registrability or ownership of
any Company Intellectual Property or the Company’s or any of its Subsidiaries’ rights with respect to any Company Intellectual Property or material Licensed Intellectual Property. 

(iv)    Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, 

  
 31 

 
(A) to the Knowledge of the Company, since June 30, 2014, no Person has misappropriated, infringed, diluted or otherwise violated any Company Intellectual Property or is
misappropriating, infringing, diluting or otherwise violating any Company Intellectual Property, (B) the Company and its Subsidiaries have taken all reasonable measures in accordance with normal industry practice to protect and to maintain the
confidentiality of the Company Intellectual Property and no Company Intellectual Property has been disclosed other than to Persons bound by valid written confidentiality agreements, (C) the Company and its Subsidiaries have taken reasonable
measures in accordance with normal industry practice to protect and maintain the Company Intellectual Property, and (D) the Company and its Subsidiaries have appropriate procedures in place designed to provide that all Intellectual Property
Rights conceived or developed by employees performing their duties for the Company and its Subsidiaries or by third parties performing research and development or other services for the Company or its Subsidiaries have been assigned to the Company
or its Subsidiary, as applicable. 
 (v)    Section 3.01(q)(v) of the Company Disclosure Letter sets
forth a true and complete list of all Contracts pursuant to which a Person has licensed or granted any right to the Company or any of its Subsidiaries involving any Licensed Intellectual Property or any other material Intellectual Property Rights or
agreed to provide any services (including hosted services) related to any material Intellectual Property Rights to the Company or any of its Subsidiaries, other than commercially available Software licensed under commercially available “shrink
wrap” or other comparable standard form licenses (“In-Licenses”). 

(vi)    Section 3.01(q)(vi) of the Company Disclosure Letter sets forth a true and complete list of
all Contracts pursuant to which the Company or any of its Subsidiaries has granted to any Person any rights, interests or licenses to any material Company Intellectual Property, excluding non-exclusive
licenses entered in the ordinary course of business (the “Out-Licenses,” and together with the In-Licenses, the “IP Contracts”).
Neither the Company nor any of its Subsidiaries has granted to any Person any exclusive or sole license under any material Company Intellectual Property. 

(vii)    Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, to the Knowledge of the Company, the Company Intellectual Property and the Company Systems do not, to the Knowledge of the Company, (A) contain any permanent viruses or any other contaminants (including
codes, commands, instructions, devices, techniques, bugs, web bugs, or design flaws) that access (without authorization), alter, delete, threaten, infect, assault, vandalize, defraud, disrupt, damage, disable, inhibit, or shut down any computer
systems, networks, infrastructures, devices, websites, databases, Software or other data or property; (B) cause or permit the unauthorized access (either internally or externally) to systems, networks, infrastructures, devices, websites,
databases, Software, or 

  
 32 

 
other data or property; (C) cause or permit the misappropriation of personal or corporate information or Intellectual Property from any computer systems, networks, infrastructures, devices,
websites, databases, Software, or other data or property or (D) cause or permit denial-of-service (DoS) attacks or distributed denial-of-service (DDoS) attacks (collectively, “Cyber Attacks”). The Company and its Subsidiaries have taken commercially reasonable steps to prevent Cyber Attacks on the Company Systems.

 (viii)    Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, the Company Software contains no Open Source Software. 

(r)    Privacy and Data Protection. Except as has not had and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect, (i) the Company and each of its Subsidiaries has complied at all times since June 30, 2014 with all applicable Privacy Laws relating to Personal Data, (ii) the Company
and each of its Subsidiaries have policies, programs and procedures that are in compliance with all applicable Privacy Laws, and (iii) since June 30, 2014, to the Knowledge of the Company, neither the Company nor any of its Subsidiaries
has received any written claim, complaint, inquiry, or notice from any Person related to the Company’s or such Subsidiary’s collection, processing, use, storage, security, and/or disclosure of Personal Data, alleging that any of these
activities are in violation of any Privacy Law. 
 (s)    Voting Requirements. Assuming the
accuracy of the representations and warranties set forth in Section 3.02(g), the affirmative vote of holders of at least two-thirds (2/3rds) of the outstanding Shares entitled to vote
thereon at the Company Shareholders Meeting or any adjournment or postponement thereof to adopt this Agreement (the “Company Requisite Vote”) is the only vote of the holders of any class or series of capital stock of the Company
necessary for the Company to adopt this Agreement and approve and consummate the Merger and the other transactions contemplated by this Agreement. 

(t)    Brokers and Other Advisors. No broker, investment banker, financial advisor or other Person,
other than Wells Fargo Securities LLC and Raymond James & Associates, Inc., is entitled to, or will be entitled to, any broker’s, finder’s, financial advisor’s or other similar fee or commission from the Company or any of its
Subsidiaries in connection with the Merger and the other transactions contemplated by this Agreement. 

(u)    Opinions of Financial Advisors. The Company Board has received the written opinions (or oral
opinions to be confirmed in writing) on or prior to the date hereof of each of Wells Fargo Securities LLC and Raymond James & Associates, Inc. to the effect that, as of the date of the meeting of the Company Board at which this Agreement
was approved by the Company Board, and subject to the assumptions, limitations, qualifications and other matters considered in connection with the preparation of such opinions, the Per Share Merger Consideration to be received by the holders of
Shares in the Merger pursuant to this Agreement is fair, from a financial point of view, to such holders. 

  
 33 

 (v)    State Takeover Statutes; No Rights Agreement.
The Company Board has taken all action necessary to render inapplicable to this Agreement and the transactions contemplated by this Agreement all potentially applicable state anti-takeover statutes or regulations (including Chapter 1704 of the OGCL)
and any similar provisions in the Company Articles of Incorporation and the Company Code of Regulations. Assuming the accuracy of the representations and warranties set forth in Section 3.02(g), as of the date of this
Agreement, no “fair price”, “business combination”, “moratorium”, “control share acquisition” or other state takeover Law or similar Law (collectively, “Takeover Statutes”) enacted by
any jurisdiction will prohibit or impair the consummation of the Merger or the other transactions contemplated by this Agreement. The Company does not have any shareholder rights plan, “poison pill” or similar arrangement in effect. 

(w)    Affiliate Transactions. There are not, and since June 30, 2014 there have not been, any
transactions, Contracts, arrangements, or understandings (each, an “Affiliate Transaction”) required to be disclosed under Item 404 of Regulation S-K promulgated under the Securities Act that
has not been disclosed in the Applicable SEC Reports filed prior to the date of this Agreement. The Company has made available to Parent copies of each material Contract or other relevant material documentation (including any amendments or
modifications thereto) available as of the date of this Agreement with respect to each Affiliate Transaction. 

(x)    Export; Foreign Corrupt Practices Act; UK Bribery Act. With respect to the business of the
Company and its Subsidiaries: 
 (i)    To the Knowledge of the Company, since that date which is five
(5) years prior to the date of this Agreement the Company and its Subsidiaries are and have been in compliance in all material respects with all applicable Laws concerning the trade of any products, technology, technical data and services
(“Export Control Laws”), including (A) the Export Administration Regulations (including the anti-boycott regulations contained therein) and Foreign Trade Regulations administered by the United States Department of Commerce;
(B) the ITAR administered by the United States Department of State; (C) those administered by the Office of Foreign Assets Control (“OFAC”) of the United States Department of the Treasury; and (D) those administered
by the Bureau of Customs and Border Protection of the United States Department of Homeland Security. There is no export-related or import-related legal or enforcement Proceeding and, to the Knowledge of the Company, there is no export related or
import related investigation or inquiry pending or threatened against the Company, any of its Subsidiaries or any officer, manager or director of the Company or any of its Subsidiaries (in his or her capacity as such) by or before (or, in the case
of a threatened matter, that would come before) any Governmental Entity. 

  
 34 

 (ii)    To the Knowledge of the Company, since the date
which is five (5) years prior to the date of this Agreement, neither the Company nor any of its Subsidiaries have provided unauthorized access to, and no Affiliate of the Company or its Subsidiaries (or any of their personnel, representatives,
or agents) has had unauthorized access to, export-controlled information in the possession of the Company or any of its Subsidiaries. To the Knowledge of the Company, no Affiliate of the Company or any of its Subsidiaries that is located outside of
the United States has had access to the electronic networks or systems of the Company or any of its Subsidiaries inside the United States in material violation of applicable Law. 

(iii)    To the Knowledge of the Company, no director, officer or employee of the Company or any of its
Subsidiaries is or, since the date which is five (5) years prior to the date of this Agreement, has been identified on any of the following: (A) the OFAC list of “Specially Designated Nationals and Blocked Persons”
(“SDNs”); (B) the Bureau of Industry and Security of the United States Department of Commerce “Denied Persons List,” “Entity List” or “Unverified List”; (C) the Office of Defense Trade Controls of
the United States Department of State “List of Debarred Parties,” including both administrative and statutory debarments; or (D) the Bureau of International Security and Nonproliferation of the United States Department of State
listing of “Nonproliferation Sanctions.” To the Knowledge of the Company, the Company and its Subsidiaries are not and, since the date which is five (5) years prior to the date of this Agreement, have not been involved in business
arrangements or otherwise engaged in transactions with or involving countries subject to economic or trade sanctions imposed by the United States Government, or with or involving SDNs, in violation of the regulations maintained by OFAC. 

(iv)    To the Knowledge of the Company, the Company and its Subsidiaries are not currently and have not
been, at any time since June 30, 2014, denied export privileges involving items subject to the Export Administration Regulations, or debarred or suspended from participating directly or indirectly in the export of defense articles, including
technical data, or in the furnishing of defense services, for which a license or approval is required under the ITAR. 

(v)    Since the date which is five (5) years prior to the date of this Agreement, the Company and
its Subsidiaries have not made any voluntary disclosure to the DDTC, the United States Department of Commerce’s Bureau of Industry and Security, OFAC, or any other Governmental Entity respecting compliance by the Company or any of its
Subsidiaries with Export Control Laws or with the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”). 

(vi)    The Company and the its Subsidiaries have had, since the date which is five (5) years prior
to the date of this Agreement, and have all necessary authority under the United States Export Control Laws to conduct their businesses as currently conducted in all material respects, including (A) necessary

  
 35 

 
permits for any import or export transactions, (B) necessary permits and clearances for the disclosure of information to foreign persons and (C) necessary registrations with any United
States Governmental Entity with authority to implement such Laws. 
 (vii)    To the Knowledge of the
Company, since the date which is five (5) years prior to the date of this Agreement, neither the Company nor its Subsidiaries nor any officer, director, employee, agent, or representative of the Company or any of its Subsidiaries (acting in
such capacity), nor any other Person acting at the direction of the Company or any of its Subsidiaries, has violated or is violating any provision of the FCPA or any other similar Law of any non-U.S.
jurisdiction. 
 (viii)    To the Knowledge of the Company, since the date which is five (5) years
prior to the date of this Agreement, the Company and its Subsidiaries are not and have not engaged in any activity, practice or conduct in violation of, and are not committing and have not committed an offence under, the UK Bribery Act 2010, to the
extent applicable. 
 (ix)    To the Knowledge of the Company, since the date which is five
(5) years prior to the date of this Agreement, neither the Company nor its Subsidiaries nor any officer, director, employee, agent, or representative of the Company or any of its Subsidiaries (acting in such capacity), nor any other Person
acting at the direction of the Company or any of its Subsidiaries, to the Knowledge of the Company, is or has been the subject of any investigation, inquiry or enforcement Proceedings by any governmental, administrative or regulatory body or any
customer regarding any offence or alleged offence, or liability or alleged liability, under the FCPA, and no such investigation, inquiry or Proceedings are pending or threatened. 

(x)    The Company and its Subsidiaries maintain on an ongoing basis written anti-corruption and
anti-bribery policies, procedures and guidelines and internal accounting controls which are designed to ensure compliance with the FCPA by the Company, its Subsidiaries and their respective officers, directors, employees, agents and representatives
(acting in such capacity) and other persons acting at the direction of the Company or any of its Subsidiaries. 

(y)    Government Contracts. 

(i)    Section 3.01(y)(i) of the Company Disclosure Letter identifies (A) each currently active
Government Contract awarded to the Company or any of its Subsidiaries or that relates to a program set forth on Section 3.01(y)(i) of the Company Disclosure Letter, or which remains open to audit periods (collectively, “Material
Government Contracts”), and (B) all outstanding quotations, bids, and proposals submitted by the Company or any of its Subsidiaries which, to the Knowledge of the Company, are still subject to acceptance by either a federal
Governmental Entity of the United States or any 

  
 36 

 
proposed prime contractor or subcontractor of a federal Governmental Entity of the United States with respect to any potential Government Contract (x) having aggregate future payments to the
Company and its Subsidiaries in excess of $250,000 or (y) for which the Company or any of its Subsidiaries provided any bid bond (collectively, “Government Bids”). 

(ii)    To the Knowledge of the Company, the Company has complied in all material respects with all
applicable statutory and regulatory requirements with respect to each Material Government Contract and Government Bid. 

(iii)    To the Knowledge of the Company, neither a federal Governmental Entity of the United States nor
any prime contractor or subcontractor of a federal Governmental Entity of the United States has notified the Company in writing that the Company or any of its Subsidiaries breached a requirement of a Material Government Contract, or violated any
applicable Law with respect to any Material Government Contract or with respect to any Government Bid. All representations, certifications, disclosures and warranties made by the Company and any of its Subsidiaries with respect to such Material
Government Contracts or Government Bids were current, accurate and complete in all material respects as of their effective date, and the Company and any of its Subsidiaries has complied in all material respects with such representations,
certifications, disclosures and warranty requirements. 
 (iv)    To the Knowledge of the Company, since
June 30, 2014, no written notices of terminations for convenience or default, show cause or cure notices and no stop work orders or notices of non-exercise of an option to extend a multi-year contract
have been issued to or against the Company or any of its Subsidiaries with respect to any Material Government Contract. 

(v)    To the Knowledge of the Company, since June 30, 2014, no costs incurred in respect of any
Material Government Contract by the Company or any of its Subsidiaries have been questioned, withheld or set-off, and remain unresolved or disallowed because of a finding or determination of any kind by a
Governmental Entity, including the Defense Contract Audit Agency, and no outstanding material costs invoiced or claimed by the Company or any of its Subsidiaries with respect to any Material Government Contract have been questioned, withheld or set-off, and remain unresolved or disallowed. 
 (vi)    To the
Knowledge of the Company, since June 30, 2014, no contracting officer’s final decisions have been issued by a federal Governmental Entity concerning and referencing any Material Government Contract. 

(vii)    To the Knowledge of the Company, none of the Company, its Subsidiaries or any of their respective
principals (as defined in FAR 52.209-5) is, or since June 30, 2014, has been, suspended, debarred or proposed for 

  
 37 

 
debarment from doing business with any federal Governmental Entity of the United States or has been declared non-responsible or ineligible for contracting
with or for any federal Governmental Entity of the United States. To the Knowledge of the Company, since June 30, 2014 the Company has not made a voluntary disclosure or a mandatory disclosure pursuant to the Federal Acquisition Regulation
(“FAR”) mandatory disclosure provisions (FAR 9.406-2, 9.407-2 & 52.203-13) to any federal Governmental
Entity of the United States and no facts exist which would reasonably be expected to give rise to a claim for fraud under federal or state Law. 

(viii)    To the Knowledge of the Company, there are no outstanding material claims or disputes against
the Company or any of its Subsidiaries by a federal Governmental Entity of the United States or by any prime contractor or subcontractor arising under or relating to any Material Government Contract 

(ix)    Neither the Company nor any of its Subsidiaries are under an organizational conflict of interest
(as defined in FAR Subpart 9.5) mitigation plan with respect to any Government Contract. 
 (x)    To
the Knowledge of the Company, all technical data, computer software (other than third party computer software), and computer software documentation delivered to a Governmental Entity of the U.S. or to any prime contractor by the Company or any of
its Subsidiaries in performance of a Material Government Contract, has included the proper restrictive legends identified in the FAR and the Department of Defense FAR Supplement to protect Intellectual Property Rights of the Company or any of its
Subsidiaries. 
 (xi)    To the Knowledge of the Company, neither the Company nor any of its
Subsidiaries has any pending requests for equitable adjustment, claims or disputes against a federal Governmental Entity of the United States, or against any prime contractor or subcontractor, arising under or relating to any Material Government
Contract, except for routine demands for payment. 
 (xii)    To the Knowledge of the Company, no
Material Government Contract or Government Bid is based on the Company or any of its Subsidiaries having some form of small business or preferred status afforded by applicable statute or regulation. 

(xiii)    To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has received
any past performance rating less than “satisfactory” with respect to any Material Government Contract with a federal Governmental Entity of the United States since June 30, 2014. 

(xiv)    Section 3.01(y)(xiv) of the Company Disclosure Letter sets forth true and complete listings
(including an indication of the type of clearance) of all facility security clearances issued by any federal Governmental Entity of the 

  
 38 

 
United States held by the Company and its Subsidiaries. To the Knowledge of the Company, the facility security clearances set forth in Section 3.01(y)(xiv) of the Company Disclosure Letter
and the personnel security clearances held by the officers, directors, managers and employees of the Company and its Subsidiaries constitute all of the facility and personnel security clearances necessary to conduct the business of the Company or
any of its Subsidiaries as it is currently being conducted. To the Knowledge of the Company, the Company and each of its cleared Subsidiaries holds, and at all relevant times since June 30, 2014, has held, at least a “satisfactory”
rating from the DSS with respect to their respective facility security clearances and there are no liabilities or obligations relating to or arising from any violation by the Company or any of its Subsidiaries of the NISPOM or prior failure by the
Company or any of its Subsidiaries to maintain at least a “satisfactory” rating from the DSS. The Company and its cleared Subsidiaries are in compliance with all national security obligations specified in the NISPOM. All facility security
clearances held by the Company and its Subsidiaries are currently in full force and effect. No termination for default, notice of rescission, notice of revocation, notice of wrongdoing, notice of breach, cure notice or show cause notice from the DSS
or any other federal Governmental Entity of the United States has been issued and remains unresolved with respect to any such facility security clearance. 

(z)    Customers and Suppliers. Section 3.01(z) of the Company Disclosure Letter contains a
true and complete list of the names of the ten (10) largest suppliers (with the dollar volume of purchases for each) of products and services to the Company and its Subsidiaries (the “Major Suppliers”) and the ten
(10) largest customers (with the dollar amount of revenue for each) of the Company and its Subsidiaries (the “Major Customers”), in each case for the fiscal year ended July 3, 2016. Since July 3, 2016 through the date
of this Agreement, none of the Major Suppliers or Major Customers has given the Company or any of its Subsidiaries written notice terminating, canceling, reducing the volume under, or renegotiating the pricing terms or any other material terms of
any Contract or relationship with the Company or any of its Subsidiaries or, to the Knowledge of the Company, threatened to take any of such actions. 

(aa)    No Other Representations or Warranties. Except for the representations and warranties
contained in Section 3.02, the Company acknowledges that neither Parent, Merger Sub nor any other Person on behalf of Parent or Merger Sub makes any express or implied representation or warranty with respect to Parent or
Merger Sub or with respect to any other information provided to the Company or its Representatives. 
 Section 3.02.
Representations and Warranties of Parent and Merger Sub. Except as set forth in the Parent Disclosure Letter (it being agreed that disclosure of any item in any section or subsection of the Parent Disclosure Letter shall also be deemed
disclosure with respect to any other section or subsection of this Agreement to the extent that it is reasonably apparent 

  
 39 

 
that such information is relevant to such other section or subsection), Parent and Merger Sub each represent and warrant to the Company as follows: 

(a)    Organization, Standing and Corporate Power. Each of Parent and Merger Sub is a legal entity
duly organized, validly existing and in good standing (where such concept is recognized under applicable Law) under the Law of its respective jurisdiction of organization and has all requisite corporate or similar power and authority to carry on its
business as presently conducted and is duly qualified or licensed to do business and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction where the nature of its business or the ownership, leasing or
operation of its properties makes such qualification or licensing necessary, other than where the failure to be so qualified, licensed or in good standing would not, individually or in the aggregate, reasonably be expected to prevent, materially
delay or impair the ability of Parent or Merger Sub to consummate the Merger and the other transactions contemplated by this Agreement. Parent has made available to the Company prior to the date of this Agreement a true and complete copy of the
organizational documents of Parent (the “Parent Organizational Documents”), and the comparable organizational documents of Merger Sub, in each case as amended and in effect as of the date of this Agreement. Parent and Merger Sub are
not in material violation of any of the provisions thereof. 
 (b)    Authority;
Noncontravention. 
 (i)    Each of Parent and Merger Sub has all requisite corporate power and
authority to execute and deliver this Agreement and, subject to receipt of the Parent Requisite Vote and, in the case of Merger Sub only, the delivery by Ultra Electronics Defense, Inc., its sole shareholder, of the written consent (as sole
shareholder of Merger Sub) referenced in Section 5.11, to perform its obligations under and to consummate the transactions contemplated by this Agreement. The execution, delivery and performance of this Agreement by Parent
and Merger Sub and the consummation by Parent and Merger Sub of the transactions contemplated by this Agreement have been duly and validly authorized by all necessary corporate action on the part of each of Parent and Merger Sub, subject to receipt
of the Parent Requisite Vote and, in the case of Merger Sub only, the delivery by Parent of the written consent (as sole shareholder of Merger Sub) referenced in Section 5.11. This Agreement has been duly executed and
delivered by each of Parent and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes a legal, valid and binding obligation of each of Parent and Merger Sub, enforceable against each of Parent and Merger
Sub in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency and other Laws of general applicability relating to or affecting creditors’ rights and to general equity principles. The Share Issuance has been duly and
validly authorized by all requisite corporate action on the part of Parent. 
 (ii)    The Parent Board
duly and validly adopted resolutions (A) determining that the Merger is fair to, and in the best interests of, Parent and the Parent Shareholders, (B) authorizing, approving and declaring advisable the execution, delivery and performance
of this Agreement and the transactions contemplated by this Agreement, including the Merger and the Share Issuance, 

  
 40 

 
(C) directing that the Parent Shareholder Circular be prepared and, subject to the approval of the UKLA, mailed, distributed or otherwise made available to Parent Shareholders in accordance with
the provisions of Section 5.02(b), (D) subject to the provisions of this Agreement, resolving that the Parent Shareholder Resolution should be submitted to a vote of the Parent Shareholders at the Parent Shareholders
Meeting; and (E) subject to the fiduciary duties of the Parent Board and the provisions of Section 5.02(e), resolving that the Parent Board recommend in the Parent Shareholder Circular that the Parent Shareholders vote
in favor of the Parent Shareholder Resolution (the “Parent Board Recommendation”), which resolutions, as of the date of this Agreement, have not been rescinded, modified or withdrawn in any way. 

(iii)    The board of directors of Merger Sub duly and validly adopted resolutions (A) determining
that the Merger is fair to, and in the best interests of, Merger Sub and its shareholder and authorizing Merger Sub to enter into this Agreement and consummate the Merger and the other transactions contemplated by this Agreement on the terms and
subject to the conditions set forth in this Agreement, (B) authorizing, approving and declaring advisable the execution, delivery and performance of this Agreement and the transactions contemplated by this Agreement, including the Merger and
(C) recommending that the sole shareholder of Merger Sub adopt this Agreement, which resolutions of Merger Sub, in each case, have not been rescinded, modified or withdrawn in any way. 

(iv)    The execution, delivery and performance by Parent and Merger Sub of this Agreement do not, and the
consummation of the Merger and the other transactions contemplated by this Agreement and compliance with the provisions of this Agreement will not, conflict with, or result in any breach or violation of, or default, with or without notice, lapse of
time or both, under, or give rise to any right or obligation (including a right of termination, modification, cancellation or acceleration of any right or obligation or any right of first refusal, participation or similar right) under, or cause the
loss of any benefit under, or require consent under, or result in the creation of any Lien upon any of the properties or assets of Parent or Merger Sub or any of their respective Subsidiaries under, any provision of (A) subject to receipt of
the Parent Requisite Vote, the Parent Organizational Documents or the comparable organizational or governing documents of any of Parent’s Subsidiaries, including Merger Sub, (B) subject to the filings and other matters referred to in the
immediately following sentence, (1) any Permit or Contract to which Parent or Merger Sub or any of their respective Subsidiaries is a party or by which any of their respective properties or assets are bound or (2) any Law applicable to
Parent or Merger Sub or any of their respective Subsidiaries or any of their respective properties or assets, other than, in the case of foregoing clause (B), any such conflicts, violations, defaults, rights, losses or Liens that would not,
individually or in the aggregate, reasonably be expected to prevent, materially delay or impair the ability of Parent or Merger Sub to perform any of its obligations under this Agreement or to consummate the Merger and the other transactions
contemplated 

  
 41 

 
by this Agreement. No consent, approval, order, waiver or permit of, action by, authorization of, or registration, declaration or filing with, or notice to, any Governmental Entity is required to
be obtained or made, or in the case of the CFIUS Approval, advisable to be obtained, by or with respect to Parent or Merger Sub, any of their respective Subsidiaries or any of Parent’s or Parent’s Subsidiaries’ material assets or
businesses in connection with the execution, delivery and performance of this Agreement by Parent and Merger Sub or the consummation by Parent and Merger Sub of the transactions contemplated by this Agreement, except for (I) the filing of a
premerger notification and report form by Parent and Merger Sub under the HSR Act and any other filings required or advisable under any applicable non-United States antitrust or competition Law,
(II) joint notification to, and submission of any supplementary information and any mitigation agreement requested by, CFIUS in order to obtain the CFIUS Approval, (III) filings with, and submissions as may be advisable to, the DSS or
other agency of the U.S. government in accordance with the NISPOM, (IV) notification to, and submission of any supplementary information and any mitigation agreement requested by, DDTC pursuant to Section 122.4(b) and other provisions of
ITAR, (V) the filing with the SEC of such reports and other documents under the Exchange Act and the rules and regulations promulgated thereunder as may be required in connection with this Agreement and the transactions contemplated by this
Agreement, (VI) the filing of the Certificate of Merger with the Secretary of State of the State of Ohio, (VII) release of the Merger Announcement in compliance with the Listing Rules, approval of the Parent Shareholder Circular and any
amendments or supplements thereto by (and the filing of the Parent Shareholder Circular and any amendments or supplements thereto with) the UKLA and publication and filing with the UKLA and the UK Financial Conduct Authority of such other documents
and information as may be required pursuant to the Listing Rules or otherwise in connection with the transactions contemplated by this Agreement, (VIII) filing with the London Stock Exchange plc of such documents and information as may be
required in connection with the transactions contemplated by this Agreement, (IX) receipt of the Parent Requisite Vote, (X) any consents, approvals, orders, waivers, permits, actions, authorizations, registrations, declarations, filings
and notices required to be made or obtained by the Company or any of its Affiliates or as a result of the identity of the Company or any of its Affiliates and (XI) such other consents, approvals, orders, waivers, permits, actions,
authorizations, registrations, declarations, filings and notices, the failure of which to be obtained or made would not, individually or in the aggregate, reasonably be expected to prevent, materially delay or impair the ability of Parent or Merger
Sub to consummate the Merger and the other transactions contemplated by this Agreement. 

(c)    Disclosure Documents. 

(i)    The Merger Announcement, the Parent Shareholder Circular, and any amendment or supplement thereto,
and any other documents filed by Parent with the UKLA or published by Parent pursuant to the Listing Rules, in each case in connection with the transactions contemplated by this 

  
 42 

 
Agreement, will in all material respects, at the time the relevant document or announcement in its final form is published, issued or released, (A) comply in all material respects with the
Listing Rules and any other applicable Laws and (B) (1) be in accordance with the facts and (2) not contain any omission likely to affect the import of such information. Notwithstanding the foregoing, Parent makes no representation or
warranty with respect to statements made, or incorporated by reference into, in any of the foregoing documents or announcements based on information supplied by or on behalf of the Company or any of its Subsidiaries or Affiliates expressly for
inclusion or incorporation by reference therein. 
 (ii)    All of the information relating to Parent
and its Subsidiaries supplied in writing by, or on behalf of, Parent, its Subsidiaries or its Affiliates to the Company expressly for inclusion in, or incorporation by reference into, the Proxy Statement, or any amendment or supplement thereto, in
each case in connection with the transactions contemplated by this Agreement will not, at the time the Proxy Statement and any amendments or supplements thereto are first mailed to the Company Shareholders and at the time of the Company Shareholders
Meeting, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.

 (d)    Litigation. Except as has not prevented, materially delayed or impaired, and would not
reasonably be expected to prevent, materially delay or impair, the ability of Parent or Merger Sub to consummate the Merger and the other transactions contemplated by this Agreement, (i) there is no Proceeding pending or, to the Knowledge of
Parent, threatened against, or pending or, to the Knowledge of Parent, threatened material governmental or regulatory investigation of, Parent or any of its Subsidiaries and (ii) there is no injunction, order, judgment, ruling, decree or writ
of any Governmental Entity outstanding or, to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries. 

(e)    Brokers and Other Advisors. No broker, investment banker, financial advisor or other Person,
other than Guggenheim Securities, LLC, RBC Europe Limited and Investec Bank plc, is entitled to, or will be entitled to, any broker’s, finder’s or financial advisor’s fee or commission or similar payments from Parent or any of its
Affiliates in connection with the Merger and the other transactions contemplated by this Agreement. 

(f)    Ownership and Operation of Merger Sub. The authorized capital stock of Merger Sub consists
solely of 100 common shares, no par value, 100 of which are validly issued and outstanding as of the date hereof. All of the issued and outstanding capital stock of Merger Sub is, and at and immediately prior to the Effective Time will be, owned by
Ultra Electronics Defense, Inc., an indirect wholly owned Subsidiary of Parent. Merger Sub has been formed solely for the purpose of engaging in the transactions contemplated by this Agreement and prior to the

  
 43 

 
Effective Time will have engaged in no other business activities and will have no assets, liabilities or obligations of any nature other than those incident to its formation pursuant to this
Agreement and the Merger and the other transactions contemplated by this Agreement. 

(g)    Ownership of Shares and Derivatives. None of Parent, Merger Sub or any of their Subsidiaries
beneficially owns (as defined in Rule 13d-3 under the Exchange Act) any Shares or any securities that are convertible into or exchangeable or exercisable for Shares, or holds any rights to acquire or vote any
Shares, or any option, warrant, convertible security, stock appreciation right, swap agreement or other security, contract right or derivative position, whether or not presently exercisable, that provides Parent, Merger Sub, or any of their
respective Subsidiaries with an exercise or conversion privilege or a settlement payment or mechanism at a price related to the value of the Shares or a value determined in whole or part with reference to, or derived in whole or part from, the value
of the Shares, in any case without regard to whether (i) such derivative conveys any voting rights in such securities to such Person, (ii) such derivative is required to be, or capable of being, settled through delivery of securities or
(iii) such Person may have entered into other transactions that hedge the economic effect of such derivative. None of Parent, Merger Sub or any of their Subsidiaries has beneficially owned during the three (3) years immediately preceding
the date of this Agreement a number of Shares that would make it an “interested shareholder” (as such term is defined in Section 1704.01(C) of the OGCL) of the Company. 

(h)    Voting Requirements. The affirmative vote of a simple majority of the votes cast on a show of
hands by the Parent Shareholders present in person or by proxy at a duly convened and held general meeting of Parent (or any adjournment thereof, such meeting or adjourned meeting being the “Parent Shareholders Meeting“) passing a
resolution (the “Parent Shareholder Resolution”) to approve the transactions contemplated by this Agreement (including the Merger but excluding, for the avoidance of doubt, the Share Issuance), or if a poll is called, the
affirmative vote of a simple majority of the votes cast on a poll by the Parent Shareholders present in person or by proxy at the Parent Shareholders Meeting passing the Parent Shareholder Resolution, in each case, for the purposes of Chapter 10 of
the Listing Rules (the “Parent Requisite Vote”) is the only vote of the holders of any class of capital stock of Parent necessary for Parent to approve this Agreement and approve and consummate the Merger and the other transactions
contemplated by this Agreement. 
 (i)    Financing. 

(i)    Sufficiency of Funds. Subject to the receipt of the Equity Financing, Parent has available
to it, and at the Closing Parent will have available to it, sufficient available funds to pay the aggregate Per Share Merger Consideration to holders of Shares pursuant to Section 2.01(a), all amounts payable to holders of
Company RSUs and Company Options pursuant to Section 2.02, any repayment or refinancing of Indebtedness of the Company required in connection with the Merger or otherwise contemplated by this Agreement and all

  
 44 

 
fees and expenses of Parent, Merger Sub and the Surviving Corporation in connection with the Equity Financing, the Merger and the transactions contemplated by this Agreement. Parent has no
obligations, commitments, restrictions or liabilities of any kind which would reasonably be expected to adversely affect the availability of such funds. 

(ii)    Equity Agreements. Parent has provided to the Company a true and complete copy of the
executed placing agreement by and between Parent and Investec Bank plc (the “Placing Agreement”) to which Parent is a party and which will be used in connection with funding the aggregate Per Share Merger Consideration payable
pursuant to this Agreement and payment of other amounts payable by Parent to consummate the transactions expressly contemplated hereby. Pursuant to the Placing Agreement, the placing agent thereto (the “Placing Agent”) has
undertaken, as agent for Parent, to use its reasonable endeavors to procure subscribers for shares of Parent in the Share Issuance on the terms and subject to the conditions set forth in the Placing Agreement, and if the Placing Agent fails to
procure subscribers for such shares, the Placing Agent will, on the terms and subject to the conditions set forth in the Placing Agreement, itself subscribe for such shares, which Share Issuance is expected to provide, subject to the terms and
conditions therein, aggregate net proceeds of approximately $173,800,000 to Parent (applying a GBP/USD exchange rate of GBP1.00/USD1.30) (the “Equity Financing”). 

(iii)    The Placing Agreement is valid and binding and in full force and effect with respect to Parent
and its Subsidiaries that are a party thereto and, to the Knowledge of Parent, the other parties thereto. No event has occurred that, with or without notice or lapse of time or both, would constitute a material breach, material default or failure of
a material condition of the Placing Agreement by Parent or any of its Subsidiaries or, to the Knowledge of Parent, any of the other parties thereto. To the Knowledge of Parent, there is no reason to believe that (A) the Placing Agreement may be
terminated by any of the parties thereto or (B) any of the conditions set forth in the Placing Agreement of any of the parties to the Placing Agreement shall not be satisfied prior to the Closing Date. There are no Contracts to which Parent or
any of its Subsidiaries is party other than the Placing Agreement related to the funding of any portion of the Equity Financing. 

(j)    Access to Information. Each of Parent and Merger Sub has conducted its own independent
investigation and analysis of the business, operations, assets, liabilities, results of operations, condition and prospects of the Company and its Subsidiaries and it and its Representatives have received access to such books, records and
facilities, equipment, Contracts and other assets of the Company and its Subsidiaries that it and its Representatives have requested for such purposes and that it and its Representatives have had the opportunity to meet with management of the
Company to discuss the foregoing, and it and its Representatives have not relied on any representation, warranty, or any other statement by any Person on behalf of the Company or any of its Subsidiaries, other than the representations and warranties
expressly set forth in Section 3.01. 

  
 45 

 (k)    Sanctions. To the Knowledge of Parent, no
director, officer or employee of Parent or Merger Sub is identified on any of the following: (i) the OFAC list of SDNs; (ii) the Bureau of Industry and Security of the United States Department of Commerce “Denied Persons List,”
“Entity List” or “Unverified List”; (iii) the Office of Defense Trade Controls of the United States Department of State “List of Debarred Parties,” including both administrative and statutory debarments; or
(iv) the Bureau of International Security and Nonproliferation of the United States Department of State listing of “Nonproliferation Sanctions”. 

(l)    No Other Representations or Warranties. Except for the representations and warranties
contained in Section 3.01, each of Parent and Merger Sub acknowledges that neither the Company nor any other Person on behalf of the Company makes any express or implied representation or warranty with respect to the
Company or with respect to any other information provided to Parent or Merger Sub, including any information, documents, projections, forecasts or other material made available to Parent or Merger Sub or their Representatives in any virtual data
room maintained by or on behalf of the Company or any confidential information package or management presentations in expectation of the transactions contemplated by this Agreement, including with respect to the completeness, accuracy or currency of
any such information. 
 ARTICLE IV 

COVENANTS RELATING TO CONDUCT OF BUSINESS 

Section 4.01. Conduct of Business Pending the Merger. 

(a)    From the date of this Agreement until the earlier of the Effective Time and the termination of this
Agreement in accordance with ARTICLE VII, except as otherwise expressly contemplated by this Agreement, set forth in Section 4.01(a) of the Company Disclosure Letter, required by applicable Law, requested by Parent to be undertaken in
connection with the MDS Sale or consented to in writing by Parent (such consent not to be unreasonably withheld, conditioned or delayed), (x) the Company shall, and shall cause each of its Subsidiaries to, carry on its business in the ordinary
course consistent with past practice and shall use commercially reasonable efforts to (I) preserve substantially intact its current business organizations, (II) maintain its goodwill and preserve its relationships with significant
customers and suppliers and other Persons with whom it has material business relationships in a manner consistent with past practice and (III) retain the services of its officers and key employees as of the date of this Agreement and
(y) without limiting the foregoing, the Company shall not, and shall cause it Subsidiaries not to: 

(i)    declare, set aside or pay any dividends on, or make any other distributions (whether in cash, stock
or property) in respect of, any of its capital stock or other voting securities or equity interests, other than cash dividends or distributions by a wholly owned Subsidiary of the Company to the Company or another wholly owned Subsidiary of the
Company; 

  
 46 

 (ii)    adjust, split, combine or reclassify any of its
capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock, other than transactions solely between or among the Company and its wholly owned Subsidiaries;

 (iii)    purchase, redeem or otherwise acquire any shares of its or its Subsidiaries’ capital
stock or other securities or any rights, warrants or options to acquire any such shares or other securities, other than (A) the withholding of Shares in the ordinary course of business consistent with past practice to satisfy Tax obligations or
the exercise price with respect to awards granted pursuant to the Company Equity Award Plans and (B) the acquisition by the Company in the ordinary course of business consistent with past practice of awards granted pursuant to the Company
Equity Award Plans in connection with the forfeiture of such awards or rights, in each case, with respect to awards that are outstanding as of the date hereof and in accordance with their terms as of the date hereof or granted after the date hereof
in accordance with this Agreement; 
 (iv)    issue, deliver, sell, pledge, dispose of, encumber or
subject to any Lien any shares of its capital stock, ownership interests, any other voting securities (other than the issuance of shares by a wholly owned Subsidiary of the Company to the Company or another wholly owned Subsidiary of the Company),
or any securities convertible into, exercisable or exchangeable for, or any rights, warrants or options to acquire, any such shares, ownership interests, voting securities or convertible securities or any “phantom” stock,
“phantom” stock rights, stock appreciation rights or stock-based performance units, other than upon the vesting or settlement of Restricted Shares, Company RSUs and Company Options granted under the Company Equity Award Plans that are
outstanding as of the date hereof or granted after the date hereof in accordance with this Agreement, in each case, vested or settled in accordance with their terms; 

(v)    amend, waive or rescind (A) the Company Articles of Incorporation or the Company Code of
Regulations or (B) the comparable organizational or governing documents of any Subsidiary of the Company, other than, in the case of this clause (B), amendments that effect solely ministerial changes to such documents; 

(vi)    merge or consolidate with any Person, or purchase property or assets (including equity interests)
of any Person, or make capital contributions to any Person, in each case, other than (A) purchases of inventory, equipment and other personal property (1) in the ordinary course of business or (2) for such purchases not in the
ordinary course of business, in an amount not in excess of $1,000,000 in the aggregate, or (B) transactions solely between or among the Company and its wholly owned Subsidiaries; 

  
 47 

 (vii)    sell, license, lease, transfer, assign, divest,
cancel, abandon or otherwise dispose of or permit a Lien (other than a Permitted Lien) to be placed upon any of its properties, rights or assets (including Company Intellectual Property) with a value in excess of $1,000,000 in the aggregate, other
than (A) sales, licenses or other dispositions of assets in the ordinary course of business consistent with past practice, (B) sales, transfers and dispositions of obsolete, non-operating or
worthless assets or properties, (C) sales, licenses, leases, transfers or other dispositions made in connection with any transaction between or among the Company and its wholly owned Subsidiaries or (D) pursuant to Contracts existing as of
the date hereof; 
 (viii)    incur, create, assume, redeem, prepay, defease, cancel, or, in any
material respect, modify any Indebtedness or enter into any arrangement having the economic effect of any of the foregoing, other than (A) borrowings and prepayments under the Company’s existing credit facilities that are made solely for
working capital purposes in the ordinary course of business consistent with past practice, (B) the incurrence, redemption, prepayment, defeasance, cancellation or modification of Indebtedness of the Company or a wholly owned Subsidiary of the
Company to the Company or a wholly owned Subsidiary of the Company, (C) the incurrence, creation or assumption of Indebtedness to replace, renew, extend, refinance or refund any existing Indebtedness on substantially the same or more favorable
terms to the Company or a Subsidiary of the Company than such existing Indebtedness and (D) with respect to any Indebtedness not incurred, created, assumed, redeemed, prepaid, defeased, cancelled or modified in accordance with the foregoing
clauses (A) through (C), the incurrence, creation, assumption, redemption, prepayment, defeasance, cancellation or modification of Indebtedness not in excess of $1,000,000 in aggregate principal amount outstanding; 

(ix)    subject to Section 5.16, settle Proceedings or investigations with a
Governmental Entity or third party, in each case, threatened, made or pending against the Company or any of its Subsidiaries, in excess of $1,000,000 in the aggregate for all such Proceedings or investigations, other than the settlement of
Proceedings or investigations made in the ordinary course of business or for an amount (excluding any amounts that are covered by any insurance policies of the Company or its Subsidiaries, as applicable) not in excess of the amount reflected or
reserved therefor in the most recent financial statements (or the notes thereto) of the Company included in the Applicable SEC Reports; provided, however, that in no event shall the Company or any of its Subsidiaries settle any
Proceeding or investigation if such settlement involves injunctive relief against the Company or any of its Subsidiaries or restricts the conduct of the Company’s business following the Effective Time; 

(x)    except as required pursuant to the terms of any Company Benefit Plan or other written agreement
disclosed to Parent in the Company Disclosure Letter, in each case, as in effect on the date hereof, (A) promote any officers or employees to a position of Vice President or more senior without first

  
 48 

 
consulting with Parent and considering its views in good faith, (B) grant to any director or executive officer or employee any increase in compensation or pay, or award any bonuses or
incentive compensation other than, in the case of non-executive employees, in the ordinary course of business consistent with past practice, (C) grant to any current or former director, executive officer
or employee any increase in severance, change of control, retention or termination pay, (D) grant or amend any equity awards, (E) enter into any new, or modify any existing, employment, consulting, severance, retention or termination
agreement with any (x) current or former director, (y) executive officer or (z) any other employee or individual consultant pursuant to which the annual base salary of such individual under such agreement exceeds $200,000, (F)
establish, adopt, enter into, terminate, waive or amend in any material respect any collective bargaining agreement or material Company Benefit Plan or (G) take any action to accelerate any rights or benefits under any Company Benefit Plan;
provided, however, that the foregoing shall not restrict the Company or any of its Subsidiaries from entering into or making available to newly hired employees or to employees in the context of promotions based on job performance or
workplace requirements, in each case, in the ordinary course of business, plans, agreements, benefits and compensation arrangements (including incentive grants, but excluding any individual severance arrangements or any options or other equity
awards) that have a value that is consistent with the past practice of making compensation and benefits available to newly hired or promoted employees in similar positions; 

(xi)    other than as required (A) by GAAP (or any interpretation thereof), including pursuant to
standards, guidelines and interpretations of the Financial Accounting Standards Board or any similar organization or (B) by Law, including pursuant to SEC rule or policy, make any change in accounting methods, principles or practices affecting
the consolidated assets, liabilities or results of operations of the Company where such change would reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole; 

(xii)    (A) make any material Tax election or change or rescind any material Tax election or Tax
method of accounting, (B) settle or compromise any Tax liability or, with respect to any claim or assessment that does not relate to U.S. federal income Tax, consent to any claim or assessment relating to a material amount of Taxes,
(C) other than in the ordinary course of business consistent with past practice, file any amended Tax Return, (D) enter into any Tax allocation, sharing, indemnity or closing Contract or similar arrangement relating to a material amount of
Taxes or (E) consent to any extension or waiver of the statute of limitations period applicable to any material Taxes; 

(xiii)    materially amend or modify or cancel or terminate, or waive any material rights under, any
Material Contract or waive any material rights with respect to any material Company Real Property; 

  
 49 

 (xiv)    enter into any Contract that would constitute a
“Material Contract” under clauses (i), (iv), (v), (xiii) and (xv) of Section 3.01(i) had it been in existence prior to or on the date of this Agreement, except as otherwise expressly permitted under this
Section 4.01(a); 
 (xv)    adopt or enter into a plan of complete or partial
liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization, other than the Merger and any other mergers, consolidations, restructurings, recapitalizations or other reorganizations solely between or among
the Company and its wholly owned Subsidiaries; or 
 (xvi)    other than in the ordinary course of
business consistent with past practice, make capital expenditures in excess of $1,000,000 in the aggregate other than in accordance with the Company’s capital expenditure plan previously provided to Parent; 

(xvii)    fail to keep in force any Insurance Policy or comparable replacement or revised provisions
providing insurance coverage with respect to the assets, operations and activities of the Company and its Subsidiaries as are currently in effect; or 

(xviii)    authorize any of, or commit or agree to take any of, the foregoing actions prohibited pursuant
to clauses (i) through (xvii) of this Section 4.01(a). 
 (b)    From the
date of this Agreement until the earlier of the Effective Time and the termination of this Agreement in accordance with ARTICLE VII, except as expressly permitted by this Agreement, neither Parent nor the Company shall, and each shall cause
its respective Subsidiaries not to, take any action that is reasonably likely to prevent, or materially impair or delay, the consummation of the Merger. 

Section 4.02. Acquisition Proposals. 

(a)    No Solicitation or Negotiation. The Company agrees that, except as may be requested, or
consented to in writing, by Parent to be undertaken by the Company in connection with the MDS Sale or as permitted by this Section 4.02, neither it nor any of its Subsidiaries nor any of the officers, directors and
employees of it or its Subsidiaries or any of its or its Subsidiaries’ investment bankers, attorneys, accountants and other advisors or representatives (such directors, officers, employees, investment bankers, attorneys, accountants and other
advisors or representatives, collectively, “Representatives”) retained by the Company or its Subsidiaries in connection with the Merger or the other transactions contemplated hereby (collectively such Representatives, the
“Company Transaction Representatives”) shall, and it shall instruct and use its reasonable best efforts to cause its and its Subsidiaries’ Representatives retained by the Company or its Subsidiaries other than in connection
with the Merger or the other transactions contemplated hereby 

  
 50 

 
(collectively such Representatives, the “Other Company Representatives”), in each case, not to, directly or indirectly, (i) initiate, solicit or knowingly take any action to
facilitate, encourage or solicit any Acquisition Proposal or the making of any proposal that would reasonably be expected to lead to an Acquisition Proposal, (ii) participate in any discussions or negotiations regarding, or furnish or provide
any non-public information to any Person in connection with, any Acquisition Proposal or afford access to the business, properties, assets, books or records of the Company or any of its Subsidiaries to, or
knowingly assist, participate in, facilitate or encourage any effort relating to an Acquisition Proposal by, any Person that is seeking to make, or has made, an Acquisition Proposal, (iii) except as required by applicable Law, amend or grant
any waiver or release under any standstill or similar agreement with respect to any class of equity securities of the Company or any of its Subsidiaries, or (iv) enter into any letter of intent, memorandum of understanding, agreement in
principle, merger agreement, acquisition agreement or other similar agreement relating to an Acquisition Proposal. In furtherance of the foregoing, except as may be requested, or consented to in writing, by Parent to be undertaken by the Company in
connection with the MDS Sale or as permitted by this Section 4.02, the Company shall and shall cause its Subsidiaries and its and their Company Transaction Representatives to, and shall instruct and use its reasonable best
efforts to cause its and its Subsidiaries’ Other Company Representatives to, immediately cease any solicitation, discussions, or negotiations with any Person (other than Parent, Parent’s Affiliates and their respective Representatives)
with respect to an Acquisition Proposal or other proposal that would reasonably be expected to lead to an Acquisition Proposal that existed on or prior to the date hereof. The Company shall promptly request the return or destruction of all non-public information furnished by or on its behalf to any Person and its Representatives (other than Parent, Parent’s Affiliates and their respective Representatives) with respect to any Acquisition Proposal
prior to the date hereof. It is understood that any violation of the restrictions on the Company set forth in this Section 4.02 by any Subsidiary of the Company or any Company Transaction Representative shall be deemed a
breach of this Section 4.02 by the Company. 
 (b)    Notice. Until the
Effective Time, promptly (and, in any event, within forty-eight (48) hours) after receipt by the Company, any of its Subsidiaries or their respective Representatives of any Acquisition Proposal or any request for
non-public information or inquiry relating to any Acquisition Proposal, the Company shall provide Parent with notice of such receipt, the identity of the Person making any such Acquisition Proposal or request
for non-public information or inquiry, the material terms and conditions of such Acquisition Proposal, request or inquiry, as applicable, and copies of any documents evidencing or delivered in connection
therewith. The Company shall keep Parent informed on a reasonably current basis of any material developments, discussions or negotiations regarding any such Acquisition Proposal, request or inquiry (including any changes thereto), and shall promptly
(and, in any event, within forty-eight (48) hours after receipt) provide to Parent copies of all correspondence and written materials sent or provided to the Company or any of its Subsidiaries that describes any terms or conditions of any
Acquisition Proposal, request or inquiry.

  
 51 

 (c)    Information Exchange; Discussions or
Negotiation. Notwithstanding anything to the contrary contained in Section 4.02(a), prior to obtaining the Company Requisite Vote, in the event that the Company, any of its Subsidiaries or any of their respective
Representatives receive from any Person, after the date of this Agreement, an unsolicited, bona fide written Acquisition Proposal that did not result from a breach of this Section 4.02, and that the Company Board
determines in good faith, after consultation with its financial advisors and outside legal counsel, is, or is reasonably likely to lead to, a Superior Proposal, then the Company may (i) furnish or provide information to the Person making such
Acquisition Proposal and its Representatives pursuant to an Acceptable Confidentiality Agreement; provided, however, that the Company shall promptly (and, in any event, within forty-eight (48) hours) make available to Parent and
its Representatives any written material non-public information concerning the Company or its Subsidiaries that is provided to any Person pursuant to this Section 4.02(c) (i) to
the extent such information was not previously made available to Parent and its Representatives and (ii) engage in discussions and negotiations with such Person and its Representatives with respect to such Acquisition Proposal. As used in this
Agreement, “Acceptable Confidentiality Agreement“ means any confidentiality agreement entered into by the Company before or after the date of this Agreement that contains confidentiality provisions that are not less favorable in the
aggregate to the Company than those contained in the Confidentiality Agreement; provided, however, that any such confidentiality agreement may contain provisions that permit the Company to comply with the terms of this Agreement, but
shall not include in any event any provisions requiring exclusive negotiations, a copy of which confidentiality agreement shall be provided to Parent promptly after the execution thereof. 

(d)    No Change in Recommendation; Exceptions. 

(i)    Except as set forth in this Section 4.02(d), the Company Board (including
any committee thereof) shall not (A) withdraw, fail to make or modify in a manner adverse to Parent or Merger Sub, or propose to withdraw, fail to make or modify in a manner adverse to Parent or Merger Sub, the Company Board Recommendation,
(B) fail to include, in the Proxy Statement, the Company Board Recommendation, (C) approve, adopt or recommend, or propose to approve, adopt or recommend, any Acquisition Proposal, (D) if any Acquisition Proposal is structured as a
tender or exchange offer that is commenced, fail to recommend against acceptance of such tender or exchange offer by the Company Shareholders within ten (10) Business Days of commencement thereof pursuant to
Rule 14d-2 of the Exchange Act, or (E) agree or resolve to take actions set forth in the foregoing clauses (A) through (D) (any of the foregoing clauses (A) through (E), a “Company
Adverse Recommendation Change”). 
 (ii)    Notwithstanding
Section 4.02(d)(i), at any time prior to obtaining the Company Requisite Vote, in the event that the Company, any of its Subsidiaries or any of their respective Representatives receive from any Person, after the date of
this Agreement, an unsolicited, bona fide written Acquisition 

  
 52 

 
Proposal that did not result from a breach of this Section 4.02 and that the Company Board determines in good faith after consultation with its financial advisors and
outside legal counsel is a Superior Proposal, the Company Board may, in response to such Superior Proposal, (A) effect a Company Adverse Recommendation Change or (B) terminate this Agreement pursuant to and in accordance with
Section 7.01(c)(i) in order to enter into a definitive, written agreement concerning such Superior Proposal; provided, however, that prior to taking any such action, and as a condition precedent to taking any
such action, (1) the Company shall provide Parent with at least four (4) Business Days’ prior written notice of the Company Board’s intention to take such action (which notice shall specify the reasons therefor and include an
unredacted copy of any relevant proposed transaction agreements, the identity of the party making such Superior Proposal and the material terms thereof) during which period Parent may propose revisions to the terms of the transactions contemplated
by this Agreement (it being understood that, in the event of any change to the financial terms or any other material terms of any such Superior Proposal, such notice period shall be extended to ensure that at least two (2) Business Days remain
in such notice period following any such change), (2) the Company Board shall have discussed and negotiated, and shall have caused its Representatives to discuss and negotiate, in good faith with Parent during such notice period to the extent Parent
reasonably desires to discuss and negotiate and (3) the Company Board, at or after 5:00 p.m. Eastern Time on the final day of such notice period, shall have considered in good faith the effect of any irrevocable written binding offer proposed
by Parent to amend the terms of this Agreement (such amendment, the “Offered Amendment”) and shall have determined, after consideration and consultation with its financial advisors and outside legal counsel, and taking into
consideration such Offered Amendment, that any such Acquisition Proposal continues to be a Superior Proposal and that the failure to take such action would continue to be inconsistent with the Company Board’s fiduciary duties under applicable
Law. 
 (iii)    Notwithstanding Section 4.02(d)(i), other than in connection
with an Acquisition Proposal (which shall be governed by Section 4.02(d)(ii)), if an Intervening Event occurs and the Company Board determines in good faith after considering advice from its financial advisors and outside
legal counsel that the failure to effect a Company Adverse Recommendation Change would be inconsistent with the Company Board’s fiduciary duties under applicable Law, the Company Board may, in response to such Intervening Event, effect a
Company Adverse Recommendation Change; provided, however, that prior to taking any such action, (A) the Company shall provide Parent with at least four (4) Business Days’ prior written notice of the Company Board’s
intention to take such action (which notice shall specify the reasons therefor and include a reasonably detailed description of the Intervening Event) during which period Parent may propose revisions to the terms of the transactions contemplated by
this Agreement, (B) the Company Board shall have negotiated, and shall have caused its Representatives to negotiate, in good faith with Parent during such notice period to the extent Parent reasonably desires to negotiate and (C) the
Company Board, at or after 5:00 p.m. Eastern Time on the final day of such notice 

  
 53 

 
period, shall have considered in good faith the effect of any Offered Amendment in consultation with its financial advisors and outside legal counsel, and shall have determined, after such
consideration and consultation and taking into consideration such Offered Amendment, that a failure to effect a Company Adverse Recommendation Change would continue to be inconsistent with the Company Board’s fiduciary duties under applicable
Law. 
 (e)    Certain Permitted Disclosure. Nothing contained in this
Section 4.02 or elsewhere in this Agreement shall prohibit the Company or any of its Subsidiaries from (i) taking and disclosing to the Company Shareholders a position contemplated by Rule 14d-9 or Rule 14e-2(a) under the Exchange Act or (ii) making a disclosure to the Company Shareholders if the Company Board determines in good faith in consultation with
its outside legal counsel that a failure to do so would be inconsistent with applicable Law; provided, however, that in no event shall the Company or the Company Board or any committee thereof take any action prohibited by
Section 4.02(d)(i) (except that any “stop, look and listen” communication that contains only the information set forth in Rule 14d-9(f) under the Exchange Act shall not be
deemed a Company Adverse Recommendation Change), unless such action is required by applicable Law and, if such action constitutes a Company Adverse Recommendation Change before the Company Requisite Vote, then Parent will have the right to terminate
this Agreement pursuant to Section 7.01(d)(i). 
 ARTICLE V 

ADDITIONAL AGREEMENTS 

Section 5.01. Proxy Statement; Company Shareholders Meeting. 

(a)    The Company shall prepare and file with the SEC, as promptly as practicable after the date of this
Agreement (and, in any event, within twenty (20) Business Days), a proxy statement, in preliminary form, relating to the Company Shareholders Meeting (such proxy statement, including any amendment or supplement thereto, the “Proxy
Statement”). The Company agrees that the Proxy Statement will comply in all material respects with the applicable provisions of the Exchange Act and the rules and regulations thereunder. The fees and expenses incurred in connection with the
filing, printing and mailing of the Proxy Statement shall be paid by the Company. As promptly as practicable after the date of this Agreement, Parent will use commercially reasonable efforts to furnish or cause to be furnished to the Company the
information relating to Parent and its Subsidiaries to be set forth in the Proxy Statement (or any amendment or supplement thereto) and the Company, Parent and Merger Sub will cooperate with one another in the preparation of the Proxy Statement (or
any amendment or supplement thereto). Without limiting the foregoing, the Company shall not file the Proxy Statement (or any amendment or supplement thereto) without first providing Parent and Merger Sub a reasonable opportunity to review and
propose comments thereon (which comments shall be considered in good faith by the Company). Each of the Company and Parent agree to correct any information provided by it for inclusion in the Proxy Statement that, to its Knowledge, was when
provided, or shall have become, false or misleading. 

  
 54 

 (b)    The Company shall promptly notify Parent of the
receipt of all comments of the SEC with respect to the Proxy Statement and of any request by the SEC for any amendment or supplement thereto or for additional information and, after the Company and its Representatives shall have had a reasonable
opportunity to review and consider any written correspondence or comments received from the SEC relating to the Proxy Statement (or any amendment or supplement thereto), provide Parent with copies of all written correspondence between the Company
and its Representatives, on the one hand, and the SEC, on the other hand, relating to the Proxy Statement (or any amendment or supplement thereto). Subject to Parent’s compliance with its obligations under
Section 5.01(a), (i) the Company shall use its commercially reasonable efforts to promptly provide responses to the SEC with respect to all comments received on the Proxy Statement from the SEC, and (ii) the Company
shall use its commercially reasonable efforts to cause the Proxy Statement in definitive form to be cleared by the SEC and mailed as promptly as possible after the date the SEC staff advises that it has no further comments thereon or that the
Company may commence mailing the Proxy Statement. 
 (c)    The Company shall cause the Company
Shareholders Meeting to be duly called and held as promptly as practicable after the clearance of the Proxy Statement by the SEC (and, in any event, within forty-five (45) days), to consider and vote upon the adoption of this Agreement. Subject
to Section 4.02, the Company Board shall recommend such adoption in the Proxy Statement and in such other materials and communications between the Company and the Company Shareholders as are reasonable and customary and
shall use reasonable best efforts to solicit such adoption of this Agreement at the Company Shareholders Meeting. Notwithstanding anything to the contrary in this Agreement, the Company may not adjourn or postpone the Company Shareholders Meeting
except (i) to the extent necessary to ensure that any necessary supplement or amendment to the Proxy Statement is provided to the Company Shareholders at least five (5) Business Days in advance of a vote on the adoption of this Agreement,
(ii) if the Company reasonably believes it is necessary and advisable to do so in order to solicit additional proxies in order to obtain the Company Requisite Vote or (iii) if, as of the time for which the Company Shareholders Meeting is
originally scheduled, there are insufficient Shares represented (either in person or by proxy) to constitute a quorum necessary to conduct the business of the Company Shareholders Meeting. The Company shall keep Parent and Merger Sub reasonably
informed with respect to proxy solicitation results. 
 Section 5.02. Parent Shareholders Meeting; Parent Shareholder Circular;
Parent Adverse Recommendation Change. 
 (a)    Subject to the Company’s compliance with its
obligations under this Section 5.02(a), Parent shall (i) if Parent has not done so prior to the date of this Agreement, submit to the UKLA as soon as practicable on or after the date of this Agreement a first draft of
the circular to be sent to Parent Shareholders entitled to vote on the Parent Shareholder Resolution in accordance with its obligations under the Listing Rules (the “Parent Shareholder Circular”) and (ii) subject to the Proxy
Statement, in preliminary form, having been filed with the SEC by the Company, use its commercially 

  
 55 

 
reasonable efforts to obtain the approval of the UKLA for such Parent Shareholder Circular as soon as reasonably practicable after such SEC filing (it being recognized and agreed by the Company
that, subsequent to such SEC filing, Parent may make one or more further submissions of draft versions of the Parent Shareholder Circular to the UKLA in order to address comments received from the UKLA and/or disclosures which Parent determines to
be reasonably necessary or desirable for the purposes of complying with its obligations pursuant to the Listing Rules). The Company will use commercially reasonable efforts to furnish or cause to be furnished to Parent all such assistance and
information (financial or otherwise) relating to the Company, its Subsidiaries and Affiliates as Parent may reasonably request for the purposes of preparing the Parent Shareholder Circular (or any amendment or supplement thereto) or as may be
required by the UKLA or pursuant to the Listing Rules in connection with the transactions contemplated by this Agreement. Without limiting the foregoing, pursuant to this Section 5.02 the Company shall use its commercially
reasonable efforts to: (i) provide all such information about itself, its Subsidiaries and its Affiliates and its and their respective directors, officers and shareholders as Parent may reasonably request for inclusion in the Parent Shareholder
Circular (or any amendment or supplement thereto) or as may be required by the UKLA or pursuant to the Listing Rules in connection with the transactions contemplated by this Agreement; (ii) provide reasonable access to the Company’s
Representatives (including its external auditors) for the purposes of allowing Parent and/or its Representatives (including its external auditors) to prepare the Parent Shareholder Circular (or any amendment or supplement thereto) or to provide any
information required by the UKLA or pursuant to the Listing Rules in connection with the transactions contemplated by this Agreement; and (iii) procure that the Company’s Representatives (including its external auditors) provide such
assistance, information and cooperation to Parent and its Representatives (including its external auditors) as they may reasonably request for the purposes of preparing the Parent Shareholder Circular (or any amendment or supplement thereto) or
providing any information required by the UKLA or pursuant to the Listing Rules in connection with the transactions contemplated by this Agreement. Except to the extent it has done so prior to the date of this Agreement, Parent shall not file with
the UKLA a draft copy of the Parent Shareholder Circular (or any draft copy of an amendment or supplement thereto) without first providing the Company a reasonable opportunity to review and propose comments thereon (which comments shall be
considered in good faith by Parent). Each of Parent and the Company agree to correct any information provided by it for inclusion in the Parent Shareholder Circular that, to its Knowledge, was when provided, or shall have become, false or
misleading, or otherwise not in accordance with the facts. 
 (b)    Parent shall promptly notify the
Company of the receipt of all written comments of the UKLA with respect to the Parent Shareholder Circular and of any request by the UKLA for any amendment or supplement thereto or for additional information and, after Parent and its Representatives
shall have had a reasonable opportunity to review and consider any written correspondence or comments received from the UKLA relating to the Parent Shareholder Circular (or any amendment or supplement thereto), provide the Company with copies of all
written correspondence between Parent and its Representatives, on the one hand, and the UKLA, on the other hand, relating to the Parent Shareholder Circular (or any amendment or supplement 

  
 56 

 
thereto). Subject to the Company’s compliance with its obligations under Section 5.02(a), (i) Parent and the Company shall each use their respective commercially
reasonable efforts to promptly provide responses to the UKLA with respect to all comments received on the Parent Shareholder Circular from the UKLA, and (ii) subject to the fiduciary duties of the Parent Board, Parent shall use its commercially
reasonable efforts to cause the Parent Shareholder Circular (or any amendment or supplement thereto) in definitive form to be mailed, delivered or otherwise made available to Parent Shareholders as promptly as possible after the date the UKLA
approve the Parent Shareholder Circular (or any amendment or supplement thereto). 
 (c)    Subject to
the fiduciary duties of the Parent Board and the Company’s compliance with its obligations under Section 5.02(a), Parent shall, as promptly as practicable after approval of the Parent Shareholder Circular by the UKLA
and in accordance with the requirements of the Listing Rules, duly call, give notice of and convene a Parent Shareholders Meeting to consider and vote upon the Parent Shareholder Resolution. Subject to the fiduciary duties of the Parent Board and
the provisions of Section 5.02(e), Parent shall include the Parent Board Recommendation in the Parent Shareholder Circular and, unless the Parent Board shall have effected a Parent Adverse Recommendation Change, shall use
reasonable best efforts to solicit approval of the Parent Shareholder Resolution by Parent Shareholders. Notwithstanding anything to the contrary in this Agreement, Parent may not adjourn or postpone the Parent Shareholders Meeting except:
(i) with the written consent of the Company, (ii) to the extent necessary to ensure that any necessary supplement or amendment to the Parent Shareholder Circular is provided to the Parent Shareholders a reasonable amount of time in advance
of (being at least five (5) Business Days in advance of) a vote of Parent Shareholders on the Parent Shareholder Resolution, (iii) if Parent reasonably believes it is necessary and advisable to do so in order to solicit additional proxies
in order to obtain the Parent Requisite Vote, (iv) if, as of the time for which the Parent Shareholders Meeting is originally scheduled, there are insufficient shares represented (either in person or by proxy) to constitute a quorum necessary
to conduct the business of the Parent Shareholders Meeting or (v) as required by applicable Law or the fiduciary duties of the Parent Board. Parent shall keep the Company reasonably informed with respect to proxy solicitation results. 

(d)    Subject to the fiduciary duties of the Parent Board and the provisions of
Section 5.02(e), the Parent Board (including any committee thereof) shall not (i) withdraw, fail to make or modify in a manner adverse to the Company, or propose to withdraw, fail to make or modify in a manner adverse
to the Company, the Parent Board Recommendation, (ii) fail to include, in the Parent Shareholder Circular, the Parent Board Recommendation, or (iii) agree or resolve to take actions set forth in the foregoing clauses (i) and (ii) (any
of the foregoing clauses (i) through (iii), an “Parent Adverse Recommendation Change”, provided, however, that where a unanimous recommendation of the Parent Board or a committee thereof, as applicable, ceases to
be unanimous, so long as a majority recommendation of the Parent Board to vote in favor of passing the Parent Shareholder Resolution remains, that shall not constitute a Parent Adverse Recommendation Change and (B) an adjournment or
postponement of the Parent Shareholders Meeting in the circumstances set out in Section 5.02(c) shall not constitute a 

  
 57 

 
Parent Adverse Recommendation Change unless and until, at or prior to the adjourned or postponed Parent Shareholders Meeting, the recommendation of the Parent Board in relation to the Parent
Shareholder Resolution is other than the Parent Board Recommendation. 
 (e)    At any time prior to
obtaining the Parent Requisite Vote, the Parent Board may effect a Parent Adverse Recommendation Change if (i) the Parent Board, acting in good faith, determines at any time, after consultation with its external legal counsel and/or external
financial advisers (as the case may be), that the failure to take such action would reasonably be expected to constitute a breach the Parent Board’s fiduciary duties under applicable Law and (ii) where reasonably practicable and not
contrary to the duties of the Parent Board, Parent shall have first provided written notice to the Company of such determination of the Parent Board and of the fact that the Parent Board intends to effect a Parent Adverse Recommendation Change,
which notice shall set forth in reasonable detail the reasons therefor. 
 Section 5.03. Filings; Other Actions;
Notification. 
 (a)    Cooperation; Efforts. Subject to the terms and conditions set
forth in this Agreement, including Section 5.01 and Section 5.02 (provided, that in the event of any conflict between Section 5.01 and/or
Section 5.02 and this Section 5.03(a), Section 5.01 and Section 5.02 shall govern with respect to the matters set forth therein), the Company and
Parent shall cooperate with each other and use (and shall cause their respective Subsidiaries to use) their respective reasonable best efforts to take or cause to be taken all actions, and do or cause to be done all things, reasonably necessary and
proper on their part under this Agreement and applicable Law to consummate and make effective the Merger and the other transactions contemplated by this Agreement as soon as practicable, including preparing and filing as promptly as practicable all
documentation to effect all necessary notices, reports and other filings and to obtain as promptly as practicable all consents, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any third party and/or
any Governmental Entity in order to consummate the Merger or any of the other transactions contemplated by this Agreement. To the extent not prohibited by applicable Law and upon the terms and subject to the terms and conditions set forth in this
Agreement, each of the Company and Parent shall cooperate with each other in connection with the matters contemplated by this Section 5.03, including (i) promptly notifying the other of, and, if in writing, furnishing
the other with copies of (or, in the case of material oral communications, advising the other orally of) any communications from or with any Governmental Entity with respect to the Merger or any of the other transactions contemplated by this
Agreement, (ii) permitting the other to review and discuss in advance, and considering in good faith the views of the other in connection with, any proposed written (or any material proposed oral) communication with any such Governmental
Entity, (iii) not participating, and not permitting any of its Representatives to participate, in any meeting with any such Governmental Entity unless it notifies the other in advance and, to the extent permitted by such Governmental Entity,
gives the other the opportunity to attend and participate thereat, (iv) furnishing the other with 

  
 58 

 
copies of all correspondence, filings and communications (and memoranda setting forth the substance thereof) between it and any such Governmental Entity with respect to this Agreement and the
Merger, and (v) cooperating with the other to furnish the other party with such necessary information and reasonable assistance as the other party may reasonably request in connection with the parties’ mutual cooperation in preparing any
necessary filings or submissions of information to any such Governmental Entity. Notwithstanding anything in this Agreement to the contrary, the Company shall not agree or consent to dispose of, license or hold separate any assets, or otherwise take
to commit or take any action that would limit Parent’s ability to retain the Company or any of its Affiliates (or any of their respective businesses, product lines or assets) or Parent or any of its Affiliates (or any of their respective
businesses, product lines or assets) or agree to alter or restrict the business or commercial practices, including any terms or conditions of any Contracts, of the Company or any of its Affiliates (or any of their respective businesses, product
lines or assets) without the prior written consent of Parent, in each case, in order to obtain the consents, registrations, approvals, permits and authorizations contemplated by this Section 5.03. 

(b)    No Divestiture or Other Remedial Action. Notwithstanding anything in this Agreement to the
contrary, nothing contained in this Agreement shall be deemed to require Parent or any Subsidiary or Affiliate thereof to agree to any action to: (i) dispose of, license or hold separate any assets, or otherwise take or commit to take any
action that limits the freedom of action of Parent or any Subsidiary or Affiliate thereof with respect to, or their ability to retain, the Company or any of its Affiliates (or any of their respective businesses, product lines or assets) or Parent or
any of its Affiliates (or any of their respective businesses, product lines or assets), or (ii) alter or restrict in any way the business or commercial practices, including any terms or conditions of any Contracts, of the Company or any of its
Affiliates (or any of their respective businesses, product lines or assets) or Parent or any of its Affiliates (or any of their respective businesses, product lines or assets); provided, however, that, if requested by a Governmental
Entity in order to obtain consents, registrations, approvals, permits or authorizations contemplated by this Section 5.03, Parent shall agree to the disposal (and the Company shall agree to do so after the Closing if
requested by Parent) of (A) the Company’s MDS business segment or (B) any assets of the Company or its Subsidiaries (but not of Parent or its Affiliates) that do not relate to the sonobuoy business of the Company or its Subsidiaries
and that, individually or in the aggregate, are not material in any respect to the Company and its Subsidiaries. 

(c)    Litigation Not Required. Notwithstanding anything in this Agreement to the contrary, Parent
shall have the right, but not the obligation, to defend (or initiate) any Proceeding instituted by a Governmental Entity (i) with respect to the legality of the Merger under any Law, including any antitrust or competition Law, or (ii) in
order to overturn any regulatory action by any such Governmental Entity to prevent consummation of the Merger or any of the other transactions contemplated by this Agreement, including by defending any Proceeding in order to avoid the entry of, or
to have vacated, overturned or terminated, including by appeal, any Order. 

  
 59 

 (d)    Information. Without limiting the generality of
Sections 5.01 and 5.02, subject to applicable Laws relating to the exchange of information, the Company and Parent each shall, and shall instruct its Representatives to, upon request by the other, furnish the other with all information
concerning itself and its Subsidiaries, directors, officers and shareholders, and such other matters as may be reasonably necessary or advisable in connection with the Proxy Statement, the Parent Shareholder Circular or any other statement, filing,
notice or application made by or on behalf of Parent, the Company or any of their respective Subsidiaries to any third party and/or any Governmental Entity in connection with the Merger and the transactions contemplated by this Agreement. 

(e)    Status. Subject to applicable Law and as required by any Governmental Entity, the Company and
Parent each shall keep the other apprised of the status of matters relating to completion of the transactions contemplated by this Agreement, including promptly furnishing the other with copies of notices or other communications received by Parent
or the Company, as the case may be, or any of its Subsidiaries, from any third party and/or any Governmental Entity with respect to the Merger and the other transactions contemplated by this Agreement. 

(f)    Regulatory Approvals. 

(i)    HSR/Antitrust. Subject to the terms and conditions set forth in this Agreement, without
limiting the generality of the undertakings pursuant to this Section 5.03, each of the Company and Parent agree (A) as promptly as practicable but in no event later than ten (10) Business Days following the
execution and delivery of this Agreement, to file or cause to be filed with the United States Federal Trade Commission and the Antitrust Division of the United States Department of Justice the notification and report form, if any, required for the
Merger and the other transactions contemplated hereby and any supplemental information requested in connection therewith and (B) as promptly as practicable, to make, or cause to be made, any filing that may be necessary or, in the reasonable
opinion of Parent, advisable under any other antitrust or competition Law and provide each and every Governmental Entity with jurisdiction over enforcement of any antitrust or competition Law applicable to the Company, its Subsidiaries or Parent all
non-privileged information and documents that are required or reasonably requested by any such Governmental Entity or by Parent pursuant to applicable antitrust or competition Law in connection with
consummation of the Merger and the other transactions contemplated by this Agreement. 

(ii)    CFIUS. Subject to the terms and conditions set forth in this Agreement, without limiting
the generality of the undertakings pursuant to this Section 5.03, Parent and the Company shall use their reasonable best efforts to obtain the CFIUS Approval. Such reasonable best efforts shall include promptly

  
 60 

 
after the date hereof preparing, prefiling, and then filing with CFIUS a joint voluntary notice pursuant to the DPA with respect to the transactions contemplated by this Agreement, and providing
any additional or supplemental information, certifications and agreements requested by CFIUS or any other agency or branch of the U.S. government in connection with the CFIUS review or investigation of the transactions contemplated by this Agreement
within the timeframes required by the DPA, unless CFIUS agrees in writing to an extension of such timeframe; provided, however, that other than operating the Company and its cleared Subsidiaries pursuant to the Special Security
Agreement existing as of the date hereof (“SSA”) of Parent or one of its Subsidiaries, neither Parent nor any of its Subsidiaries shall be required to agree to take or commit to take any action or agree to any mitigation under
Section 721(l) of the DPA or the NISPOM that are reasonably unacceptable to Parent or any of its Subsidiaries, including any actions or mitigation that could reasonably be expected to limit its freedom of action with respect to, or ability to
retain, one or more of the Company’s businesses or product lines; and provided, further, that in the event that CFIUS notifies Parent, Merger Sub or the Company that CFIUS (A) has completed its review or investigation and
(B) intends to send a report to the President of the United States recommending that the President suspend or prohibit the Merger or any of the other transactions contemplated by this Agreement, Parent and the Company may, at the discretion of
Parent or the Company, request a withdrawal of any filing or notification made to CFIUS. Each party hereto shall afford the other the opportunity to review and comment in advance on any submissions to CFIUS to be made by the submitting party, except
for personal identifier information or other information proprietary to the submitting party. 

(iii)    DDTC. Subject to the terms and conditions set forth in this Agreement, without limiting
the generality of the undertakings pursuant to this Section 5.03, Parent and the Company shall use their reasonable best efforts to prepare and submit, as promptly as practicable but in no event later than ten
(10) Business Days following the execution and delivery of this Agreement, the Company’s notification to DDTC pursuant to Section 122.4(b) of ITAR, including such information about the Company and its Affiliates as may be required,
and to prepare and submit any other information or agreement as may be required by DDTC in connection with the transactions contemplated by this Agreement. 

(iv)    NISPOM. Subject to the terms and conditions set forth in this Agreement, without limiting
the generality of the undertakings pursuant to this Section 5.03, Parent and the Company shall use their reasonable best efforts to: 

(A)    have the Company prepare and submit, at its sole expense, to the DSS and, to the extent applicable,
any other agency of the U.S. government, notification of the Merger and the other relevant transactions contemplated hereby pursuant to the NISPOM, and the Company shall reasonably cooperate with Parent in requesting, at Parent’s

  
 61 

 
sole expense, from the DSS approval to operate the business of the Company and its cleared Subsidiaries pursuant to the SSA in accordance with NISPOM (“DSS Approval”); and 

(B)    take all steps advisable, necessary or desirable to obtain assurances, reasonably deemed sufficient
by Parent or one of its Subsidiaries, that favorable National Interest Determinations in accordance with the NISPOM, or similar determinations under any applicable national or industrial security regulations of any federal Governmental Entity of the
U.S. Government, will be granted authorizing access to proscribed or other relevant information by the Company and its cleared Subsidiaries following the Closing as may be necessary for the Company and its cleared Subsidiaries to continue to perform
their Government Contracts. 
 Section 5.04. Access and Reports; Confidentiality. 

(a)    Subject to applicable Law, upon reasonable notice, the Company shall (and shall cause its
Subsidiaries to) afford Parent’s and its Affiliates’ officers and other authorized Representatives reasonable access, during normal business hours throughout the period prior to the Effective Time, to its employees, properties, books,
Contracts and records and, during such period, the Company shall (and shall cause its Subsidiaries to) furnish promptly to Parent all information concerning its business, properties and personnel as may reasonably be requested (including such
information as Parent may request in accordance with Section 5.03(c)); provided, however, that no investigation pursuant to this Section 5.04 shall affect or be deemed to modify any
representation or warranty made by the Company herein; provided, further, that the foregoing shall not require the Company to (i) permit any inspection, or to disclose any information, that in the reasonable judgment of the
Company would result in the disclosure of any trade secrets of third parties or violate any of its obligations to a third party with respect to confidentiality if the Company shall have used commercially reasonable efforts to obtain the consent of
such third party to such inspection or disclosure, (ii) disclose any attorney-client privileged information of the Company or any of its Subsidiaries or information of the Company or any of its Subsidiaries subject to the work product doctrine,
(iii) permit any invasive environmental testing or sampling at any property or (iv) take or allow any action that would unreasonably interfere with the Company’s or any of its Subsidiaries’ business or operations. Except to the
extent already performed prior to the date of this Agreement, the Company shall instruct its external auditors to provide any cooperation as Parent’s external auditors may reasonably request as soon as practicable to agree on the necessary
processes and procedures that are required to be undertaken by each of them in relation to the preparation of the Parent Shareholder Circular and any information and comfort letters reasonably required in relation to the preparation of the Parent
Shareholder Circular. All requests for information made pursuant to this Section 5.04 shall be directed to the executive officer or other Person designated by the Company. 

  
 62 

 (b)    Each of Parent and Merger Sub will comply with the
terms and conditions of that certain letter agreement, dated May 9, 2016, by and between Parent and the Company (as may be amended from time to time, the “Confidentiality Agreement”), and will hold and treat, and will cause
their respective Representatives to hold and treat, in confidence all documents and information concerning the Company and its Subsidiaries furnished to Parent or Merger Sub in connection with the transactions contemplated by this Agreement
(including pursuant to Section 5.04(a)) in accordance with the Confidentiality Agreement, which Confidentiality Agreement shall remain in full force and effect in accordance with its terms; provided, that in no event
shall the terms of the Confidentiality Agreement be deemed to prevent the disclosure of any information by Parent (A) to the UKLA, (B) in the Merger Announcement or the Parent Shareholder Circular (in the case of the Parent Shareholder
Circular, to the extent required in order for Parent to comply with the Listing Rules or any other requirements of the UKLA or applicable Law), or (C) to the Placing Agent in the Share Issuance in connection with the Equity Financing or to
Parent’s existing providers of debt finance in connection with the Merger and the transactions contemplated by this Agreement. 

Section 5.05. Stock Exchange Delisting. Prior to the Closing Date, the Company shall cooperate with Parent and use reasonable
best efforts to take or cause to be taken all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable Law and rules and policies of the NYSE to enable the delisting by the Surviving
Corporation of the Shares from the NYSE and the deregistration of the Shares under the Exchange Act as promptly as practicable after the Effective Time (and, in any event, within ten (10) days after the Closing Date). 

Section 5.06. Publicity. Each of the Company and Parent shall issue its own initial news release regarding the Merger, the form
of which, in both cases, shall be mutually agreed upon by the Company and Parent and, except with respect to any action taken pursuant to Section 4.02, Section 5.02(e) or
Section 7.01 or in respect of the Share Issuance, thereafter neither the Company nor Parent (nor any of their respective Affiliates) shall issue or disseminate any press release or public announcement with respect to the
Merger and/or the other transactions contemplated by this Agreement without the consent of the other (such consent not to be unreasonably withheld or delayed) and the Company and Parent shall consult with each other prior to issuing and, to the
extent practicable and permitted by applicable Law, give each other the reasonable opportunity to review and comment upon, any press releases or other public announcements with respect to the Merger and the other transactions contemplated by this
Agreement, except where and to the extent any such press release or public announcement is required by Law (including the Listing Rules and the UK Disclosure Guidance and Transparency Rules) or by obligations pursuant to any listing agreement with
or rules of any national securities exchange (including the UKLA and the London Stock Exchange) or any interdealer quotation service or by the request of any Governmental Entity. 

Section 5.07. Employee Matters. 

(a)    Following the Effective Time and until the later of the first (1st) anniversary of the Closing Date and December 31, 2018 (the “Continuation Period”), 

  
 63 

 
Parent shall provide, or shall cause the Surviving Corporation to provide, each individual who is employed by the Company or any of its Subsidiaries immediately before the Effective Time (the
“Company Employees”) and who continues employment with the Company or any of its Subsidiaries during such time period with compensation and benefits that are substantially comparable in the aggregate to the compensation and benefits
(including target cash incentive amounts but excluding equity compensation incentives, severance payments and any compensation or benefits triggered in whole or in part by the consummation of the transactions contemplated hereby or other
transactions that would constitute a “change in control” or “change of control” or similar transaction for purposes of a Company Benefit Plan or comparable plan) provided to such Company Employee immediately prior to the
Effective Time. The foregoing notwithstanding, and for the avoidance of doubt, those individuals who are employed by MDS or otherwise are transferred to a buyer in connection with a MDS Sale shall cease to be Company Employees as of the closing of
the MDS Sale, and the Continuation Period with respect to such individuals shall, if not previously expired, expire on the closing of the MDS Sale. 

(b)    With respect to all plans (if any) maintained by Parent, the Surviving Corporation or their
respective Subsidiaries in which the Company Employees are eligible to participate after the Closing Date (including any vacation and paid time-off and severance plans), Parent, the Surviving Corporation and
their respective Subsidiaries, as applicable, shall cause each Company Benefit Plan or comparable benefit plan to take into account each Company Employee’s service with the Company or any of its Subsidiaries (as well as service with any
predecessor employer of the Company or any such Subsidiary, to the extent service with the predecessor employer is recognized by the Company or such Subsidiary) for purposes of determining such Company Employee’s eligibility to participate and
vesting in such plan (but not for accrual of benefits other than determining the level of vacation pay accrual); provided, however, that such service need not be considered to the extent that such recognition would result in any
duplication of benefits for the same period of service. 
 (c)    Without limiting the generality of
Section 5.07(a), to the extent permitted by applicable Law and the relevant insurance carriers, Parent shall, or shall cause the Surviving Corporation to, waive any pre-existing
condition limitations, exclusions, actively-at-work requirements and waiting periods under any welfare benefit plan maintained by Parent, the Surviving Corporation or
any of their respective Subsidiaries in which Company Employees (and their eligible dependents) will be eligible to participate from and after the Effective Time, except to the extent that such pre-existing
condition limitations, exclusions, actively-at-work requirements and waiting periods would not have been satisfied or waived under the comparable Company Benefit Plan
immediately prior to the Effective Time. Parent shall, or shall cause the Surviving Corporation to, recognize the dollar amount of all co-payments, deductibles and similar expenses incurred by each Company
Employee (and his or her eligible dependents) during the calendar year in which the Effective Time occurs for purposes of satisfying such year’s deductible and co-payment limitations under the relevant
welfare benefit plans in which they will be eligible to participate from and after the Effective Time. 

  
 64 

 (d)    The provisions of this
Section 5.07 are solely for the benefit of the parties to this Agreement, and no other Person (including any Company Employee or any beneficiary or dependent thereof) shall be regarded for any purpose as a third-party
beneficiary of this Section 5.07, and no provision of this Section 5.07 shall create such rights in any such Persons. No provision of this Agreement shall be construed (i) as a guarantee of
continued employment of any Company Employee, (ii) to limit the right of Parent or the Surviving Corporation to terminate the employment of any Company Employee or require Parent, the Surviving Corporation or any of its Subsidiaries to provide
any such employee compensation or benefits for any period following any such termination, (iii) to prevent the amendment, modification or termination of any Company Benefit Plan after the Closing (in each case in accordance with the terms of
the applicable Company Benefit Plan) or (iv) as an amendment or modification of the terms of any Company Benefit Plan. 

Section 5.08. Expenses. Except as otherwise provided in this Agreement, whether or not the Merger is consummated, all costs and
expenses incurred in connection with this Agreement and the Merger and the other transactions contemplated by this Agreement shall be paid by the party incurring such expenses. 

Section 5.09. Indemnification; Directors’ and Officers’ Insurance. 

(a)    Parent shall, and shall cause the Surviving Corporation to, indemnify and hold harmless each present
and former director and officer of the Company and its Subsidiaries (in each case, when acting in such capacity) (collectively, the “Indemnified Parties”) to the fullest extent permitted under applicable Law from and against any
costs or expenses (including reasonable attorneys’ fees), judgments, fines, losses, claims, damages or liabilities (collectively, “Costs”) incurred in connection with any Proceeding arising out of or pertaining to
matters existing or occurring at or prior to the Effective Time relating to the Indemnified Party’s service with, at the request of or for the benefit of the Company or any of its Subsidiaries, including the transactions contemplated by this
Agreement. 

  
 65 

 
From and after the Effective Time, the Parent shall, and shall cause the Surviving Corporation to, advance expenses to any Indemnified Party claiming indemnification pursuant to this
Section 5.09 as incurred to the fullest extent permitted under applicable Law; provided, however, that such Indemnified Party provides a written undertaking in form and substance reasonably satisfactory to
Parent to repay such advances if it is ultimately determined that such Indemnified Party is not entitled to indemnification. 

(b)    From and after the Effective Time, Parent shall cause the Surviving Corporation to honor the
provisions, to the extent they are enforceable under applicable Law, regarding (i) exculpation of directors, (ii) limitation of liability of directors and officers and (iii) advancement of expenses, in each case, contained in the
Company Articles of Incorporation, Company Code of Regulations, the comparable organizational documents of any of the Company’s Subsidiaries or any indemnification Contract between the applicable Indemnified Party and the Company or any of its
Subsidiaries immediately prior to the Effective Time. 
 (c)    From and after the Effective Time, Parent
shall cause the Surviving Corporation to maintain for a period of at least six (6) years following the Effective Time directors’ and officers’ liability insurance and fiduciary liability insurance policies (collectively,
“D&O Insurance”) from an insurance carrier with the same or better credit rating as the Company’s current insurance carrier with benefits, levels of coverage and terms and conditions that are at least as favorable as the
Company’s D&O Insurance existing immediately prior to the Effective Time with respect to matters existing or occurring at or prior to the Effective Time, including for acts or omissions in connection with this Agreement and the consummation
of the transactions contemplated by this Agreement. Notwithstanding the foregoing, in no event shall Parent or the Surviving Corporation be required to expend for any year of such D&O Insurance coverage an annual premium amount greater than
three hundred percent (300%) of the annual premium paid by the Company for D&O Insurance for the fiscal year immediately prior to the Effective Time (such amount, the “Maximum Annual Premium”). The Company represents and
warrants that the annual premium paid by the Company for D&O Insurance for the fiscal year immediately prior to the Effective Time is set forth in Section 5.09(c) of the Company Disclosure Letter. If the annual premiums of such D&O
Insurance coverage exceed the Maximum Annual Premium, Parent and the Surviving Corporation shall obtain a policy with the greatest coverage available for a an annual premium not exceeding the Maximum Annual Premium. 

(d)    Notwithstanding Section 5.09(c), the Company may in its sole discretion
obtain, prior to the Effective Time, six (6) year pre-paid “tail” insurance coverage, at an aggregate cost no greater than six (6) times the Maximum Annual Premium, providing for D&O
Insurance not less favorable than that described in Section 5.09(c). If the Company has obtained such policy pursuant to this Section 5.09(d), Parent will cause such policy to be maintained in full
force and effect for its full term and cause all obligations thereunder to be honored by the Surviving Corporation, and Parent will have no further obligation to purchase or pay for insurance pursuant to Section 5.09(c).

  
 66 

 (e)    If the Surviving Corporation or any of its successors
or assigns (i) consolidates or merges with or into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any
Person, then, and in each such case, Parent shall cause proper provisions to be made so that the successors and assigns of the Surviving Corporation shall assume and comply with all of the obligations set forth in this
Section 5.09. 
 (f)    The provisions of this
Section 5.09 are intended to be for the benefit of, and shall be enforceable by, each of the Indemnified Parties. The obligations of Parent and the Surviving Corporation in this Section 5.09 will
not be terminated or modified in any manner which could adversely affect any Indemnified Party without the consent of such Indemnified Party. 

(g)    The rights of the Indemnified Parties under this Section 5.09 shall be in
addition to, and not in limitation of, any rights such Indemnified Parties may have under the Company Articles of Incorporation, the Company Code of Regulations or any of the comparable organizational documents of any of the Company’s
Subsidiaries, or under any applicable Contracts or Law. 
 Section 5.10. Rule 16b-3.
Prior to the Effective Time, the Company shall take such steps as may be reasonably necessary or advisable to cause any dispositions of Company equity securities (including derivative securities) pursuant to the transactions contemplated by this
Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the Exchange Act.

 Section 5.11. Written Consents, Resolutions and Other Materials . 

(a)    Immediately following the execution of this Agreement, Parent shall cause Ultra Electronics Defense,
Inc., the sole shareholder of Merger Sub, to execute and deliver, in accordance with applicable Law and in its capacity as the sole shareholder of Merger Sub, a written consent adopting this Agreement. 

(b)    Promptly following the date hereof, Parent shall make available to the Company true and complete
copies of (i) the resolutions described in Sections 3.02(b)(ii) and 3.02(b)(iii) and (ii) the written consent described in Section 5.11(a). 

(c)    Promptly following the date hereof, the Company shall make available to Parent true and complete
copies of (i) the resolutions described in Section 3.01(d)(ii) and (ii) the opinions described in Section 3.01(u) for informational purposes only. 

Section 5.12. Merger Sub and Surviving Corporation Compliance. Parent shall cause Merger Sub and the Surviving Corporation to
comply with all of its obligations under this Agreement, and Merger Sub shall not engage in any activities of any nature except as provided in or contemplated by this Agreement. 

  
 67 

 Section 5.13. Takeover Statutes. If any Takeover Statute is or may become applicable
to the Merger or the other transactions contemplated by this Agreement, Parent, Merger Sub, the Company and their respective boards of directors shall grant such reasonable approvals and take such reasonable actions as are necessary so that such
transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on such transactions. 

Section 5.14. Control of Operations. Without limiting any party’s rights or obligations under this Agreement, the parties
understand and agree that (a) nothing contained in this Agreement will give any party hereto, directly or indirectly, the right to control or direct any other party’s operations prior to the Effective Time and (b) prior to the
Effective Time, each party will exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its operations. 

Section 5.15. Resignation of Directors and Officers. The Company will cause each of the directors and officers of the Company and
its Subsidiaries requested by Parent in writing to the Company not later than ten (10) Business Days prior to the Closing Date to submit at the Closing a letter of resignation in form reasonably satisfactory to Parent and effective on or before
the Effective Time. Notwithstanding the foregoing, the Company will not be in breach of this Section 5.15 if it fails to obtain the resignation of any such director or officer if Parent will have the power, directly or
indirectly, to remove any such Person from his or her position as a director or officer without cause immediately after the Effective Time. 

Section 5.16. Transaction Litigation. The Company and Parent shall promptly notify each other of, and shall give each other the
opportunity to participate in the defense, settlement and/or prosecution of, any Proceeding (including derivative claims) brought by any of the Company Shareholders against the Company and/or members of the Company Board relating to the Merger or
the other transactions contemplated by this Agreement (collectively, “Transaction Litigation”); provided, however, that (a) the parties shall keep each other reasonably informed with respect to the status of any
Transaction Litigation brought against such party, and (b) the Company shall not compromise, settle, come to an arrangement regarding or agree to compromise, settle or come to an arrangement regarding any Transaction Litigation or consent to
the same, without the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed). 
 Section 5.17.
Government Contracts. 
 (a)    With respect to any Government Contract to which the Company or
any of its Subsidiaries is a party, if a “Responsible Contracting Officer” (as that term is defined in FAR 42.1202) for the United States government determines before the Closing that there are any issues related to the transactions
contemplated by this Agreement that should be addressed in a formal agreement between the Company or any of its Subsidiaries and the United States government (including pursuant to FAR 

  
 68 

 
42.12), the Company and Parent shall, and, if applicable, the Company shall cause the applicable Subsidiary of the Company to, prepare (with Parent’s assistance) the required agreement
within a reasonable time following the Effective Time, which shall be submitted by the Company to the Responsible Contracting Officer, for the United States government. Each party shall provide to the others promptly any information with respect to
such party that may be required in connection with preparing, processing, entering into and completing the agreement. Each party shall each use reasonable best efforts to obtain all consents, approvals and waivers required for the purpose of
processing, entering into, and completing the agreement with respect to the Government Contracts, including responding to any requests for information by the U.S. Government with regard to such agreement. 

(b)    With respect to any Government Contract set forth in Section 3.01(y)(i) of the Company
Disclosure Letter, at Parent’s reasonable request, the Company shall, or, if applicable, cause its Subsidiary to, communicate to each Responsible Contracting Officer for the United States government the fact that the transactions contemplated
by this Agreement are pending. Such communications shall be made as soon as practicable after the date hereof and prior to the Closing Date and shall be made in such manner as Parent reasonably determines to be appropriate to preserve the
Company’s or its applicable Subsidiary’s relationship with such Responsible Contracting Officers for the United States government. 

Section 5.18. Notification of Certain Matters. Each party hereto shall give prompt written notice to the other of (a) any
notice or other communication received by such party from any Governmental Entity in connection with the Merger or the other transactions contemplated hereby or from any Person alleging that the consent of such Person is or may be required in
connection with the Merger or the other transactions contemplated hereby, or (b) to the Knowledge of such party, the occurrence, or non-occurrence, of any change or event that, individually or in the
aggregate, would reasonably be expected to cause any condition to the obligations of any party to effect the Merger set forth in ARTICLE VI not to be satisfied; provided, however, that (i) the delivery of any notice
pursuant to this Section 5.18 shall not cure any breach of any representation or warranty, breach of covenant or failure to satisfy the conditions to the obligations of the parties under this Agreement or otherwise limit or
affect the remedies available hereunder to the party receiving such notice and (ii) a failure to comply with clause (b) of this Section 5.18 will not be deemed to be a breach of this Agreement. 

Section 5.19. Sale of MDS. 

(a)    The parties hereto shall cooperate with one another, following the date of this Agreement, to
arrange for the sale, whether by merger, acquisition or otherwise, after the Effective Time of MDS (such a sale solely of MDS, a “MDS Sale”), and achieve a tax efficient disposition of MDS. Without limiting the generality of the
foregoing, the Company shall, and shall cause its Subsidiaries and shall use its reasonable best efforts to cause its and their respective Representatives to, (i) provide to Parent and prospective purchasers of MDS approved by Parent who have
signed or will sign confidentiality agreements in form reasonably acceptable to Parent and the Company (the “Prospective Purchasers”) reasonable access, subject to 

  
 69 

 
Section 5.04(a), to the Company and its Subsidiaries and their facilities, books and records (including copies of Tax Returns and supporting work schedules and such
other financial, Tax and operating data, including information regarding tax basis of the assets and stock of each of the Company’s Subsidiaries and any net operating losses and current year income) and other information relating to MDS and, to
the extent applicable, the Company and its Subsidiaries, (ii) make employees of the Company and its Subsidiaries reasonably available to Parent, Prospective Purchasers and their respective Representatives, subject to
Section 5.04(a), to provide additional information and explanation as may be reasonably requested of any materials provided hereunder and to facilitate discussions regarding employment of such employees following the MDS
Sale, (iii) in anticipation of, and prior to, signing the definitive purchase agreement with respect to a MDS Sale with a Prospective Purchaser, facilitate customary pre-signing calls between such
Prospective Purchaser and the material customers and suppliers of MDS to assist with due diligence by such Prospective Purchaser (it being understood that the Company shall have the option to, at its sole discretion, participate in all such calls),
(iv) make available an electronic data room and contribute information relating to MDS as may be reasonably requested by Parent or the Prospective Purchasers, (iv) cause its and its Subsidiaries’ officers and employees to provide
assistance reasonably requested by Parent in Parent’s preparation and negotiation of the definitive purchase agreement, including appropriate covenants, representations, warranties and disclosure schedules and customary ancillary agreements,
and (v) take such additional actions as reasonably requested by Parent in connection with the foregoing (which shall include providing such information as may be reasonably requested by Parent in connection with any announcement it is required
to issue in respect of the MDS Sale in compliance with the Listing Rules). 
 (b)    Notwithstanding the
foregoing, nothing in Section 5.19(a) shall require the Company, any of its Subsidiaries or any of their respective Affiliates or Representatives to (i) enter into any Contract in connection with the MDS Sale (other
than a non-disclosure agreement with a Prospective Purchaser, to the extent that it does not have one), (ii) provide any cooperation, or take any action, that would reasonably be expected to cause the Company,
any of its Subsidiaries or any of their respective Affiliates or Representatives to incur any actual or potential material liability, (iii) provide any cooperation, or take any action, that
the Company reasonably determines would be expected to result in a violation of a confidentiality agreement or any other material Contract or the loss of any attorney-client privilege, privilege under the work product doctrine or any other similar
privilege, (iv) provide any cooperation, or take any action, that would reasonably be expected to materially interfere with the business or operations of the Company, any of its Subsidiaries or any of their respective Affiliates or
Representatives, (v) provide any cooperation, or take any action, that would reasonably be expected to prevent, materially delay or impair the ability of the Company, Parent or Merger Sub to consummate the Merger and the other transactions
contemplated by this Agreement, (vi) make any representation or warranty with respect to MDS or in connection with the MDS Sale or (vii) cause any member of the Company Board or of any similar governing body of any of the Company’s
Subsidiaries or the Company and its Subsidiaries respective 

  
 70 

 
Affiliates or Representatives to adopt or approve any written consent, resolution or similar approval with respect to the MDS Sale or any Contracts entered into in connection with the MDS Sale.

 Section 5.20. Equity Financing. Parent shall use its reasonable best efforts to take, or cause to be taken, all actions and
shall use its reasonable best efforts to do, or cause to be done, all things necessary to obtain, and close on or prior to the Closing Date, the Equity Financing. Parent shall not, without the prior written consent of the Company (which consent
shall not be unreasonably withheld or delayed), agree to any amendment or modification of the Placing Agreement that materially and adversely affects the ability of Parent to receive the Equity Financing required to consummate the Merger and the
other transactions expressly contemplated hereby to be effected at the Closing. Parent and Merger Sub acknowledge and agree that obtaining the Equity Financing is not a condition to Parent’s and Merger Sub’s obligations to consummate the
Merger and the other transactions contemplated by this Agreement. 
 Section 5.21. Letters of Credit; Company Credit
Facilities. Prior to the Closing and as promptly as practicable following the date hereof, the Company shall, and shall cause its Subsidiaries and its and its Subsidiaries’ respective Representatives to, use commercially reasonable efforts
to cooperate with Parent, in connection with facilitating (a) the replacement (effective as of the Closing Date) of all outstanding letters of credit of the Company or any its Subsidiaries issued under the Company’s existing credit
facility with BMO Harris Bank N.A. (such letters of credit, the “Existing Letters of Credit”) with letters of credit issued under Parent’s credit facility and (b) the payoff of other credit facilities of the Company and
its Subsidiaries as of the Closing Date and, as applicable, release of Liens thereunder and receipt of documentation confirming same. Such cooperation shall include facilitating the direct contact between Parent and parties under credit facilities
of the Company and its Subsidiaries, the beneficiaries of the Existing Letters of Credit with the Parent and its Representatives, as well as direct contact between such beneficiaries and the Parent’s lenders, in all such cases upon reasonable
advance notice. 
 ARTICLE VI 

CONDITIONS 

Section 6.01. Conditions to Each Party’s Obligation to Effect the Merger. The respective obligation of each
party hereto to effect the Merger is subject to the satisfaction or (to the extent permitted by Law) waiver at or prior to the Closing of each of the following conditions: 

(a)    Company Shareholder Approval. This Agreement shall have been duly adopted by the holders of
Shares constituting the Company Requisite Vote; 
 (b)    Parent Shareholder Resolution. The
Parent Shareholder Resolution shall have been duly passed by a vote of the Parent Shareholders constituting the Parent Requisite Vote; 

  
 71 

 (c)    No Orders. No Governmental Entity of competent
jurisdiction shall have enacted, entered, promulgated or enforced any Law, executive order, ruling, injunction, or other order (whether temporary, preliminary or permanent) (collectively, “Orders”) that is in effect and restrains,
enjoins or otherwise prohibits the consummation of the Merger; 
 (d)    Investment Canada Act and
Antitrust Clearance. (i) The waiting or other time periods applicable to the consummation of the Merger under the Investment Canada Act (or any extension thereof) shall have expired, lapsed or been terminated and any applicable regulatory
clearance shall have been obtained, (ii) the waiting period applicable to the consummation of the Merger under the HSR Act (or any extension thereof) shall have expired or early termination thereof shall have been granted, (iii) all
applicable waiting and other time periods applicable to the consummation of the Merger under the antitrust or competition Laws of each Applicable Jurisdiction shall have expired, lapsed or been terminated (as appropriate) and all antitrust or
competition regulatory clearances applicable to the consummation of the Merger in each Applicable Jurisdiction shall have been obtained, in each case unless waived by Parent in its sole discretion, and (iv) any agreement with a Governmental
Entity not to consummate the Merger, which agreement shall have been entered into with the prior written consent of both the Company and Parent, shall have expired or been terminated; 

(e)    CFIUS Approval. The CFIUS Approval shall have been obtained; 

(f)    DSS Approval. The DSS Approval shall have been obtained; and 

(g)    DDTC. Any applicable prior notice period under ITAR relating to the Merger and the other
transactions contemplated by this Agreement shall have expired or otherwise been waived by DDTC. 
 Section 6.02. Additional
Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to effect the Merger are further subject to the satisfaction or (to the extent permitted by Law) waiver at or prior to the Closing of each of the
following conditions: 
 (a)    Representations and Warranties. Each of (i) the
representations and warranties of the Company set forth in the second sentence of Section 3.01(b) (Subsidiaries), Section 3.01(c) (Capital Structure),
Section 3.01(d)(i) (Authority) and Section 3.01(t) (Brokers and Other Advisors) shall be true and correct in all respects as of the date of this Agreement and as of the Closing
Date as though made on and as of such date (except for any such representation or warranty that is expressly made as of a specified date (including the date of this Agreement) in which case such representation or warranty shall be true and correct
only as of such specified date), except, in the case of Section 3.01(b) or Section 3.01(c), for de minimis inaccuracies, (ii) the representation and warranty set forth in
Section 3.01(g)(i) (Absence of Certain Changes or Events) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of such date,
(iii) the 

  
 72 

 
representations and warranties of the Company set forth in Section 3.01(d)(ii) and (iii)(A) (Authority; Noncontravention) shall be true and correct in all
material respects (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” or words of similar import set forth therein) as of the date of this Agreement and as of the Closing Date as though
made on and as of such date (except for any such representation or warranty that is expressly made as of a specific date (including the date of this Agreement, in which case such representation or warranty shall be true and correct only as of such
specific date), and (iv) the representations and warranties of the Company set forth in Section 3.01 (other than the representations and warranties referred to in the foregoing clauses (i), (ii) and (iii)) shall be
true and correct in all respects (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and words of similar import set forth therein) as of the date of this Agreement and as of the Closing
Date as though made on and as of such date (except for any such representation or warranty that is expressly made as of a specified date (including the date of this Agreement), in which case such representation or warranty shall be true and correct
only as of such specified date), except, in the case of this clause (iv) only, where the failure of such representations and warranties to be so true and correct has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect; 
 (b)    Performance of Obligations of the Company. The
Company shall have performed in all material respects all obligations required to be performed by it under this Agreement on or prior to the Closing Date; and 

(c)    Certificate. Parent shall have received a certificate of the Chief Executive Officer or the
Chief Financial Officer of the Company, certifying that the conditions set forth in Section 6.02(a) and (b) have been satisfied. 

Section 6.03. Additional Conditions to Obligation of the Company. The obligation of the Company to effect the Merger is further
subject to the satisfaction or (to the extent permitted by Law) waiver on or prior to the Closing of the following conditions: 

(a)    Representations and Warranties. Each of (i) the representations and warranties of Parent
and Merger Sub set forth in Section 3.02(b)(i) (Authority) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as though made on and as of such date (except for any
such representation or warranty that is expressly made as of a specified date (including the date of this Agreement) in which case such representation or warranty shall be true and correct only as of such specified date) except for de minimis
inaccuracies and (ii) the representations and warranties of Parent and Merger Sub set forth in Section 3.02 (other than the representations and warranties referred to in the foregoing clause (i)) shall be true and
correct in all respects (disregarding all qualifications or limitations as to “materiality”, “material adverse effect” and words of similar import set forth therein) as of the date of this Agreement and as of the Closing Date as
though made on and as of such date (except for any such representation or warranty that is expressly made as of a specified date (including the date of this Agreement) in which 

  
 73 

 
case such representation or warranty shall be true and correct only as of such specified date), except in the case of this clause (ii) only, where the failure to such representations and
warranties to be so true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on Parent or Merger Sub’s ability to consummate the transactions contemplated by this
Agreement; 
 (b)    Performance of Obligations of Parent and Merger Sub. Each of Parent and
Merger Sub shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing Date; and 

(c)    Certificate. The Company shall have received a certificate of the Chief Executive Officer or
the Chief Financial Officer (or comparable officer) of Parent, certifying that the conditions set forth in Section 6.03(a) and (b) have been satisfied. 

ARTICLE VII 
 TERMINATION

 Section 7.01. Termination. This Agreement may be terminated and the Merger may be abandoned at any time prior to the
Effective Time, whether before or after (except as set forth below) the Company Requisite Vote is obtained: 

(a)    by mutual written consent of Parent and the Company; 

(b)    by either Parent or the Company: 

(i)    if the Merger shall not have been consummated on or before January 31, 2018 (such date or such
later date, if any, as provided in the proviso of this Section 7.01(b)(i), the “Termination Date”); provided, however, that if any of the conditions set forth in
Section 6.01(c) (solely with respect to any Order entered pursuant to the HSR Act or any other applicable antitrust or competition Law) or Section 6.01(d), 6.01(e), 6.01(f) or
6.01(g) shall not have been satisfied as of January 31, 2018 (or, if the extension described in clause (x) of this Section 7.01(b)(i) has occurred, March 31, 2018), (x) either Parent or the Company may
extend the Termination Date to March 31, 2018 and (y) following any extension described in clause (x) of this Section 7.01(b)(i), Parent, in its sole discretion, may further extend the Termination Date to
July 31, 2018; provided, further, that the right to terminate this Agreement pursuant to this Section 7.01(b)(i) shall not be available to any party if such party (or, in the case of Parent, Merger Sub)
has materially breached its obligations under this Agreement in a manner that shall have been the principal cause of or resulted in the failure of a condition to any party’s obligation to effect the Merger on or prior to such date; 

(ii)    if at the Company Shareholders Meeting (or any adjournment or postponement thereof), a proposal to
adopt this Agreement shall have been voted upon by the Company Shareholders and the Company Requisite Vote shall not have been obtained; 

  
 74 

 (iii)    if at the Parent Shareholders Meeting (or any
adjournment or postponement thereof), the Parent Shareholder Resolution shall have been voted upon by the Parent Shareholders and the Parent Requisite Vote shall not have been obtained; 

(iv)    if any Order permanently restraining, enjoining or otherwise prohibiting consummation of the
Merger shall have become final and non-appealable; provided, however, that a party may not terminate this Agreement pursuant to this Section 7.01(b)(iv) if such party
(or, in the case of Parent, Merger Sub) has not complied in all material respects with its obligations under Section 5.03. 

(c)    by the Company: 

(i)    at any time prior to obtaining the Company Requisite Vote and, subject to the Company being in
compliance in all respects with Section 4.02, in order to accept a Superior Proposal and enter into an acquisition agreement providing for such Superior Proposal, in accordance with Section 4.02,
concurrently with such termination; 
 (ii)    (A) if the Parent Board shall have effected a Parent
Adverse Recommendation Change or (B) if (1) the Parent Shareholders Meeting shall not have been convened or (2) the Parent Shareholders Meeting shall have been convened without a vote on the Parent Shareholder Resolution by the Parent
Shareholders having taken place, in the case of the foregoing clauses (1) and (2), by January 24, 2018 and in circumstances where Parent has not effected a Parent Adverse Recommendation Change; provided, however, that, with
respect to each of Section 7.01(c)(ii)(A) and 7.01(c)(ii)(B), the Company shall not have the right to terminate this Agreement pursuant to this Section 7.01(c)(ii) if the Parent Requisite
Vote shall have been obtained; 
 (iii)    if Parent or Merger Sub shall have breached any of their
respective representations or warranties or failed to perform any of their respective covenants or other agreements contained in this Agreement, where such breach or failure to perform (A) would give rise to the failure of a condition set forth
in Section 6.03(a) or 6.03(b) and (B) such breach is incapable of being cured or, if capable of being cured, is not cured prior to the earlier of (1) the forty-fifth (45th) day after written notice thereof is given by the Company to Parent and (2) the Termination Date; provided, however, that the Company shall not have the right to terminate this
Agreement pursuant to this Section 7.01(c)(iii) if the Company is then in material breach of this Agreement such that any of the conditions set forth in Section 6.02(a) or 6.02(b) would not
be satisfied; 

  
 75 

 (d)    by Parent: 

(i)    (A) if the Company Board shall have effected a Company Adverse Recommendation Change or (B) if
the Company shall have breached or been deemed to have breached (as provided in the last sentence of Section 4.02(a)) Section 4.02(a) in any material respect; provided, however, that,
with respect to each of Section 7.01(d)(i)(A) and 7.01(d)(i)(B), Parent shall not have the right to terminate this Agreement pursuant to this Section 7.01(d)(i) if the Company Requisite Vote
shall have been obtained; 
 (ii)    if the Company shall have breached any of its representations or
warranties or failed to perform any of its covenants or other agreements contained in this Agreement, where such breach or failure to perform (A) would give rise to the failure of a condition set forth in
Section 6.02(a) or 6.02(b) and (B) such breach is incapable of being cured, or if capable of being cured, is not cured prior to the earlier of (1) the forty-fifth (45th) day after written notice thereof is given by Parent to the Company and (2) the Termination Date; provided, however, that Parent shall not have the right to terminate this
Agreement pursuant to this Section 7.01(d)(ii) if either Parent or Merger Sub is then in material breach of this Agreement such that any of the conditions set forth in Section 6.03(a) or
6.03(b) would not be satisfied; or 
 (iii)    by Parent in its sole discretion if any
Governmental Entity shall institute any Proceeding challenging the validity or legality of, or seeking to restrain the consummation of, the transactions contemplated by this Agreement. 

Section 7.02. Effect of Termination and Abandonment. In the event of termination of this Agreement and the abandonment of the
Merger as provided in Section 7.01, written notice thereof shall be given to the other parties hereto, specifying the provision hereof pursuant to which such termination is made, and this Agreement shall forthwith become
void and of no effect, except as provided in the provisions of Section 5.04(b) (Access and Reports; Confidentiality), Section 5.08 (Expenses), this
Section 7.02, Section 7.03 (Termination Fee), Section 7.04 (Parent Termination Fee), Section 7.05 (VAT),
Section 7.06 (Costs and Expenses), Section 7.07 (Limitation) and ARTICLE VIII (Miscellaneous) and the Confidentiality Agreement, all of which shall survive such
termination; provided, however, that no such termination shall relieve any party hereto of any liability for damages to any other party hereto resulting from any Willful Breach by such party prior to such termination, and the aggrieved
party will be entitled to all rights and remedies available at law or in equity (including, in the case of a Willful Breach by Parent or Merger Sub, the right of the Company to pursue damages, which shall include the loss to the holders of Shares
and awards granted pursuant to the Company Equity Award Plans of the economic benefits of the Merger, including the loss of any premium associated with any amounts that would have been received by such holders in connection with the consummation of
the transactions contemplated hereby had such transactions been consummated in accordance with the terms hereof, it being understood that the Company (but not any holders of Shares or awards granted pursuant to the Company Equity Award Plans) shall
be entitled to pursue damages for such losses and to enforce the right to recover such losses on behalf of such holders in its sole and absolute discretion, and any amounts 

  
 76 

 
recovered in connection therewith shall be paid to the Company). The parties hereto acknowledge and agree that nothing in this Section 7.02 shall be deemed to affect
their right to specific performance under Section 8.11. 
 Section 7.03. Termination Fee. 

(a)    The Company shall pay Parent (or its designee) a fee equal to $7,500,000 (the “Termination
Fee”) if: 
 (i)    this Agreement is terminated by the Company pursuant to
Section 7.01(c)(i); 
 (ii)    after the date of this Agreement and prior to
the date of the Company Shareholders Meeting (or the date of any postponement or adjournment thereof, if applicable), a bona fide Acquisition Proposal shall have been publicly announced or otherwise publicly disclosed and not have been
withdrawn prior to the date of the Company Shareholders Meeting (or the date of any postponement or adjournment thereof, if applicable) and thereafter (A) this Agreement is terminated by Parent or the Company pursuant to
Section 7.01(b)(ii), and (B) (1) within twelve (12) months after such termination, the Company enters into a definitive agreement to consummate an Acquisition Proposal and such Acquisition Proposal is subsequently
consummated or (2) an Acquisition Proposal is otherwise consummated within twelve (12) months after such termination; or 

(iii)    after the date of this Agreement and prior to the Termination Date, a bona fide
Acquisition Proposal shall have been publicly announced or otherwise disclosed to the Company Board and not have been withdrawn as of the Termination Date and the Company, as of the Termination Date, shall have been in breach of this Agreement
such that Parent could have terminated this Agreement pursuant to Section 7.01(d)(ii) and thereafter (A) this Agreement is terminated by Parent or the Company pursuant to Section 7.1(b)(i),
and (B) (i) within twelve (12) months after such termination, the Company enters into a definitive agreement to consummate an Acquisition Proposal and such Acquisition Proposal is subsequently consummated or (2) an Acquisition
Proposal is otherwise consummated within twelve (12) months after such termination; or 

(iv)    this Agreement is terminated by Parent pursuant to Section 7.01(d)(i)(A)
or 7.01(d)(i)(B). 
 (b)    The Termination Fee shall be paid by wire transfer of immediately
available funds to an account designated by Parent (x) in the case of Section 7.03(a)(i), simultaneously with the termination of this Agreement pursuant to Section 7.01(c)(i), (y) in the case
of Section 7.03(a)(ii) or 7.03(a)(iii), on the date of consummation of such Acquisition Proposal and (z) in the case of Section 7.03(a)(iv), within three (3) Business Days of the
termination of this Agreement pursuant to Section 7.01(d)(i)(A) or 7.01(d)(i)(B), it being understood that in no event shall the Company be required to pay the Termination Fee on more than one occasion. Parent 

  
 77 

 
shall provide to the Company notice designating an account for purposes of payment of the Termination Fee within forty-eight (48) hours of a request by the Company to provide such
information. For purposes of this Section 7.03, the term “Acquisition Proposal” shall have the meaning assigned to such term in Annex I, except that all references to fifteen percent (15%) therein shall be
deemed to be references to fifty percent (50%) and shall exclude a MDS Sale. 
 Section 7.04. Parent Termination Fee. Parent
shall pay to the Company a fee equal to $7,500,000 (provided, however, that nothing in this Agreement shall require Parent to pay any amount which is in excess of that which is permitted to be paid without the prior approval of Parent
Shareholders pursuant to LR 10.2.7R of the Listing Rules and, accordingly, that such fee shall be reduced to the extent necessary to ensure prior Parent Shareholder approval of the payment of such fee is not required pursuant to LR 10.2.7R of the
Listing Rules) (the “Parent Termination Fee”) if this Agreement is terminated by (a) either Parent or the Company pursuant to Section 7.01(b)(iii) or (b) by the Company pursuant to
Section 7.01(c)(ii)(A) or 7.01(c)(ii)(B). The Parent Termination Fee shall be paid by wire transfer of immediately available funds within three (3) Business Days of the termination of this Agreement pursuant to
Section 7.01(b)(iii), 7.01(c)(ii)(A) or 7.01(c)(ii)(B), as applicable, it being understood that in no event shall Parent be required to pay the Parent Termination Fee on more than one occasion. The Company
shall provide to Parent notice designating an account for purposes of payment of the Parent Termination Fee within forty-eight (48) hours of a request by Parent to provide such information. 

Section 7.05. VAT. The parties anticipate that the Termination Fee and the Parent Termination Fee, if paid, being liquidated
damages and compensatory in nature, shall not be treated, in whole or in part, as consideration for a supply for VAT purposes. However, if the Termination Fee or the Parent Termination Fee, as applicable, is or is deemed to be consideration, in
whole or in part, for a supply for VAT purposes, then the amount of the Termination Fee or the Parent Termination Fee, as applicable, shall be reduced by an amount such that the sum payable by Parent or the Company, as applicable, when aggregated
with any VAT in respect thereof which is not eligible for recovery through either a VAT return or by a claim under the 13th directive, shall be equal to the amount of the Termination Fee or the Parent Termination Fee, as applicable, that would be
payable but for this Section 7.05. Such adjusting payment or payments as may be required between the parties to give effect to this Section 7.05 shall be made as soon as reasonably practicable.

 Section 7.06. Costs and Expenses. Each party acknowledges that the agreements contained in this ARTICLE VII are an
integral part of the transactions contemplated by this Agreement and that, without these agreements, such party would not enter into this Agreement. Accordingly, if the applicable party fails promptly to pay any amount due pursuant to this
ARTICLE VII, such party shall also pay any reasonable out-of-pocket costs, fees and expenses incurred by the other party (including reasonable legal fees and
expenses) in connection with a legal action to enforce this Agreement that results in a final non-appealable judgment for such amount against the party failing to promptly pay such amount. Any amount not paid
when due pursuant to this ARTICLE VII shall bear interest from the date such amount is due until the date paid at a rate equal to the prime rate as published in The Wall Street Journal, Eastern Edition, in effect on the date of such
payment. 

  
 78 

 Section 7.07. Limitation. 

(a)    The parties agree and understand that in no event shall the Company be required to pay the
Termination Fee on more than one occasion and in no event shall Parent be required to pay the Parent Termination Fee on more than one occasion. Notwithstanding anything to the contrary in this Agreement, if Parent or its designee, as applicable,
receives the Termination Fee from the Company pursuant to Section 7.03(a) or if the Company receives the Parent Termination Fee from Parent pursuant to Section 7.04, such payment, together with the
costs, fees or expenses payable pursuant to Section 7.06, shall be the sole and exclusive remedy of the receiving party against the paying party and its Subsidiaries and their respective former, current or future partners,
stockholders, managers, members, Affiliates and Representatives in connection with this Agreement or the transactions contemplated hereby and none of the paying party, any of its Subsidiaries or any of their respective former, current or future
partners, stockholders, managers, members, Affiliates or Representatives shall have any further liability or obligation relating to or arising out of this Agreement or the transactions contemplated hereby, in each case including with respect to any
Willful Breach. 
 (b)    Notwithstanding anything to the contrary in this Agreement, none of the
Financing Sources shall have any liability to the Company or any Person that is an Affiliate of the Company relating to or arising out of this Agreement, the Equity Financing or otherwise, whether at law, or equity, in contract, in tort or
otherwise, and neither the Company nor any Person that is an Affiliate of the Company shall have any rights or claims against any Financing Sources hereunder or thereunder. As used in this Agreement, the term “Financing Sources”
means any agent, arranger, lender or other Person that, in each case, (i) is not Parent or a Subsidiary of Parent and (ii) has committed to provide or arrange, or has entered into definitive agreements related to, the Equity Financing, or
any of such Person’s Affiliates or its or their respective officers, directors, employees, partners, trustees, shareholders, controlling persons, agents, representatives, successors or assigns. 

ARTICLE VIII 

MISCELLANEOUS 

Section 8.01. Non-Survival. None of the representations, warranties, covenants and
agreements in this Agreement or in any instrument delivered pursuant to this Agreement, including any rights arising out of any breach of such representations, warranties, covenants and agreements, shall survive the Effective Time, except for
(a) those covenants and agreements contained herein that by their terms apply or are to be performed in whole or in part after the Effective Time and (b) those contained in this ARTICLE VIII. 

Section 8.02. Modification or Amendment. Subject to the provisions of applicable Law, at any time prior to the Effective Time,
the parties hereto (in the case of the Company or Merger Sub, by action of their respective boards of directors to the extent required by Law) may modify or amend this Agreement by written agreement, executed and delivered by duly authorized
officers of the respective parties. 

  
 79 

 Section 8.03. Waiver. At any time prior to the Effective Time, any party hereto may
(a) extend the time for the performance of any of the obligations or other acts of the other parties, (b) to the extent permitted by Law, waive any inaccuracies in the representations and warranties of the other parties contained herein or
in any document delivered pursuant hereto and (c) subject to the requirements of applicable Law, waive compliance with any of the agreements or conditions of the other parties contained herein; provided, however, that neither
Parent nor Merger Sub may perform any of the actions set forth in the foregoing clauses (a), (b) and (c) with respect to Merger Sub or Parent, respectively. Any such extension or waiver shall be valid only if set forth in an instrument in
writing signed by the party or parties to be bound thereby and specifically referencing this Agreement. The failure of any party hereto to assert any rights or remedies shall not constitute a waiver of such rights or remedies. 

Section 8.04. Notices. All notices, consents, waivers, requests, claims, demands and other communications hereunder shall be in
writing and shall be deemed given if (a) on the date of delivery if delivered personally, (b) on the date of delivery if sent by overnight courier (providing proof of delivery) or (c) on the date of transmission if faxed (with
confirmation of transmission) or electronically mailed in portable document format (PDF) (with confirmation of transmission by the sender) and, in the case of this clause (c) confirmed with a copy delivered as provided in the foregoing clauses
(a) or (b), in each case to the parties at the following addresses (or at such other address for a party as shall be specified by like notice): 

if to Parent, to: 
 Ultra
Electronics Holdings plc 
 417 Bridport Road, Greenford 

Middlesex, UB6 8UA, UK 
 Fax
No.:         +44(0)20 8813 4322 
 Attention:       Sharon Harris,
Company Secretary and General Counsel 
 Email:
            Sharon.harris@ultra-electronics.com 
 with a copy to (which shall
not constitute notice): 
 Arnold & Porter Kaye Scholer LLP 

250 West 55th Street 

New York, New York 10019 
 Fax
No.:         (212) 836-6565 

                       
(202) 942-5999 
 Attention:       Nancy E. Fuchs, Esq. 

                       
Andrew J. Varner, Esq. 
 Email:            nancy.fuchs@apks.com 

                       
andrew.varner@apks.com 

  
 80 

 if to Merger Sub, to: 

Ultra Electronics Aneira Inc. 

c/o Ultra Electronics Inc. 
 107
Church Hill Road 
 Unit GL-2 

Sandy Hook, Connecticut 06482 

Fax No.:         (203) 270-3699 

Attention:       Scott Myers, VP Finance & Administration, NA 

Email:
            scott.meyers@ultra-na.com 

with a copy to (which shall not constitute notice): 

Arnold & Porter Kaye Scholer LLP 

250 West 55th Street 

New York, New York 10019 
 Fax
No.:         (212) 836-6565 

                       
(202) 942-5999 
 Attention:       Nancy E. Fuchs, Esq. 

                       
Andrew J. Varner, Esq. 
 Email:            nancy.fuchs@apks.com 

                       
andrew.varner@apks.com 
 if to the Company, to: 

Sparton Corporation 
 425 North
Martingale Road, Suite 1000 
 Schaumburg, Illinois 60173 

Fax No.:         (847) 762-5820 

Attention:       Joseph J. Hartnett 

Email:             Joseph.Hartnett@sparton.com 

with a copy to (which shall not constitute notice): 

Mayer Brown LLP 
 71 South
Wacker Drive 
 Chicago, Illinois 60606 

Fax No.:         (312) 706-8183 

Attention:       Frederick B. Thomas 

                       
Andrew J. Noreuil 
 Email:            fthomas@mayerbrown.com 

                       
anoreuil@mayerbrown.com 

  
 81 

 Section 8.05. Definitions. Capitalized terms used in this Agreement have the
meanings specified in Annex I. 
 Section 8.06. Interpretation. 

(a)    When a reference is made in this Agreement to an Article, a Section or an Exhibit, such
reference shall be to an Article or a Section of, or an Exhibit to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement. 
 (b)    Whenever the words “include”,
“includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation” and shall not be interpreted as limiting the category or class of items immediately preceding
such phrase. The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The word
“or” when used in this Agreement is not exclusive and the word “or” shall be deemed to mean “and/or”. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other
thing extends, and such phrase shall not mean simply “if”. 
 (c)    When a reference is made
in this Agreement or the Company Disclosure Letter to information or documents being “provided”, “made available” or “disclosed” to Parent or its Affiliates, such information or documents shall include any information
or documents (i) included in the SEC Reports filed with, or furnished to, the SEC by the Company publicly available at least two (2) Business Days prior to the date of this Agreement, (ii) furnished at least two (2) Business Days
prior to the date of this Agreement in the electronic “data room” maintained by the Company and to which access has been granted to Parent and its Representatives or (iii) otherwise provided in writing (including electronically) to
Parent or any of its Affiliates or Representatives. 
 (d)    All terms defined in this Agreement shall
have the meanings set forth herein when used in any certificate or document made or delivered pursuant hereto unless otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of
such terms and to the masculine as well as to the feminine and neuter genders of such term. 
 (e)    Any
agreement, instrument or statute defined or referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the
case of statutes) by succession of comparable successor statutes, and all attachments thereto and instruments incorporated therein. 

(f)    References to a Person are also to its permitted successors and permitted assigns but, if
applicable, only if such successors and assigns are not prohibited by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity. 

  
 82 

 (g)    Where this Agreement states that a party
“shall”, “will” or “must” perform in some manner, it means that the party is legally obligated to do so under this Agreement. 

(h)    The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If
an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provision of this Agreement. 
 Section 8.07. Counterparts. This Agreement may be executed in one or more counterparts
(including by facsimile or by attachment to electronic mail in portable document format (PDF), each of which shall be deemed an original to the other parties), and by the different parties hereto in separate counterparts, each of which when executed
shall be deemed an original but all of which taken together shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties
hereto. 
 Section 8.08. Parties in Interest. This Agreement shall be binding upon and inure solely to the benefit of the
parties hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement, other than (a) after the
Effective Time, with respect to the provisions of Section 5.09 which shall inure to the benefit of the Persons benefiting therefrom, who are intended to be third-party beneficiaries thereof, (b) after the Effective
Time, the rights of the holders of Shares (including Restricted Shares) to receive the Per Share Merger Consideration in accordance with the terms and conditions of this Agreement and (c) after the Effective Time, the rights of the holders of
Company RSUs and Company Options to receive the payments contemplated by the applicable provisions of Section 2.02, in each case, in accordance with the terms and conditions of this Agreement. The representations and
warranties in this Agreement are the product of negotiations among the parties hereto and are for the sole benefit of such parties. Any inaccuracies in such representations and warranties are subject to waiver by the parties hereto in accordance
with Section 8.03 without notice or liability to any other Person. In some instances, the representations and warranties in this Agreement may represent an allocation among the parties hereto of risks associated with
particular matters regardless of the knowledge of any of the parties hereto. Consequently, Persons other than the parties hereto may not rely upon the representations and warranties in this Agreement as characterizations of actual facts or
circumstances as of the date of this Agreement or as of any other date. 
 Section 8.09. Governing Law. This Agreement shall be
governed by, and construed in accordance with, the internal Law and judicial decisions of the State of Ohio applicable to agreements executed and performed entirely within such State, regardless of the Law that might otherwise govern under
applicable principles of conflicts of Law thereof. 

  
 83 

 Section 8.10. Entire Agreement; Assignment. This Agreement (including the Exhibits,
the Company Disclosure Letter and the Parent Disclosure Letter) and the Confidentiality Agreement constitute the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous
agreements and undertakings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof and thereof; provided, however, that nothing herein shall be deemed to limit or modify in any way the
rights or obligations of Parent, the Company or their respective Subsidiaries with respect to the joint venture between Parent, the Company and/or one of their Affiliates (“ERAPSCO”) or under or relating to the agreements between
the ERAPSCO joint venture parties and/or their Affiliates with respect to ERAPSCO. Neither this Agreement nor any of the rights, interests or obligations hereunder may be assigned, in whole or in part, by operation of law or otherwise by any of the
parties without the prior written consent of the other parties hereto. Any purported assignment in contravention of this Agreement is null and void and of no effect. Subject to the two immediately preceding sentences, this Agreement will be binding
upon, inure to the benefit of and be enforceable by the parties hereto and their respective successors and assigns. No assignment by any party shall relieve such party of any of its obligations hereunder. 

Section 8.11. Specific Enforcement; Consent to Jurisdiction. 

(a)    The parties hereto agree that irreparable damage for which monetary damages, even if available, may
not be an adequate remedy, would occur in the event that the parties hereto do not perform the provisions of this Agreement (including failing to take such actions as are required of it hereunder in order to consummate the transactions contemplated
by this Agreement) in accordance with its specified terms or otherwise breach such provisions. The parties hereto acknowledge and agree that each party hereto shall be entitled to an injunction, specific performance and other equitable relief to
prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which it is entitled at law or in equity. Each of the parties hereto further agrees that it will not oppose
the granting of an injunction, specific performance and other equitable relief as provided herein on the basis that (x) the other party has an adequate remedy at law or (y) an award of specific performance is not an appropriate remedy for
any reason at law or equity. Any party hereto seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required to provide any bond or other
security in connection with any such order or injunction. 
 (b)    Each of the parties hereto
irrevocably (i) submits itself to the personal jurisdiction of the state and federal courts located in Cleveland, Ohio and any appellate court therefrom, in connection with any matter based upon or arising out of or relating to this Agreement
or any of the transactions contemplated by this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement hereof and thereof, (ii) agrees that it will not attempt to deny or
defeat such personal jurisdiction by motion or other request for leave from any such court, (iii) agrees that it will not bring any action relating to this Agreement or any of the transactions contemplated by this Agreement

  
 84 

 
in any court other than the state and federal courts located in Cleveland, Ohio and (iv) consents to service being made through the notice procedures set forth in
Section 8.04; provided, that nothing in this Section 8.11 shall affect the right of any party to serve legal process in any other manger permitted by Law. Each of the Company, Parent and
Merger Sub hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth in Section 8.04 shall be effective service of process for any Proceeding in
connection with this Agreement or the transactions contemplated by this Agreement. Each party hereto hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any Proceeding with respect to
this Agreement, any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason other than the failure to serve process in accordance with this Section 8.11, that it or its property
is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or
otherwise), and to the fullest extent permitted by applicable Law, that the Proceeding in any such court is brought in an inconvenient forum, that the venue of such Proceeding is improper, or that this Agreement, or the subject matter hereof or
thereof, may not be enforced in or by such courts and further irrevocably waives, to the fullest extent permitted by applicable Law, the benefit of any defense that would hinder, fetter or delay the levy, execution or collection of any amount to
which any party is entitled pursuant to the final judgment of any court having jurisdiction. Each party hereto expressly acknowledges that the foregoing waiver is intended to be irrevocable under the Law of the State of Ohio and of the United States
of America; provided, however, that each such party’s consent to jurisdiction and service contained in this Section 8.11 is solely for the purpose referred to in this
Section 8.11 and shall not be deemed to be a general submission to said courts or in the State of Ohio other than for such purpose. 

Section 8.12. WAIVER OF JURY TRIAL. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY AND ALL RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT,
TORT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY OR THE ACTIONS OF PARENT, MERGER SUB OR THE COMPANY
IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF OR THEREOF. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER
PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO
THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 8.12. 

  
 85 

 Section 8.13. Severability. If any term or other provision of this Agreement is
found by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the transactions contemplated by this Agreement is not affected in any manner adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced,
the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in an acceptable manner to the end that the transactions contemplated by this Agreement are
fulfilled to the fullest extent possible. 
 Section 8.14. Transfer Taxes. All transfer, documentary, sales, use, stamp,
registration and other similar Taxes and fees (including penalties and interest, but excluding, for the avoidance of doubt, any Taxes based upon or measured by net income or gain) incurred in connection with the Merger shall be paid by Parent and
Merger Sub when due. 
 Section 8.15. Disclosure Letters. Certain items and matters are listed in the Company Disclosure Letter
and the Parent Disclosure Letter for informational purposes only and may not be required to be listed therein by the terms of this Agreement. In no event shall the listing of items or matters in the Company Disclosure Letter or the Parent Disclosure
Letter be deemed or interpreted to broaden, or otherwise expand the scope of, the representations and warranties or covenants and agreements contained in this Agreement. No reference to, or disclosure of, any item or matter in any Section of
this Agreement or any section or subsection of the Company Disclosure Letter or the Parent Disclosure Letter shall be construed as an admission or indication that such item or matter is material or that such item or matter is required to be referred
to or disclosed in this Agreement or in the Company Disclosure Letter or the Parent Disclosure Letter, as applicable. Without limiting the foregoing, no reference to, or disclosure of, a possible breach or violation of any Contract or Law in the
Company Disclosure Letter or the Parent Disclosure Letter shall be construed as an admission or indication that a breach or violation exists or has actually occurred. 

Section 8.16. Further Assurances. At and after the Effective Time, the officers and directors of the Surviving Corporation shall
be authorized to execute and deliver, in the name and on behalf of the Company or Merger Sub, any deeds, bills of sale, assignments or assurances and to take and do, in the name and on behalf of the Company or Merger Sub, any other actions and
things to vest, perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets of the Company acquired or to be acquired by the Surviving
Corporation as a result of, or in connection with, the transactions contemplated by this Agreement. 
 [Signature Page Follows] 

  
 86 

 IN WITNESS WHEREOF, the Company, Parent and Merger Sub have caused this Agreement to be signed
by their respective officers thereunto duly authorized, all as of the date first written above. 
  

					
	SPARTON CORPORATION
		
	By:	 	 /s/ Joseph J. Hartnett

		 	Name:	 	Joseph J. Hartnett
		 	Title:	 	Interim President & CEO
	
	ULTRA ELECTRONICS HOLDINGS PLC
		
	By:	 	 /s/ Rakesh Sharma

		 	Name:	 	Rakesh Sharma
		 	Title:	 	Chief Executive
	
	ULTRA ELECTRONICS ANEIRA INC.
		
	By:	 	 /s/ Thomas Link

		 	Name:	 	Thomas Link
		 	Title:	 	President

  
 [Signature page to
Agreement and Plan of Merger] 

 ANNEX I 

DEFINITIONS 

(a)    The following terms have the following meanings: 

“Acquisition Proposal” means any inquiry, proposal or offer from any Person (other than Parent, Merger Sub or their
respective Affiliates) relating to (i) a MDS Sale or any direct or indirect acquisition or purchase of a business in a single transaction or series of related transactions that constitutes more than fifteen percent (15%) of the net revenues,
net income or assets of the Company and its Subsidiaries, on a consolidated basis, or more than fifteen percent (15%) of the issued and outstanding Shares of the Company, (ii) any tender offer or exchange offer that if consummated would result
in any Person beneficially owning, directly or indirectly, more than fifteen percent (15%) of the issued and outstanding Shares of the Company, or (iii) any merger, reorganization, consolidation, share exchange, business combination,
recapitalization, liquidation, joint venture, partnership, dissolution or similar transaction involving the Company (or any Subsidiary or Subsidiaries of the Company whose business constitutes more than fifteen percent (15%) of the net revenues, net
income or assets of the Company and its Subsidiaries, on a consolidated basis). 
 “Affiliate” means, with respect to any
Person, any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first Person. 

“Applicable Jurisdiction” means (i) each of the jurisdictions listed in Section 8.05(a) of the Company Disclosure
Letter and (ii) each additional jurisdiction for which Parent reasonably determines, within fifteen (15) days of the Company providing the Company 2017 Data to Parent, a filing under applicable antitrust or competition Laws is mandatory
based on the Company 2017 Data. 
 “Business Day” means any day other than a Saturday or Sunday or a day on which banks in
the City of New York are required or authorized to be closed. 
 “CFIUS” means the Committee on Foreign Investment in the
United States, or any member agency thereof acting in its capacity as a CFIUS member agency. 
 “CFIUS Approval” means
(i) a written determination from CFIUS to the effect that the transactions contemplated by this Agreement do not constitute a “covered transaction” pursuant to 31 C.F.R. § 800.207, (ii) a written notice issued by CFIUS indicating
that CFIUS has made a determination there are no unresolved national security concerns with respect to the transactions contemplated by this Agreement and that CFIUS has concluded its review or investigation of the notification voluntarily provided
pursuant to the DPA with respect to the transactions contemplated by this Agreement, or (iii) if CFIUS has sent a report to the President of the United States requesting the President’s decision, then (A) the President has announced a
decision not to take any action to suspend or prohibit the transactions contemplated by this Agreement or (B) having received a report from CFIUS requesting the President’s decision, the President has not taken any action after fifteen
(15) days from the date the President received such report from CFIUS. 

  
 I-1 

 “Code” means the Internal Revenue Code of 1986, as amended. 

“Commonly Controlled Entity” means, with respect to a Person, any other Person that, together with such first Person, is
treated as a single employer under Section 414 of the Code. 
 “Company 2017 Data” means the revenues of the Company
and each of its Subsidiaries (aggregated and by entity) in each country outside of the United States for the fiscal year ended July 2, 2017. 

“Company Benefit Plan” means any (i) pension plan (as defined in Section 3(2) of ERISA) or post-retirement or
employment profit-sharing, insurance, health, medical or fringe plan, program, policy or arrangement, (ii) “employee benefit plan” (within the meaning of Section 3(3) of ERISA), (iii) bonus, incentive or deferred compensation or
equity or equity-based compensation plan, program, policy or arrangement (including the Company Equity Award Plans), (iv) severance, change in control, employment, consulting, retirement, retention or termination plan, program, agreement, policy or
arrangement or (v) other compensation or benefit plan, program, agreement, policy, practice, contract, arrangement or other obligation, whether or not in writing and whether or not subject to ERISA, in each case, sponsored, maintained,
contributed to or required to be maintained or contributed to by the Company, any of its Subsidiaries or any other Commonly Controlled Entity of the Company (A) for the benefit of any current or former director, officer or employee of the
Company or any of its Subsidiaries or (B) under which the Company or any Commonly Controlled Entity of the Company had or has any present or future liability, other than any (x) “multiemployer plan” (within the meaning of
Section 3(37) of ERISA) or (y) plan, program, policy or arrangement mandated by applicable Law. 
 “Company Disclosure
Letter” means the confidential disclosure letter dated as of the date of this Agreement delivered by the Company to Parent and Merger Sub. 

“Company Equity Award Plans” means the Sparton Corporation Stock Incentive Plan and the Sparton Corporation 2010 Long-Term
Incentive Plan. 
 “Company Intellectual Property” means any and all of the Intellectual Property Rights owned by the
Company or any of its Subsidiaries. 
 “Company Systems” means all Systems, including any and all outsourced systems and
processes that are owned or used by the Company or any of its Subsidiaries in the conduct of the business of the Company or any of its Subsidiaries. 

“Contract” means a contract, teaming agreement or arrangement, basic ordering agreement, purchase order, task order,
delivery order, change order, license, sublicense, lease, sublease, option, warrant, guaranty, indenture, note, bond, mortgage, estoppel certificate or other legally binding agreement or instrument, whether written or unwritten. 

“control” (including in the terms “controlling”, “controlled”, “controlled
by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a Person, whether through the ownership of voting securities, by
contract or otherwise. 

  
 I-2 

 “DDTC” means the U.S. Department of State’s Directorate of Defense Trade
Controls. 
 “DPA” means Section 721 of Title VII of the Defense Production Act of 1950 (50 U.S.C. § 4501
et seq), as amended by the Foreign Investment and National Security Act of 2007, including the implementing regulations thereof codified at 31 C.F.R. Part 800. 

“DSS” means the Defense Security Service of the United States Department of Defense. 

“Environmental Law” means any Law relating to (i) pollution or protection of the environment or natural resources,
including indoor and ambient air, soil, surface water or groundwater, sediment, flora and fauna, (ii) the exposure to hazardous, deleterious or toxic materials, human health or safety and (iii) the presence of, exposure to, or the
management, manufacture or other generation, use, storage, recycling, treatment, discharge, release, transportation, processing, disposal or remediation of Hazardous Materials. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Government Contract” means any Contract between the Company or any of its Subsidiaries, on the one hand, and (i) any
federal Governmental Entity of the United States, (ii) any prime contractor to any federal Governmental Entity of the United States or (iii) any subcontractor with respect to any Person described in the foregoing clauses (i) and (ii),
including ERAPSCO, on the other hand. A task, purchase or delivery order under a Government Contract will not constitute a separate Government Contract, for purposes of this definition, but will be part of the Government Contract to which it
relates. 
 “Governmental Entity” means any government or political subdivision, whether federal, state, local, non-U.S. or supranational, or any agency, authority, department, official or instrumentality of any such government or political subdivision, or any federal, state, local,
non-U.S. or supranational court or tribunal, body, board or any other entity exercising executive, legislative, regulatory (including a stock exchange), judicial, military, regulatory or administrative
functions of or pertaining to government, including public international organizations (e.g., the North Atlantic Treaty Organization and the United Nations). 

“Hazardous Materials” means any substance, waste or material defined, characterized or regulated as hazardous, acutely
hazardous, toxic, a pollutant or a contaminant, or that could reasonably be expected to result in liability, controls or restrictions under any applicable Environmental Law currently in effect, including petroleum, petroleum products, by-products and distillates, pesticides, dioxin, polychlorinated biphenyls, mold, biological hazards, asbestos and asbestos-containing materials. 

  
 I-3 

 “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended. 
 “Indebtedness” means, with respect to any Person, without duplication, other than trade payables entered into
in the ordinary course of business consistent with past practice, (i) all obligations of such Person for borrowed money, including accrued and unpaid interest, (ii) all obligations of such Person evidenced by bonds, debentures, notes or
similar instruments, (iii) any obligations of such Person under any lease of property, real or personal, which obligations are required to be classified as capital leases in accordance with GAAP, (iv) all obligations of others secured by a
Lien on property or assets owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (v) all letters of credit or performance bonds issued for the account of such Person and (vi) all guarantees and
keepwell arrangements of such Person of any obligation of any other Person other than a wholly owned Subsidiary of such Person. 

“Intellectual Property” means all information, materials and other subject matter that are covered by, or are embodiments
of, Intellectual Property Rights, including, by way of example, proprietary business methods and other inventions, works of authorship, artistic works and other subject matter that are covered by copyrights, trademarks, service marks, logos, domain
names, and all information subject to protection as trade secrets. For avoidance of doubt, without limiting the foregoing, Intellectual Property includes algorithms, formulae, protocols, software code (in any format, including Source Code and
executable formats), software documentation, books and reports, marketing and advertising content, audiovisual works, websites, system architectures and configurations, database schemas, non-public data, and
all electronic and digital records or any kind. 
 “Intellectual Property Rights” means any and all statutory and/or
common law intellectual property rights and all other intellectual or industrial property and proprietary rights throughout the world, including any of the following: (i) patents, patent applications and invention disclosures, including all
reissues, divisionals, provisionals, continuations and continuations-in-part, re-examinations, renewals, substitutions and
extensions thereof, and other Governmental Entity-issued indicia of invention ownership (including certificates of invention, petty patents and patent utility models) (collectively, “Patents”); (ii) trade secrets, know-how, inventions (whether or not patentable), discoveries, improvements, technology, business and technical information, databases, database rights, data compilations and collections (including knowledge
databases, customer lists and customer databases), tools, methods, processes, techniques and other confidential and proprietary information and all rights therein (collectively, “Trade Secrets”); (iii) moral rights, copyrights and
works of authorship, whether or not copyrightable, and all registrations, applications for registration, and renewals for any of the foregoing (collectively, “Copyrights”); (iv) trademarks, service marks, brands, certification
marks, logos, trade dress, rights in get-up, trade names and other similar indicia of source or origin, together with the goodwill connected with the use of and symbolized by, and all registrations,
applications and renewals for, any of the foregoing (collectively, “Trademarks”); (v) internet domain names and social media account or user names (including “handles”), whether or not Trademarks, all associated web
addresses, URLs, websites and web pages, and social media sites and pages, and all content and data thereon or relating thereto, whether or not Copyrights, together with all goodwill relating thereto (collectively, “Domain Names”);
(vi) 

  
 I-4 

 
unregistered design rights, design rights and rights in the nature of design rights, registered designs and all applications for registrations and renewals for any of the foregoing (collectively,
“Designs”); (vii) similar, corresponding or equivalent rights to any of the foregoing or any tangible embodiments thereof; and (viii) registrations and renewals of or applications to register any of the foregoing. 

“Intervening Event” means any material event, circumstance, change, effect, development, or condition that was not known to
the Company Board as of the date hereof (or if known, the consequences of which were not known to the Company Board as of the date hereof); provided, however, that (i) in no event shall the receipt, existence or terms of an
Acquisition Proposal constitute an Intervening Event and (ii) in no event shall any event, circumstance, change, effect, development, or condition arising out of or resulting from an MDS Sale or the actions contemplated by
Section 5.19, individually or in the aggregate, constitute an Intervening Event. 
 “IRS” means
the U.S. Internal Revenue Service. 
 “ITAR” means the U.S. Department of State’s International Traffic In Arms
Regulations, codified at 22 C.F.R. parts 120-130. 
 “Investment Canada Act” shall
mean the Investment Canada Act, R.S. 1985, c. 28 (1st Supp.), as amended. 
 “Knowledge” means (i) with respect to
the Company, the actual knowledge of any of the Persons set forth in Section 8.05 of the Company Disclosure Letter after reasonable inquiry and (ii) with respect to Parent or Merger Sub, the actual knowledge of any of the Persons set forth
in Section 8.05(b) of the Parent Disclosure Letter after reasonable inquiry. 
 “Law” means any federal, state, local
or non-United States law, statute, regulation, rule, ordinance, judgment, order, injunction or decree of any Governmental Entity, including treaties and conventions and the common law. 

“Licensed Intellectual Property” means any and all Intellectual Property Rights in which the Company or any of its
Subsidiaries holds any rights or interests granted from other Persons. 
 “Listing Rules” means the Listing Rules of the
UKLA made pursuant to Part VI of the Financial Services and Markets Act 2000. 
 “Material Adverse Effect” means any
Change that has a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that no Changes arising out of or resulting from any of
the following shall, either alone or in combination, constitute or contribute to a Material Adverse Effect: (i) Changes in the economy in the United States or elsewhere in the world, including as a result of changes in geopolitical conditions,
(ii) Changes that affect any of the industries in which the Company or any of its Subsidiaries do business, (iii) Changes in financial, debt, capital, credit or securities markets generally in the United States or elsewhere in the world,
including 

  
 I-5 

 
changes in interest rates, (iv) Changes in the stock price or trading volume of the Shares or credit rating of the Company or any of its Subsidiaries or any failure by the Company to meet
published analyst estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period, or any failure by the Company to meet its internal or published projections, budgets, plans
or forecasts of its revenues, earnings or other financial performance or results of operations for any period (it being understood that the Changes underlying any such Change or failure described in this clause (iv) that are not otherwise
excluded from the definition of a “Material Adverse Effect” may be considered in determining whether there has been a Material Adverse Effect), (v) Changes in any applicable Law or GAAP (or any principles or interpretations of GAAP),
(vi) an act of terrorism or an outbreak or escalation of hostilities or war (whether declared or not declared) or any weather related events, force majeure events or natural disasters, (vii) the execution and delivery of this Agreement or
the public announcement or pendency of the Merger or the other transactions contemplated by this Agreement, including any impact thereof on relationships, contractual or otherwise, with customers, suppliers, distributors, lenders, partners or
employees of the Company and its Subsidiaries, or any action taken or requirements imposed by any Governmental Entity in connection with the Merger or the other transactions contemplated by this Agreement, (viii) the performance by the Company
of this Agreement and the transactions contemplated by this Agreement, including compliance with the covenants set forth herein and any action taken or omitted to be taken by the Company at the written request of, as a result of an express
instruction by or with the prior written consent of, Parent or Merger Sub, (ix) the performance by the Company of its obligations under Section 5.19 relating to the MDS Sale, including any impact thereof on
relationships, contractual or otherwise, with customers, suppliers, distributors, regulators, lenders, partners or employees of MDS, (x) any actions or omissions of ERAPSCO undertaken by or at the direction of Parent or any of its Subsidiaries,
and any actions taken by Parent or any of its Subsidiaries in performing any of their obligations under or pursuant to the organizational documents of ERAPSCO or otherwise in connection with ERAPSCO and (xi) any matter disclosed in the Company
Disclosure Letter; provided, further, that, with respect to the foregoing clauses (i), (ii), (iii) and (vi), such Changes do not disproportionally adversely affect the Company and its Subsidiaries, taken as a whole, compared to the
other companies operating in the industries in which the Company and its Subsidiaries operate in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether there has been a Material Adverse
Effect. 
 “MDS” means the Company’s Manufacturing & Design Services segment. 

“NISPOM” means the National Industrial Security Program Operating Manual (DoD
5220.22-M). 
 “NYSE” means the New York Stock Exchange. 

“Object Code” means computer Software in binary form that, is intended to be directly executable by a computer after
suitable processing and linking but without the intervening steps of compilation or assembly. 
 “Open Source License”
means a license that is considered an “Open Source License” by the Open Source Initiative (www.opensource.org), including, for example, the GNU 

  
 I-6 

 
General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License (MPL), or any other license that may otherwise require, as a condition of use or distribution of the
Software licensed thereunder, that other Software incorporated into, derived from or distributed with, such Software (i) be disclosed or distributed in Source Code form, (ii) be licensed for purposes of preparing derivative works,
(iii) be redistributed at no charge, or (iv) be otherwise limited, restricted or conditioned with respect to any right or ability to use or distribute such Software. 

“Open Source Software” means any Software that is distributed as “free software,” “open source software”
or pursuant to any Open Source License. 
 “Parent Disclosure Letter” means the confidential disclosure letter dated as of
the date of this Agreement delivered by Parent to the Company. 
 “Permitted Liens” means (i) mechanics’,
materialmen’s, carriers’, workmen’s, repairmen’s, vendors’, operators’ or other like statutory Liens arising out of operation of Law, if any, for amounts that are not yet due and payable and were incurred in the
ordinary course of business, (ii) title defects (other than those constituting Liens for the payment of Indebtedness or Taxes and other than judgments and other involuntary Liens), if any, that do not or would not, individually or in the
aggregate, impair in any material respect the use, occupancy or marketability of the assets to which they relate, (iii) Liens for Taxes that are not yet due or payable or that are being contested by appropriate Proceedings and for which
appropriate reserves have been reflected on the most recent consolidated balance sheet of the Company included in the Applicable SEC Reports or notes thereto, (iv) Liens supporting surety bonds, performance bonds and similar obligations issued
in connection with the businesses of the Company and its Subsidiaries, (v) Liens that are disclosed on the most recent consolidated balance sheet of the Company included in the Applicable SEC Reports or notes thereto or securing liabilities
reflected on such balance sheet, (vi) Liens arising under or pursuant to the organizational documents of the Company or any of its Subsidiaries, (vii) grants to others of
rights-of-way, surface leases or crossing rights and amendments, modifications, and releases of
rights-of-way, surface leases or crossing rights in the ordinary course of business that do not or would not, individually or in the aggregate, impair in any material
respect, the use, occupancy or marketability of the Company Owned Real Property and the Company Leased Real Property, as applicable, as presently operated, (viii) Liens resulting from any facts or circumstances relating to Parent or any of its
Affiliates and (ix) Liens that do not and would not reasonably be expected to materially impair the continued use of a Company Owned Real Property or a Company Leased Real Property as presently operated. 

“Person” means an individual, corporation (including
not-for-profit), Governmental Entity, general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, unincorporated
organization, other entity of any kind or nature or group (as defined in Section 13(d)(3) of the Exchange Act). 
 “Personal
Data” means a natural person’s name, street address, telephone number, e-mail address, date of birth, gender, photograph, Social Security Number or Tax identification number, driver’s
license number, passport number, credit card number, bank account information and other financial information, account numbers, account access codes and passwords, or any other piece of information that allows the identification of such person or
enables access to such person’s financial information, or as that term is otherwise defined by applicable Law. 

  
 I-7 

 “Privacy Law” means any and all applicable Laws, rules, regulations and
guidance pertaining to privacy, data processing, data protection, data security, encryption, and confidentiality, including (i) directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of
individuals with regards to the processing of Personal Data and on the free movement of such data, including The General Data Protection Regulation (679/2016/EU); (ii) all national or other Laws implementing the Laws set forth in the foregoing
clause (i), including the UK Data Protection Act 1998; (iii) Subtitle A of Title V of the Gramm-Leach-Bliley Act and all regulations issued thereunder and any other federal and state financial privacy and information security Laws, and (iv) all
other applicable Laws relating to the processing of Personal Data in force 
 “Registered Intellectual Property” means any
and all United States, international and foreign: (i) Patents; (ii) Trademarks; (iii) Copyrights; (iv) Designs; and (v) other Intellectual Property Rights, in each case, that are the subject of an application, certificate,
filing, registration or other document issued, filed with, or recorded by any state, government or other public legal authority. 

“SEC” means the United States Securities and Exchange Commission. 

“SEC Reports” means all forms, statements, certifications, reports and other documents required to be filed or furnished by
the Company with the SEC, including (i) those filed or furnished subsequent to the date of this Agreement and (ii) all exhibits and other information incorporated therein and all amendments and supplements thereto. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Share Issuance” means the proposed issue of new ordinary shares by the Parent by way of placing in accordance with the
terms of the Placing Agreement. 
 “Software” means any and all (i) computer programs, including any and all software
implementations of algorithms, models and methodologies, whether in Source Code or Object Code, (ii) databases and compilations, including any and all data and collections of data, whether machine readable or otherwise, (iii) descriptions,
flow-charts and other work product used to design, plan, organize and develop any of the foregoing and (iv) all user documentation, including user manuals and training materials, relating to any of the foregoing. 

“Source Code” means computer Software and code, in form other than Object Code or machine readable form, including related
programmer comments and annotations, help text, data and data structures, instructions and procedural, object-oriented and other code, which may be printed out or displayed in human readable form. 

“Subsidiary” means, with respect to any Person, (i) any other Person (other than a partnership, joint venture or
limited liability company) of which more than 50% of the total voting power of shares of stock or other equity interests entitled to vote in the election of directors, managers or trustees is at the time of determination owned or controlled,
directly or 

  
 I-8 

 
indirectly, by such first Person and (ii) any partnership, joint venture or limited liability company of which (A) more than 50% of the capital accounts, distribution rights, total
equity or voting interests or general or limited partnership interests, as applicable, are owned or controlled, directly or indirectly, by such Person, whether in the form of membership, general, special or limited partnership interests or otherwise
or (B) such Person or any Subsidiary of such Person is a controlling general partner or otherwise controls such entity, but excluding, in each case, ERAPSCO with respect to the Company. 

“Superior Proposal” means a bona fide, unsolicited written Acquisition Proposal that did not result from a breach of
Section 4.02 and relating to any direct or indirect acquisition or purchase of (i) assets that generate more than fifty percent (50%) of the consolidated total revenues or operating income of the Company and its
Subsidiaries, taken as a whole, (ii) assets that constitute more than fifty percent (50%) of the consolidated total assets of the Company and its Subsidiaries, taken as a whole or (iii) more than fifty percent (50%) of the total voting
power of the equity securities of the Company, in each case, that the Company Board determines in good faith (x) is reasonably likely to be consummated in accordance with its terms, taking into account all legal, financial and regulatory
aspects of the proposal and the Person making the proposal and (y) if consummated, would result in a transaction more favorable to the Company’s shareholders from a financial point of view than the Merger (taking into account the most
recent Offered Amendment, if any, proposed by Parent). Notwithstanding anything to the contrary, no Acquisition Proposal for a MDS Sale shall constitute a Superior Proposal. 

“Systems” means computers, computer systems, workstations, computer hardware, computer software, data, databases,
documentation, designs, files, records, mask works, firmware, middleware, servers, networks, platforms, peripherals, data communication lines, routers, hubs, switches, and all other information technology equipment and other information technology
equipment and related systems, including Software and Technology. 
 “Tax” (including, with correlative meaning, the term
“Taxes”) means any and all taxes, including all U.S. federal, state, local and non-U.S. income, profits, franchise, gross receipts, environmental, customs duty, capital stock, severances,
stamp, payroll, sales, employment, unemployment, disability, government pension, estimated, use, property, withholding, excise, unclaimed property, production, value added, goods and services, harmonized sales, occupancy and other taxes, premiums
and duties or assessments in the nature of a tax in each case, imposed by a Governmental Entity, together with all interest, penalties and additions imposed with respect to such amounts and any interest in respect of such penalties and additions,
whether disputed or not. 
 “Tax Return” means any return, declaration, report, election, claim for refund or information
return or any other statement or form filed or required to be filed with any Governmental Entity relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof. 

“Technology” means all tangible items constituting, disclosing or embodying any or all of the following: technology,
technical information, know how, works of authorship, trade secrets, inventions (whether or not patented or patentable), show how, design rules, algorithms, routines, models, methodologies, Software, computer programs (whether Source Code or Object
Code), files, compilations, including databases processes, prototypes, schematics, netlists, test methodologies, development work and tools and all user documentation. 

  
 I-9 

 “UKLA” means the United Kingdom Listing Authority. 

“Willful Breach” means, with respect to any breach or failure to perform any of the covenants or other agreements contained
in this Agreement, a material breach that is a consequence of an act or failure to act undertaken by the breaching party with actual knowledge that such party’s act or failure to act would result in or constitute a breach of this Agreement. For
the avoidance of doubt, the failure of a party hereto to consummate the Closing when required pursuant to Section 1.02 shall be a Willful Breach of this Agreement. 

(b)    Each of the following terms is defined in the Section set forth opposite such term: 

 

			
	 Term
	  	 Section

	 Acceptable Confidentiality Agreement
	  	Section 4.02(c)
	 Affiliate Transaction
	  	Section 3.01(w)
	 Agreement
	  	Preamble
	 Applicable SEC Reports
	  	Section 3.01(e)
	 Balance Sheet
	  	Section 3.01(e)(v)
	 Balance Sheet Date
	  	Section 3.01(e)(v)
	 Book-Entry Shares
	  	Section 2.01(a)
	 Cancelled Shares
	  	Section 2.01(b)
	 Certificate
	  	Section 2.01(a)
	 Certificate of Merger
	  	Section 1.03
	 Changes
	  	Section 3.01(g)
	 Closing
	  	Section 1.02
	 Closing Date
	  	Section 1.02
	 Company
	  	Preamble
	 Company Adverse Recommendation Change
	  	Section 4.02(d)(i)
	 Company Articles of Incorporation
	  	Section 3.01(a)
	 Company Board
	  	Recitals
	 Company Board Recommendation
	  	Section 3.01(d)(ii)
	 Company Code of Regulations
	  	Section 3.01(a)
	 Company Employees
	  	Section 5.07(a)
	 Company Leased Real Property
	  	Section 3.01(p)(i)
	 Company Option
	  	Section 2.02(c)
	 Company Owned Real Property
	  	Section 3.01(p)(ii)
	 Company Preferred Stock
	  	Section 3.01(c)(i)
	 Company Real Property
	  	Section 3.01(p)(ii)
	 Company Real Property Lease
	  	Section 3.01(p)(i)
	 Company Registered Intellectual Property
	  	Section 3.01(q)(i)
	 Company Requisite Vote
	  	Section 3.01(s)
	 Company RSU
	  	Section 2.02(b)
	 Company Shareholders
	  	Recitals

  
 I-10 

			
	 Company Shareholders Meeting
	  	Section 3.01(d)(ii)
	 Company Transaction Representatives
	  	Section 4.02(a)
	 Confidentiality Agreement
	  	Section 5.04(b)
	 Continuation Period
	  	Section 5.07(a)
	 Costs
	  	Section 5.09(a)
	 Cutoff Date
	  	Section 3.01(c)(i)
	 Cyber Attacks
	  	Section 3.01(q)(vii)
	 D&O Insurance
	  	Section 5.09(c)
	 Dissenting Shares
	  	Section 2.05
	 DSS Approval
	  	Section 5.03(f)(iv)(A)
	 Effective Time
	  	Section 1.03
	 Equity Financing
	  	Section 3.02(i)(ii)
	 ERAPSCO
	  	Section 8.10
	 Exchange Fund
	  	Section 2.03(a)
	 Existing Letters of Credit
	  	Section 5.21
	 Export Control Laws
	  	Section 3.01(x)(i)
	 FAR
	  	Section 3.01(y)(vii)
	 FCPA
	  	Section 3.01(x)(v)
	 Financing Sources
	  	Section 7.07(b)
	 GAAP
	  	Section 3.01(e)(ii)
	 Government Bids
	  	Section 3.01(y)(i)
	 In-Licenses
	  	Section 3.01(q)(v)
	 Indemnified Parties
	  	Section 5.09(a)
	 Insurance Policies
	  	Section 3.01(o)
	 International Plan
	  	Section 3.01(l)(x)
	 IP Contracts
	  	Section 3.01(q)(vi)
	 Liens
	  	Section 3.01(b)
	 Major Customers
	  	Section 3.01(z)
	 Major Suppliers
	  	Section 3.01(z)
	 Material Contract
	  	Section 3.01(i)
	 Material Government Contracts
	  	Section 3.01(y)(i)
	 Maximum Annual Premium
	  	Section 5.09(c)
	 MDS Sale
	  	Section 5.19(a)
	 Merger
	  	Section 1.01
	 Merger Announcement
	  	Section 3.01(f)(ii)
	 Merger Sub
	  	Preamble
	 OFAC
	  	Section 3.01(x)(i)
	 Offered Amendment
	  	Section 4.02(d)(ii)
	 OGCL
	  	Section 1.01
	 Orders
	  	Section 6.01(c)
	 Other Company Representatives
	  	Section 4.02(a)
	 Out-Licenses
	  	Section 3.01(q)(vi)
	 Parent
	  	Preamble
	 Parent Adverse Recommendation Change
	  	Section 5.02(d)
	 Parent Board
	  	Recitals
	 Parent Board Recommendation
	  	Section 3.02(b)(ii)

  
 I-11 

			
	 Parent Organizational Documents
	  	Section 3.02(a)
	 Parent Requisite Vote
	  	Section 3.02(h)
	 Parent Shareholder Circular
	  	Section 5.02(a)
	 Parent Shareholder Resolution
	  	Section 3.02(h)
	 Parent Shareholders
	  	Recitals
	 Parent Shareholders Meeting
	  	Section 3.02(h)
	 Parent Termination Fee
	  	Section 7.04
	 Paying Agent
	  	Section 2.03(a)
	 Paying Agent Agreement
	  	Section 2.03(a)
	 Per Share Merger Consideration
	  	Section 2.01(a)
	 Permits
	  	Section 3.01(j)(ii)
	 Placing Agent
	  	Section 3.02(i)(ii)
	 Placing Agreement
	  	Section 3.02(i)(ii)
	 Proceeding
	  	Section 3.01(h)
	 Proxy Statement
	  	Section 5.01(a)
	 Prospective Purchasers
	  	Section 5.19(a)
	 Representatives
	  	Section 4.02(a)
	 Restricted Share
	  	Section 2.02(a)
	 Sarbanes-Oxley Act
	  	Section 3.01(e)(i)
	 SDNs
	  	Section 3.01(x)(ii)
	 Share
	  	Section 2.01(a)
	 SSA
	  	Section 5.03(f)(ii)
	 Surviving Corporation
	  	Section 1.01
	 Takeover Statutes
	  	Section 3.01(v)
	 Termination Date
	  	Section 7.01(b)(i)
	 Termination Fee
	  	Section 7.03(a)
	 Transaction Litigation
	  	Section 5.16
	 VAT
	  	Section 3.01(m)(vii)
	 Voting Company Debt
	  	Section 3.01(c)(iii)
	 WARN Act
	  	Section 3.01(k)(iii)

  
 I-12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]